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ABSTRACT
Background: Cardiovascular disease (CVD) remains among the leading causes of death
in the United States despite widespread knowledge about risk factors as well as effective
primary prevention strategies. Risk perception is a complex phenomenon that plays an
important role in how persons view disease and ultimately how they make health
behavior choices. This study is supported by the knowledge that few studies have
examined how persons perceive cardiovascular risk or the variables thought to contribute
to the formation of risk perception.
Purpose: The purpose of this study was to examine how accurately persons perceive
personal risk for cardiovascular disease and identify variables that contribute to the
formation of risk perception.
Methods: This study used a cross-sectional descriptive correlational design with adults
at least forty years old and without known cardiovascular disease. The nonprobability
convenience sample was recruited at health screenings held at multiple locations within a
single hospital system in Northwest Indiana. One hundred thirteen participants who could
read, write, and speak English completed the study booklet containing a compendium of
questions regarding knowledge and awareness of CVD from the American Heart
Association, as well as established tools to measure the key variables: the Cardiovascular
Risk Individual Perception instrument (CRIP) measuring risk perception, the Revised
Life Orientation Test (LOT-r) measuring optimism, the Life Engagement Test (LET)
measuring life satisfaction, and the Patient Health Questionnaire (PHQ-8) measuring
xvi

depression. Participants also consented to share physiological measurements and
laboratory results from the community screening program. Actual cardiovascular risk was
calculated using two tools: the Heart Health Scale (HHS; Wellsource screening tool) that
provides information on “current risk”, and the Framingham Risk Score (FRS) that
“projects one’s 10-year risk” for a cardiac event. The study was approved by the
institutional review boards from Loyola University Chicago, the hospital where the
screenings were held and the university where the investigator is on faculty.
Results: Study participants had a mean age of 58 years, 69% were female, 70% were
White Caucasian (non-Hispanic), and the majority were married, well-educated,
employed, and had private insurance. Overall the sample recognized heart disease as the
leading cause of death for men and women and could identify the key prevention steps to
reduce personal risk. While physiological measurements obtained during the screenings
revealed a relatively healthy group, with the majority of participants at goal for glucose,
LDL-C, HDL-C and triglyceride levels, the majority were also found to be either
overweight or obese, and physically inactive. Overall, 80% had two or more selfreported risk factors, and 43% had three or more.
Participants did accurately perceive their personal risk, with the
prevalence/number of self-reported risk factors being significantly correlated with higher
levels of risk perception as measured by the CRIP (r=.44, p < .01). HHS scores showed
that more than 55% of the participants were categorized as either “Needs Improving” or
“High Risk”, indicating the presence of multiple risk factors. HHS scores were also
statistically correlated with risk perception (r=-.40, p < .01). In addition, chi square
analysis showed a significant relationship between increased risk (using HHS) and
xvii

increased risk perception scores (using CRIP). Framingham Risk Scores, a measure of
projected future cardiac risk, were not correlated with current risk perception.
The majority of the sample had increased levels of optimism and life satisfaction
and low levels of depression. While three variables (having a friend with CVD,
optimism, and depression) were correlated with risk perception, depression was found to
be the single predictor when entered into multiple regression analysis (β = .278, p =
.003).
Implications for Providers: Community based health screenings play an important role
in primary prevention strategies. Although persons may accurately recognize that they
have risk factors for CVD, this alone may not be enough to prompt positive health
behavior changes. Persons often need further counseling to understand the role risk
factors play in subsequent subclinical atherosclerosis. While mass media campaigns
related to healthy eating, exercise, and heart disease have increased health literacy in this
area, health care providers need to be part of this dialogue since they are uniquely
positioned to counsel patients on effective methods for promoting positive health
behaviors.
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CHAPTER ONE
INTRODUCTION
Although much is known about cardiovascular risk factors and the subsequent
development of related co-morbid conditions, the United States and much of the world
continue to face cardiovascular disease (CVD) as the number one killer among the adult
population (American Heart Association [AHA], 2013). Risk factor modification is
crucial in reducing the development of CVD. The way an individual views risk has an
impact on decision-making and ultimately health behavior choices. Thus risk perception
plays an important role in primary prevention strategies. This study describes the
phenomena of risk perception and its related concepts and proposed relationships
between them. This introductory chapter provides support for the need for this study
through an overview of the problem of CVD, how primary prevention efforts can reduce
CVD, and the importance of risk perception in the design of intervention strategies. The
chapter ends with a description of the research questions for this study and their
significance.
Overview of the Problem of CVD
CVD encompasses coronary heart disease (CHD), peripheral vascular disease
(PVD), stroke, and heart failure (HF). It is estimated that one in every three adults has
some form of cardiovascular disease. Furthermore, 600,000 people die annually from
heart disease alone accounting for one in every four deaths in the United States (Centers
for Disease Control [CDC], 2013). These statistics are expected to increase as the
1
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population ages in the United States (AHA, 2013). Consequently, CVD will continue to
threaten lives and, in addition, have a great economic impact.
The economic burden of CVD is astounding. As cited in the 2013 update from the
AHA, the annual projected estimated direct and indirect costs of CVD in the United
States is $312.6 billion. Direct costs are defined in terms of financial cost of
hospitalization and treatment, while indirect costs are defined in terms of healthcare visits
and lost productivity. However, using a methodology to project future cost of care, it is
estimated that by 2030, 40.8% of the US population will have some form of CVD with
predicted costs topping $818 billion annually (AHA, 2013). Therefore, the importance of
CVD prevention is paramount because it not only reduces morbidity and mortality, but
also the associated economic burden.
Primary Prevention
There is overwhelming evidence to confirm that both modifiable and nonmodifiable risk factors contribute to the development of CVD. Therefore, risk factor
modification is crucial in reducing the development of CVD. The CDC and the National
Heart, Lung, and Blood Institute (NHLBI) have recognized that more emphasis needs to
be placed on primary prevention strategies in an effort to impact this growing problem
and reverse the “epidemic” of heart disease. “Primary prevention pertains to the
prevention of the onset of symptomatic disease in persons without prior symptoms of
cardiovascular disease” (Wilson & Pearson, 2005, p. 494). One example of primary
prevention in cardiovascular disease is to treat hypertension through lifestyle changes or
medications. Primary prevention interventions that target individuals at increased risk
have been proven successful in reducing the incidence of CVD and in decreasing
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morbidity and mortality (AHA, 2013; Bacon, Sherwood, Hindliter, & Blumenthal, 2004;
CDC, 2008; Crichley & Capewell, 2003; Warburton, Nicol, & Bredin, 2006; Wilson &
Pearson, 2005). Not only does risk factor reduction reduce atherogenesis through
endothelial stabilization, but it also prevents/addresses CVD and other co-morbid
conditions such as hypertension and obesity.
The AHA has emphasized that those adults who maintain healthy lifestyles and do
not present with traditional risk factors for CVD by approximately 50 years of age have a
greater likelihood of sustaining longevity (AHA, 2013). While many states fund primary
prevention programs, this author’s home state of Indiana remains an unfunded state,
despite ranking among the highest for total CVD and coronary heart disease (CHD). In
fact, Indiana is one of 12 states which has a multiple risk factor prevalence of greater than
40% (AHA, 2013). However, primary prevention cannot occur unless there is awareness
regarding the presence of risk factors and counseling on ways to address these risks.
Risk Perception
Even though knowledge and awareness about risk factors and CVD is crucial in
addressing its development, it is not enough. Examining areas that impact how
individuals view risk for the development of CVD and ultimately make decisions
regarding health behavior choices is crucial. In order to be effective, interventions will
need to be tailored to individual health beliefs and perception of risk for CVD
development. Thus, an underlying challenge for healthcare providers is to examine
individual risk perception for cardiovascular disease.
Risk perception implies that risk is perceived, not assigned or calculated. It
surrounds an individual on a daily basis; however, these risks all vary in degree. For
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example, risks related to which product to purchase is, overall, less threatening than risk
related to a health threat. The way in which an individual views risk has an impact on
decision-making and ultimately health behavior choices. Risk perception plays an
important role in primary prevention strategies. It is through cognitive realization that an
individual recognizes the threat of risk to their well-being. Once an individual realizes the
threat to well-being, prevention strategies can be utilized to foster health behavior choices
and ultimately prevent the onset of the threat.
Risk perception is not a new concept in the field of behavioral science. In fact, its
roots stretch back as far as the late 1970s. It has been studied in topics such as
environmental risk and consumer purchasing to examine why and how individuals form
perceptions related to risk. More recently, healthcare researchers have investigated risk
perception.
A large challenge to addressing individual risk perception is identifying how
perception is formed. In fact, risk perception is a multifaceted concept comprised of
overlapping concepts. Initially, risk perception was identified in the cancer literature, but
was actually being measured and reported as optimism and optimistic bias (Katapodi,
Lee, Facione, & Dodd, 2004). These areas have overlap both conceptually and
contextually. Therefore, the concepts of optimism and optimistic bias need to be explored
as they relate to risk perception. Although optimism and optimistic bias have been
studied in disease processes such as arthritis progression and breast, colon and skin
cancers, they have not been studied in depth in cardiovascular disease. In addition, the
concept of “negative emotions”, specifically depression, has emerged as yet another link
to risk perception and health behaviors. It has been purported that the opposite of
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optimism may not be pessimism, but actually depression. Lastly, the concept of life
purpose has been associated with risk perception. Thus, risk perception needs to be
viewed as a complex phenomenon with attention to how all these concepts contribute to
an individual’s risk perception. In doing so, new intervention strategies can be tailored to
increase health behavior choices that will ultimately affect morbidity and mortality
related to CVD development.
Significance/Research Questions
This study examines the concept of risk perception in cardiovascular disease. The
primary aims are to: examine the accuracy of one’s perceived risk for CVD; and to
examine the relationship between perceived risk and key demographic and psychological
variables that may influence risk perception. Therefore, this study is framed by the
following research questions:
1. Do persons perceive their risk for cardiovascular disease accurately?
2. Do the psychological variables of optimism, life purpose, and depressive symptoms
predict risk perception?
3. Do the sociodemographic variables (age, gender, family history, personal knowledge,
level of education, and socioeconomic status) predict risk perception? By
examining risk perception and the associated terms of optimism, life purpose,
optimistic bias, and negative emotions, it is this researcher’s hope that there will
be a greater understanding of the variables affecting health behavior
choices. Through this understanding, nurses can address more meaningful and
effective ways to assist persons to incorporate primary prevention strategies that
will impact and maintain optimal health.

CHAPTER TWO
LITERATURE REVIEW
There is little dispute that CVD causes both personal and social burden. Chapter
one explained how morbidity, mortality and economics are all affected by the epidemic
of CVD. Furthermore, a brief discussion of prevention highlighted the need to understand
the concept of risk perception and the related psychological variables of optimism, life
purpose, and depressive symptoms (or so called “negative emotions”). Before exploring
the literature on risk perception and its related variables, this chapter will begin with a
brief overview of the pathogenesis of atherosclerosis leading to CVD. Known risk factors
that contribute to atherosclerosis and CVD will be reviewed, including: smoking, obesity,
sedentary lifestyle, dyslipidemia, and hypertension. Benefits of reducing these risk
factors will be highlighted. Measurements for predicting an individual’s personal risk for
a future cardiac event will be discussed. Finally, the concept of risk perception will be
explored in depth, since successful risk factors reduction cannot occur unless individuals
are aware of their personal CVD risk.
Atherogenesis
The Endothelium
The relationship between endothelial dysfunction and cardiovascular events has
been clearly established, with endothelial dysfunction found to be an independent
predictor of future cardiac events (Gokce et al., 2002; Halcox, et al., 2002; Perticone et
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al., 2001). The function of the endothelium is complex as it acts to maintain both
homeostasis and hemostasis within the vascular bed (Corti, Fuster, & Badimon, 2003;
Davignon & Ganz, 2004; Halcox et al., 2002). The healthy endothelium exhibits
atheroprotective properties that include promotion of vasodilation; anti-inflammatory,
anticoagulant, and profibrinolytic effects, while inhibiting leukocyte adhesion and
migration, smooth muscle cell proliferation and migration, and platelet aggregation and
adhesion (Bonetti, Lerman, & Lerman 2003). Conversely, when these properties are
disrupted and the endothelium becomes less stable, atherogenic manifestations take place.
Plaque Formation
Atherogenesis is an immune/inflammatory response that develops as a complex,
cascading process (Glass & Witzum, 2001). The evolution of atherosclerotic lesions
progess through a multi-step process including: endothelial injury, monocyte migration,
lipid accumulation, smooth muscle cell proliferation and cap formation, lipid core
formation, plaque vascularization, plaque remodeling, and plaque progression (Gotto &
Pownall, 2003). This can be further broken down into the following three distinct stages:
the fatty streak, the fibrous plaque, and plaque progression.
The fatty streak is characterized by the accumulation of intercellular lipids and
foam cells within the intimal lining of the artery and is the hallmark of both early and late
developing atherosclerotic lesions (Glass & Witzum, 2001). The formation of the fatty
streak is initiated by impairment of the endothelium leading to inflammation within the
vessel wall. Cardiovascular risk factors such as dyslipidemia, hypertension, and smoking
contribute to the inflammatory process and oxidative stress (Ross, 1999; Schlächinger &
Zeiher, 2002). The resultant oxidative process allows monocyte-derived macrophages to
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invade the intimal lining of the artery. Monocytes are present in all phases of
atherogenesis (Ross, 1999; Schlächinger & Zeiher, 2002). Cellular mediators of the
inflammatory process play a key role in the low density lipoprotein cholesterol (LDL-C)
particles binding to the endothelium. Once there, circulating LDL-C particles become
engulfed by the macrophages and transform into foam cells, which contain liquid
cholesterol esters (Ross, 1999). This process contributes to more inflammation and a
vicious cycle ensues, as long as the LDL particles are present.
The fibrous plaque is characterized by smooth muscle cell migration from the
medial to the intimal layer of the endothelium (Ross, 1999). Platelets and macrophages
stimulate the proliferation of smooth muscle cells and allow a fibrous matrix to form. The
core beneath the cap contains degenerating foam cells, which are full of lipids and
cholesterol esters.
Plaque progression leads to the increase in size and density of the lesion as the
inflammatory process progresses. The progressive stage of the process allows the lesions
to encroach into the lumen of the vessel, compromising blood flow (Ross, 1999). It is at
this point that the plaque will calcify or rupture, depending on the morphology of the
particular lesion.
The formation and morphology of plaque plays a significant role in the diagnosis
and treatment of cardiovascular disease. Plaque can be categorized as stable or unstable.
Stable plaque is morphologically different from unstable plaque. The formation of the
fibrous plaque and the size of the lipid core are directly related to endothelium function
and dysfunction.
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Stable plaque develops a thick, uniform fibrous cap, which is less likely to rupture
(Ross, 1999). Over time, calcification of the lesions develops and encroachment of the
vessel lumen occurs. Conversely, unstable plaque is described as more prone to rupture
due to a thinner, uneven fibrous cap and larger lipid core (Fayad & Fuster, 2001; Ross,
1999). As the lesion grows, the vessel lumen may also narrow. The continuation of
oxidative stress and inflammation, the same processes that contribute to the cascade of
endothelial dysfunction, also contribute to plaque destabilization and fibrous cap thinning
(Ross, 1999; Schlächinger & Zeiher, 2002). Unstable plaque has been linked to acute
coronary syndrome (ACS), unstable angina, acute myocardial infarctions, and sudden
cardiac death (SCD).
Risk Factors
The development of coronary artery disease (CAD) has long been linked to
known risk factors, thus identification of one’s risk factors is key to stemming this tide.
Large national and international studies have consistently reported that nine potentially
modifiable risk factors account for greater than 90% of the risk of an acute myocardial
infarction (MI) (Yusuf et al., 2004). Moreoever, it is estimated that more than 90% of
CVD events occur in persons with a single risk factor (Vasan et al., 2005). Each risk
factor contributes to the complex dynamic of endothelial function and dysfunction and
the subsequent development of CAD (Bonetti et al.; 2003; Corti et al., 2003; Lerman &
Zeiher, 2005; Ross, 1999). Risk factor reduction has been shown to reduce the incidence
of cardiovascular disease and is clearly supported by literature. Risk factor reduction
strategies have confirmed increased stabilization of the endothelium as well as decreased
morbidity and mortality from cardiovascular disease. Risk factor reduction is significant

10
because many strategies impact more than one risk factor. For example, implementing a
walking program not only addresses the risk of physical inactivity, but also affects weight
and obesity. Likewise, smoking cessation would impact the negative effects of smoking
in addition to high density lipoprotein cholesterol (HDL-C) levels. For the purposes of
this paper, smoking, obesity, sedentary lifestyle, dyslipidemia, hypertension, and
depression are discussed related to both endothelial dysfunction and the subsequent
impact of risk factor modification.
Smoking
While smoking is commonly discussed as the leading cause of lung cancer, it also
greatly affects the number of deaths related to cardiovascular disease. Globally, smoking
causes 5 million deaths annually and is expected to climb to at least 8 million by 2030
(CDC, 2013). Furthermore, smoking triples the risk of dying from heart disease among
middle-aged men and women and, on average, men die 13 years sooner and women die
14.5 years sooner than their non-smoking counterparts (AHA, 2013). Both active and
passive (second-hand) smoking contributes to atherogenesis. In addition, smoking
contributes to physiologic conditions such as hypertension and decreases high density
lipoprotein (HDL) cholesterol (AHA, 2013). Furthermore, when smoking is combined
with other risk factors the synergistic effect substantially raises the risk for CVD.
Roth and Shick (1958) described the effects of smoking on the cardiovascular
system, stating that early investigation of smoking and cardiovascular damage dates back
to 1848. Since that time, scientists have continued to study and document the deleterious
effects of smoking on the human body. Early descriptions of “heart dysfunction” have
more recently been replaced with scientific knowledge that smoking adversely affects
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vascular endothelial function, which leading to cardiovascular disease (Newby et al.,
2001; Ross, 1999; U.S. Department of Health and Human Services, 2004). Smoking
disrupts endothelial homeostasis and hemostasis leading to atherothrombosis (Newby et
al., 2001). In addition, smoking is not only associated with CAD, but also with sudden
cardiac death (SCD). The incidence for SCD is related to impaired hemostasis,
endothelial dysfunction, and atherothrombosis (Newby et al., 2001).
Crichley and Capewell (2003) conducted a systematic review to determine the
effects of smoking cessation on cardiovascular risk. A total of 20 prospective cohort
studies were used from a screening of 665 publications. The authors included studies that
reported all-cause mortality data, patients diagnosed with CHD, and those with a followup of at least two years. Conclusions from this review state that smoking cessation is
correlated with a substantial decrease in all-cause mortality among persons with CHD.
The World Health Organization (WHO) reported a dramatic 50% reduction in CHD risk
one year after quitting smoking. In addition, smoking cessation decreases the risk of
dying prematurely (CDC, 2013).
Obesity
Obesity is a complex risk factor for CAD. Although it is an independent CVD risk
factor, it is also closely related to other risk factors such as physical inactivity,
hypertension, lipid abnormalities, elevated C-reactive protein (CRP) and insulin
resistance. Since 1993, the prevalence of obesity has steadily increased and forecasts that
by 2030 more than 51% of the population will be obese (AHA, 2013). Public health
officials have recognized the detriments on health related to obesity and have stated that
the continuation of current trends may negate gains made in treatment of heart disease
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and other chronic diseases (Fontaine, Redden, Wang, Westfall, & Allison, 2003).
Furthermore, obesity is associated with a shortened lifespan, especially among younger
adults (Fontaine et al., 2003).
Obesity is associated with increased coagulopathy, endothelial dysfunction and
inflammation. Moreoever, there are many metabolic effects that are derived from adipose
tissue that can mediate the development of atherosclerosis: secretion of tumor necrosing
factor-alpha (TNF-α), interluken 6, and plasminogin activator inhibitor. Abdominal
adiposity carries a higher risk than general adiposity (Warziski, Choo, Novak, & Burke,
2008).
The contribution of general obesity to atherosclerosis has been debated. While the
Seven Countries Study showed little correlation between body weight and
atherosclerosis, both the Framingham Heart Study and the Pathobiological Determinants
of Atherosclerosis in Youth (PDAY) Study demonstrated a clear association between
obesity and atherosclerosis (Grundy, 2002). Grundy proposed that variability among
groups may help to explain the differences. For example, the PDAY study found that
obesity was associated with atherosclerosis in adolescent and young men, but not in their
female counterparts (McGill et al., 2002). Similarly, McKeigue and colleagues (1993)
found that moderate weight gain increased the risk for CHD in South Asians. Further
explanation may lie within the endothelial dysfunction mechanisms specific to obesity.
Grundy (2002) suggested that obesity acts as a mediator through emerging risk factors
including insulin resistance, C-reactive protein, and plasminogen activator inhibitor-1.
Therefore it may be a stronger and more complex risk factor than originally thought.
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Hotamisligil, Shargill, and Spiegelman (1993) were among the first to establish the
link between obesity and factors affecting endothelial dysfunction, namely tissue necrosis
factor-alpha (TNF-α). They used rodent models to identify how obese animals differed
from the lean control models. At this time, TNF-α was already known to affect serum
triglycerides and very low density lipoproteins (VLDLs). The results of their study
indicated that the obese animals produced a minimum of five to ten times the amount of
TNF-α mRNA than the lean control animals. Since this landmark study, the relationship
between obesity and endothelial dysfunction continues to be supported and informed
(Dandona, Aljada, Chaudhuri, Mohanty, & Garg, 2005; Rutter, Meigs, Sullivan,
D’Agostino, & Wilson, 2004; Ziccardi, et al., 2002).
Since obesity contributes to other traditional risk factors, such as hypertension,
hyperlipidemia, and increased glucose values, weight loss also has a dramatic effect on
these variables. Anderson, Konz, Frederich, and Wood (2001) conducted a meta-analysis
of eleven studies and concluded that the effect of weight loss systematically modifies risk
factors for CHD, thereby reducing overall risk from CHD. While modification of this
factor has the potential to greatly impact overall cardiovascular risk, the high rate of
recidivism with weight loss programs poses a significant challenge.
Sedentary Lifestyle
Sedentary lifestyle has been identified as a cardiovascular risk factor since the
1970s. It is closely related to the risk factors of obesity and hypertension. In addition,
sedentary lifestyle has an impact on the lipid profile, especially high density lipoprotein
cholesterol (HDL-C). Given these factors, physical inactivity, like obesity, has the
potential to not only impact these related risk factors, but overall cardiovascular risk.
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Trends have shown that with the advances in modern technology and changes in
transportation modes American have adopted a more sedentary lifestyle. Most American
adults are not physically active on a regular basis. In fact, more than 50% of adults in the
United States do not engage in enough physical activity to gain any health benefits
(CDC). This resultant lack of physical activity is associated with an increased risk for
CVD and all-cause mortality (Blair & Church, 2004).
While there is an established relationship between sedentary lifestyle and
cardiovascular health, exact pathways and mediating mechanisms continue to be explored
(Mora, Cook, Buring, Ridker, & Lee, 2007). Novel risk factors such as homocysteine,
creatinine, C-reactive protein (CRP), and other inflammatory biomarkers are examples of
potential mediating mechanisms that may explain the role sedentary lifestyle plays in
reducing CVD.
Physical activity is related to increased health benefits. Not only can enough
physical activity help to achieve or maintain a healthy weight, but it can also help lower
blood pressure, triglycerides, insulin resistance and glucose intolerance, and enhance
HDL cholesterol levels (CDC, 2008). At the cellular level, increased physical activity has
an antioxidant effect, thereby stabilizing the endothelium (Harrison et al., 2006). Harrison
and colleagues (2006) reported that increased blood flow, produced by increased activity,
within the vasculature provides laminar shear stress. In turn, nitric oxide production
increases which results in decreased inflammation in the endothelium. Chronic or
habitual physical activity, therefore, provides a lasting and protective effect on the
endothelium.
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The level of physical activity needed to provide health benefits is referred to as dose
response. This is important because many people have limitations that allow for only low
to moderate levels of physical activity. The level of physical activity does not need to be
strenuous or intense to provide health benefits (Church, Earnest, Skinner, & Blair, 2007).
Current recommendations suggest adults need to accumulate 150 minutes per week of
moderate level aerobic exercise such as walking, bicycle riding, water aerobics, or
playing doubles tennis. This prescription can be completed in 10 minute intervals if
preferred (CDC, 2013).
Dyslipidemia
The traditional components of the lipid profile have been studied at length. Low
density lipoprotein cholesterol (LDL-C) has been shown to contribute to plaque
development, while high density lipoprotein cholesterol (HDL-C) has been shown to be
atheroprotective. Research data has consistently shown through major trials such as The
Helsinki Heart Study, Multiple Risk Factor Intervention Trial (MRFIT), and the Seven
Countries Study that when these components are maintained at recommended levels, the
endothelium remains healthier and poses less risk for the development of CVD and CVD
related mortality. More recently, focus has shifted to more specific subcomponents of the
lipid profile, such as apolipoprotein subgroups. However, since the focus of this paper is
to provide an overview of risk factors, only the traditional components will be discussed.
LDL-C plays a significant role in the development of atherogenesis via the
oxidative process. Oxidation of LDL particles stimulates the release of a host of negative
factors such as interleukin-6 and tumor necrosis factor-alpha from the endothelial cells
and macrophages. This contributes to stimulating the inflammatory process, causing
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further endothelial dysfunction. In addition, LDL-C contributes to direct injury of the
endothelial lining and underlying vascular smooth muscle (Ross, 1999; Vogel, 1999).
Very low density lipoprotein cholesterol (VLDL) also contributes to oxidation and
inflammation within the endothelium (Libby, Ridker, & Masseri, 2002).
A large body of studies from epidemiological, angiographic outcomes trials, and
randomized controlled trials consistently support the evidence that lowering LDL
cholesterol has a positive effect on CVD prevention. This evidence served as the basis for
The National Cholesterol Education Program (NCEP) first issued in 1985. This program
and the two subsequent panels provide clear directives and strategies for reaching
primary prevention goals. Strategies for improving the lipid profile include lifestyle or
behavioral changes and medication therapy (ATP III, 2004). NCEP refers to the nonpharmacologic measures as Therapeutic Lifestyle Changes (TLC). The TLC diet consists
of limiting total fat intake to 25-35% of diet (with up to 20% of this from
monounsaturated fat), saturated fat to less than 7% of total calories, 20-30 grams of high
fiber foods, increased levels of fruits and vegetables and addition, of plant sterols. This
diet is supported by the American Heart Association to decrease the risk of CVD (AHA,
2013). For primary prevention, this diet should be monitored for six weeks, and if not at
goal, another six week trial should be prescribed. After those efforts, pharmacological
therapy is recommended to treat any persistent dyslipidemia. Medications that lower
both LDL-C and total cholesterol while increasing HDL-C have consistently shown
reduction in mortality related to CVD. In particular HMG CoA reductase inhibitors, or
statins reduce endothelial inflammation through decreased oxidative stress (Libby et al.,
2002; Vogel, 1999).
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Hypertension
Approximately 77.9 million Americans over the age of 20 have high blood pressure
(AHA, 2013). This startling statistic translates to slightly more than one in every three
adults. While the etiology for the majority of hypertension is unknown, the disease can be
easily identified through screening and treated in a variety of ways. Hypertension is not
only one of the major risk factors for CVD, but is also a co-morbid condition with serious
health consequences. Hypertension has been studied in many epidemiological studies
such as the Framingham Heart Study, followed by an extensive number of randomized
control trials that showed that antihypertensive drug therapy works to reduce the risk of
CVD events.
Hypertension causes vascular damage including impaired endothelium-dependent
vasodilation, decreased production of nitric oxide, increased resistance in the coronary
vasculature and atherosclerotic narrowing of the coronary arteries. With hypertension, the
endothelium is subjected to increased shear stress that also results in inflammation (Libby
et al., 2002). Libby and colleagues suggest that the inflammatory process may be the link
between hypertension and CVD. Angiotensin II, which is part of the physiologic process
of hypertension not only causes vasoconstriction, but also instigates endothelial
inflammation.
Lifestyle modifications are an essential component of prevention and treatment of
hypertension. These treatments include dietary management, weight loss, and exercise.
Dietary Approaches to Stop Hypertension (DASH) eating plan is one of the most
successful adjuncts to decreasing blood pressure. The original DASH study and the
second DASH study both demonstrated that adherence to this program resulted in a
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decrease in blood pressure (Bacon et al., 2004). The Premier study, which utilized the
DASH eating plan and other lifestyle modifications, showed similar findings (Lien et al.,
2007). The DASH eating plan utilizes a modest amount of sodium and increased amounts
of fruits and vegetables, and is recommended by the American Heart Association and the
National Heart, Lung, and Blood Institute.
Pharmacologic treatment of hypertension is guided by the Joint National Committee
guidelines (JNC). The most recent guidelines recommend a variety of medications
including thiazide diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin
II receptor blockers (ARBs), beta blockers, and calcium channel blockers based on
compelling indications. ACE-I and ARBs interrupts the pathways that lead to the
inflammatory process (Libby et al., 2002). Furthermore, ACE inhibitors affect
fibrinolysis and coagulation, further stabilizing the endothelium. Consequently, research
has demonstrated that these two classifications of medications used to treat hypertension
have demonstrated a decrease in both cardiovascular related events such as myocardial
infarction and mortality related to CHD.
Depression
Psychosocial components are becoming more widely recognized as risk factors for
CVD. Initially, the “type A” behavior was considered as a risk factor. More recently,
other psychosocial components such as depression, anxiety, and personality traits have
been recognized as more significant contributing factors to CVD (Elovainio et al., 2005;
Frasure-Smith & Lespérance, 2006; Rosansky & Kubzansky, 2005). In fact, the
prevalence of depression is nearly three times higher in those with CVD (Thombs, 2005).
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While there are various psychosocial factors discussed in the literature, this paper will
focus on depression.
It is important to distinguish between depression and the presence of depressive
symptoms. Rozanski, Blumenthal, and Kaplan (1999) describe depression as the presence
of depressed mood and a marked decrease in all activities that persists for at least two
weeks. In addition, this mood alteration is also accompanied by at least two of the
following symptoms: “changes in appetite, sleep disturbance, fatigue, psychomotor
retardation or agitation, feelings of guilt or worthlessness, problems concentrating, and
suicidal thoughts” (p. 2193). Depressive symptoms may have components of clinical
depression, but lack sufficient magnitude to be classified as such. Rozanski and
colleagues outlined the presence of a threefold higher depression rate among those with
CAD. In addition, these authors also highlight that the risk for CAD is associated with the
degree of depressive symptoms, suggesting that depression manifests itself on a
continuum.
Depression and the presence of depressive symptoms affect endothelial function in
three different ways. First, increases in cortisol results in the promotion of central
adiposity, insulin resistance and development of diabetes (Rozansky, Blumenthal,
Davidson, Saab & Kubzansky, 2005). Second, increased platelet reactivity and
hypercoagulability develops which contributes to prothrombotic properties in the
endoethelium (Matthews, Schott, Bromberger, Cyranowski, Everson-Rose, & Sowers,
2007; Miller, Rohleder, Stetler, & Kirschbaum, 2005; Rozansky et al., 2005). Lastly,
inflammation increases within the endothelium and is demonstrated, in part, by increases
in C-reactive protein, interleukin-6, and tumor necrosing factor (Barr-Taylor et al., 2006;
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Rozansky et al., 2005). Thus, strong evidence demonstrates the relationship between
depression and depressive symptoms and endothelial dysfunction that leads to the
development of CVD. Biobehavioral mechanisms are also responsible for the link
between depressive symptoms and depression to cardiovascular disease. Both have been
shown to contribute to behaviors leading to other risk factors for CVD. This complexity
poses a challenge for adherence to both treatment modalities for depression and other
underlying risk factors for CVD (DiMatteo, Lepper & Croghan, 2000).
Similar to other risk factors, depression and manifestation of depressive symptoms
can be successfully treated with both behavioral and pharmacological interventions
(Blumenthal et al., 2007). Pharmacological treatments for depression have been studied
both for safety and efficacy, with several classes of antidepressants, most notably
selective serotonin reuptake inhibitors (SSRIs), and found to be quite effective.
Psychosocial and behavioral interventions have not been explored in as much depth.
Types of psychosocial intervention have included: one on one counseling, group
counseling, educational programs, and physiologic stress management to name a few.
Further research should be conducted in the area of psychosocial and behavioral
intervention to elucidate the effectiveness of these techniques (Frasure-Smith &
Lespérance, 2006; Rosansky & Kubzansky, 2005). While there is evidence to support
psychosocial and behavioral therapy to treat depression and depressive symptoms,
combination with pharmacological treatment is recommended for the maximum benefit.
Summary
Risk factor reduction has been shown to reduce the incidence of CVD and is clearly
supported by research. Healthcare providers are being challenged to find ways to assist
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the public to identify and modify their personal CVD risk factors. Many evidence-based
strategies and therapies are currently available. But the greatest challenge is assisting
individuals to “perceive” that they are at risk in the first place. To help persons address
the development of CVD, measuring cardiovascular risk is thus necessary.
Measuring Cardiovascular Risk
Measuring risk for developing cardiovascular disease (CVD) or having a cardiac
event, such as a myocardial infarction, is an evolving science. While the risk factors for
cardiovascular disease and their subsequent contribution to disease progression have been
extensively studied and well-documented, it remains difficult to precisely predict the
likelihood of a cardiovascular event. Epidemiologic research has shown that reliance on
one single risk factor can be misleading. Rather, quantitative multivariable risk
assessments confer a more accurate prediction, especially since most of the standard risk
factors tend to synergistically affect each other as discussed earlier in this paper (Kannel,
2005). Therefore, multivariable cardiovascular risk assessment has become a necessity.
Several methods are available to mathematically estimate risk, including the
Framingham Risk Score (FRS), coronary artery calcium (CAC) score and intravascular
ultrasound (IVUS). While each method contributes a greater understanding of actual risk
for a cardiac event and possesses individual strengths and weaknesses, no one method
completely or accurately calculates risk for a cardiac event. The FRS will be discussed in
this paper, since it is the method employed in this study. In addition, the Heart Health
Score will also be discussed as a tool commonly used for health screenings among the lay
population.
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Framingham Risk Score
The Framingham Risk Score (FRS) is one of the most widely used methods for
predicting and calculating risk for a future cardiovascular event. This method evolved
from the Framingham Heart Study, which began in 1948, and ultimately identified risk
factors for CVD. A mathematical calculation integrates age, gender, smoking history,
blood pressure, and cholesterol as well as blood glucose or a history of diabetes in
persons without a history of CAD to demonstrate the multiplicative and cumulative
aspects of atherogenesis (Greenland, LaBree, Azen, Doherty, & Detrano, 2004). Based
on the presence of these risk factors, a 10-year risk of having a cardiovascular event is
calculated. However, this method has both strengths and weaknesses.
A positive attribute of this method is the inclusion of multiple or “global” risk
factors. The presence of CVD is most frequently attributed to risk factor combinations
closely associated with one another. For example, persons who smoke and also have
dyslipidemia will be at higher risk for CVD. By addressing the multiplicity of risk factors
through the FRS mathematical equation, a more comprehensive view of true risk is
examined.
The FRS provides a 10-year, gender specific projected risk of having a
cardiovascular event. In addition, risk results are stratified with a percentage. A low risk
is correlated with a calculated risk of less than 10%. A moderate risk is correlated with a
risk between 11% and 20%. High risk is correlated with a calculated risk of greater than
20%. This level of risk is used to determine which patients require more intensive
management of LDL cholesterol, as outlined by the ATP III recommendations (Grundy et
al., 2004).
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Risk stratification may act as a motivational factor to inspire behavior changes in at
risk individuals. However, there are limitations to projecting risk. For example, how
much projected risk for a cardiovascular event in the next ten years would it take to
motivate a person to stop smoking, exercise more, lose weight, or become more
physically active? Logically, it would seem that the higher the projected risk, the more
motivated a person would be to make positive behavior choices. But theoretically,
motivation could also depend on how that person “perceives” their risk. Do people
consider “time” when formulating risk perception? Does projecting risk out to a 10-year
period negatively affect how risk is perceived? Is 10 years too long of a projection?
Would a shorter time frame be more of a motivating factor? These and other questions
bring to light the challenges of using the FRS.
This tool is indicated for primary prevention screening. Those individuals who
already have known CVD, or who have a CVD “risk equivalent” such as diabetes,
peripheral artery disease, abdominal aortic aneurysm or symptomatic carotid artery
disease are already at 20% risk of a cardiac event in 10 years, so calculation of personal
risk factors is not necessary for prediction.
Heart Health Score
Wellsource© is a company that provides health appraisal programs to organizations
and has been in business for more than 30 years. Wellsource© offers a wide range of
wellness programs and is commonly used in the cardiac rehabilitation setting as well as
corporate wellness programs. Wellsource© compiles individual risk profiles based on
self-report and physiological data and also offers a variety of online educational resources
for customer use (Wellsource, 2013).
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The Heart Health Score (HHS) is derived from a combination of physiologic and
self-report data and is based on the NCEP III revised guidelines taking into account both
the severity and amount of major versus moderate risk factors. In addition to using the
same variables as the Framingham risk calculation, it considers fitness level as well as
personal and family history of cardiovascular disease and reflects current risk as opposed
to future projected risk (Wellsource©, 2012). A computer program generates a “Heart
Health Score” (HHS) in one of four categories:


“Excellent” or “Ideal risk” (score of 75-100), defined as no risk factors other than
age;



“Doing Well” or “Low Risk” (score of 50-74),defined as having 1 to 3 moderate
CHD risks factors not including age, or having a personal history of CHD when
blood lipids are “not known”



“Needs Improving” or “Moderate Risk” (score of 25-49), defined as having only one
major CHD risk factor not including age or family history or having 4 or more
moderate CHD risk factors (counting age and family history as moderate risk
factors), and



“Caution” or “High Risk” (score of 0-24 defined as having moderate CHD risk blood
lipids AND 2 or more major CHD risks OR having two or more major CHD risks not
including age OR having one major CHD risk, plus the age major risk AND Low
fitness OR having blood lipids or triglycerides within “Ultra-high” category.
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Risk Perception
Risk perception is a complex concept comprised of several interrelated concepts.
A cross-disciplinary literature review was conducted using the term “risk perception” in
the areas of business, law, medicine, psychology, sociology, and nursing using: ABI
inform, Criminal Justice Periodicals Index, Medline, PsychINFO, Social Science
Abstracts and CINAHL data bases. The search was limited to English only. Both a
computerized and hand-search of current literature was performed to elicit relevant
current information on risk perception. Main themes were identified in each discipline
after reviewing the literature on risk perception (see Table 1). These themes were used to
identify additional literature on optimism, optimistic bias, and negative emotions such as
anger, hostility, uncertainty, anxiety, and depression. While risk perception, optimism,
and optimistic bias are recognized in many disciplines, including medicine, there is little
literature regarding risk perception directly relating to cardiovascular disease. However,
there is a connection between these concepts that will be demonstrated throughout the
paper. A relationship between negative emotions and CVD has been demonstrated in the
literature and will also be explored in this paper.
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Table 1. Risk Perception Literature Search
Search
terms used
Risk
perception

Discipline searched:
Data base used
Business:
ABI Inform
Law:
Criminal justice periodicals
Medicine:
Medline
Nursing:
CINAHL

Psychology:
PsychINFO
Sociology:
Social science abstracts

Main themes
Consumer marketing strategies, Risk versus benefit
Gun policy, crime deterrents, violence in prison, sexual
violence, burglary, criminal decision making, fear of
crime, HIV, date rape
HIV/AIDS, blood transfusions, cancer, spinal cord
injury, immunization, surgery and treatment options,
informed consent
Breast cancer, colon cancer, tanning, genetics,
HIV/AIDS, pain, peripheral vascular disease, infectious
disease, asthma, tanning, genetics, vaccination, and
pregnancy
Reasons for perception, differences in perception,
comparative vs real risk
Population risk, risks important to people, social theory
and social support

Literature from the areas of business, law, medicine, nursing, psychology and
sociology addresses different, but important aspects of risk perception. The business
literature focuses on consumer marketing strategies and ways that consumers make
decisions about purchases and investments. These decisions are made using a risk versus
benefit analysis. While this decision-making process may appear to be specific to
purchases, it is really a part of human psychology that examines how persons make
decisions regarding behaviors and actions. In contrast, the law literature draws on the
concept of fear, such as being a target of crime or the risk of contracting the human
immunodeficiency virus (HIV) in prison. While both the medical and nursing literature
address risk perception by examining specific disease processes, such as HIV and
different types of cancer, the medical literature also includes decision-making about
treatment options and specific processes such as informed consent. In contrast, the
nursing literature examines beliefs about a disease process and/or behaviors that either
lead to or prevent a disease process. Breast and colon cancer literature are the most
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prevalent disease processes in the nursing literature. Psychology literature examines
reasons and differences in perception of risk, while the sociology literature focuses on
theories that attempt to explain behavior and behavior choices. Both the psychology and
sociology literature use theory and empirical findings to explain how persons make
decisions involving risk. For example, one area of study is public perception of fear
involving violence. This fear has been linked to the media’s sensationalizing crime and
violence through newspapers and increased television programming of both drama and
reality police shows demonstrating violence. However, this paper will focus primarily on
business and healthcare concepts.
Literature on Risk Perception
Current business literature relevant to this paper on risk perception addresses:
consumer-marketing strategies, risk benefit ratio, and risk factors. In business literature,
risk perception is used as a consumer-marketing tool and is viewed from a consumer
psychology standpoint. Consumer psychology evaluates the reasons a consumer will or
will not buy a product or service. While consumers use a risk versus benefit process to
make a decision with regards to purchases, the decision making process is driven by the
potential to encounter potentially negative outcomes. Risk perception arises from the
potential for unanticipated and uncertain consequences related to purchasing of products
(Dholakia, 2001). The marketing of products is based on the strategies to reduce
consumer risk perception related to the product or service. Risk perception has been an
integral part of economic growth, however, in order for it to be successfully utilized, it
must first be understood.
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Ropeik (2002) reviewed articles spanning over 20 years to compile a list of 14 risk
perception factors (see Table 2). Each factor explains a different aspect of consumer
decision-making and acts as motivational factors to influence behavioral responses. Each
of the fourteen factors will be discussed with an example related to healthcare.
Table 2. Risk Perception Factors
Number
1
2
3
4

5

6
7
8

9
10

11
12
13

14

Risk Perception Factors in Consumer Purchasing
Perception factor Label
Definition
Trust versus Lack of Trust Factor
The more trust there is in those informing us about a
risk, the less fear there will be of that risk.
Imposed versus Voluntary Factor
There is increased fear of a risk that is imposed than
a risk that is chosen.
Natural versus Human-made Factor
Exposure to natural risk, sun exposure is less feared
than nuclear exposure.
Catastrophic versus Chronic Factor
Most often, people are more afraid of things/events
that kill a large number of people at once, suddenly
and violently, than things such as heart disease.
Although heart disease kills more people annually, it
is individual and more dispersed.
Dread Factor
The worse the outcome from a risk, the more a
person is afraid of it. It is postulated that cancer has
a high dread factor.
Hard to Understand Factor
The harder a potential risk is to understand the higher
the fear of that risk.
Uncertainty Factor
When science provides the answers to problems with
technology, fear about the technology will decrease.
Familiar versus New Factor
The first time encounter to a new risk increases the
fear of that risk. However, after a person lives with
the risk, the fear will eventually begin to decrease.
Awareness Factor
Increased media coverage of a risk has a positive
influence on risk perception.
A Known Victim Factor
Personal knowledge of someone who has been
affected by a risk will lead to increased fear of that
risk
Future Generations Factor
When children are involved, the fear of a risk is
increased.
Does it Affect Me?
A person perceives risk more personally than they do
for society.
Risk versus Benefit Factor
The more a person perceives a benefit from a
potential hazard, the less likely a person will be
afraid of the risk. This can be specifically applied to
medication and treatment therapies.
Control versus No Control Factor
If a person feels that he or she can control the
outcome of a hazard or risk, the less likely that
person will be to be afraid of that risk

Note: From “Understanding Factors of Risk Perception,” by D. Ropeik, 2002, Nieman Reports, 4, p.52.
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The trust versus lack of trust factor (#1) addresses the trust that the consumer places
on the person(s) informing the consumer. Specifically, the more trust there is in the
person(s) informing the consumer about a risk, the less fear the consumer will have about
the presented risk. Conversely, if there is a lack of trust in the person informing the
consumer, the consumer is more likely to be fearful of the risk. An example related to
healthcare is receiving advice on decreasing cholesterol in one’s diet from a dietician or
nurse versus a lay person in the supermarket. While a friendly face in the vegetable aisle
may be accurate in providing information, a person would trust information given to them
by a healthcare professional.
The imposed versus voluntary factor (#2) posits that an imposed risk is more feared
than a risk taken voluntarily. For example, while smokers realize that there is a health
risk associated with tobacco consumption they are often not fearful enough to stop
smoking. However, if consumers were told they would be exposed to an unhealthy
smoking environment every day in the workplace, they would be more fearful of the
health consequences (exposure on the job does not involve addiction and also removes all
control).
The natural versus human-made factor (#3) examines risk based on whether or not
the risk is human-made or naturally occurring. A simple example is fear of cancer. While
the sun exposes people to a form of radiation and an increased potential for skin cancer,
consumers are more afraid of getting cancer from a nuclear exposure or manufacturing
exposure, which are human-made processes.
The catastrophic versus chronic factor (#4) bases the fear of risk on the numbers of
people that are harmed at one given time. Consumers tend to be more afraid of those
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events that kill large numbers of people catastrophically than things that kill people
annually. While it is known that cardiovascular disease kills more Americans annually in
the United States, there is a greater fear of dying in a plane crash because this
catastrophic incident can kill hundreds of people at one time.
The dread factor (#5) posits that the worse the perceived outcome from an event,
the more fear that is associated with the event. Cancer has a high dread factor. This may
explain the misconception that American women have regarding breast cancer. Studies
have shown that more women are afraid of dying from breast cancer than from
cardiovascular disease, when scientific evidence clearly demonstrates that more women
die annually from cardiovascular disease than from breast and colon cancer combined
(NHLBI, 2006). Perhaps death from breast cancer is perceived as being more painful than
with cardiovascular disease. In addition, the dread may be related to whether death is
quick or drawn out. Finally, breast cancer is often viewed as disfiguring.
The hard to understand factor (#6) states that fear about a risk increases as difficulty
in understanding the risk increases. Disease processes are complex and difficult to
understand, which provokes fear in patients. From laboratory results to a spectrum of
procedures such as percutaneous transluminal angioplasty, persons possess a fear of
things that they do not understand. However, fear associated with these processes can be
lessened when the healthcare provider is able to educate the patient about signs and
symptoms, diagnostic procedures, treatment regimens, and recovery processes.
The uncertainty factor (#7) is related to science and technology. This factor states
that fear regarding specific technology will decrease if science explains problems with
that particular technology. There has been an increase in health-related technology over
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the last decade. Magnetic resonance imaging (MRI) was originally termed nuclear
magnetic resonance imaging (NMRI). Although there were no instances that this test was
harmful in studying brain function, the change in name gained the confidence of the
public (Goldberg, 2007). It can be explained to the patient that, unlike x-rays, the MRI
does not expose patients to any form of radioactivity or radiation.
The familiar versus new factor (#8) established that repeated exposure to a risk
results in decreased fear regarding the risk over time. For example, air travel is feared by
many people. However, those who frequently travel by air (repeated exposure) do not
view this mode of transportation as an unnecessary risk. Traveling by automobile actually
carries more risk for injury and death than does air travel, however, due to familiarity
with auto travel, most people do not fear driving in a car at all. In healthcare, new
treatment regimens such as chemotherapy may be fearful to people. However, after a
patient has gone through one or two rounds of chemotherapy, the anxiety about the
treatment regimen decreases.
The awareness factor (#9) is related to the amount of media coverage that is focused
on the risk. Increased media coverage of a given risk will increase the fear of that risk
(Ropeik, 2002; Sjöberg, 2000). This is similar to the media coverage prevalent today to
market drugs and to advertise drug recalls. When Vioxx was publicly linked to an
increase in cardiac deaths, there was a frenzy of people calling their physicians about
continued use of Vioxx and similar non-steroidal anti-inflammatory medications
(Mukherjee, Nissen, & Topol, 2001).
The known victim factor (#10) supports that personal knowledge of someone who
has been affected by a risk will influence fear about the risk. Knowing either a friend or
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relative with cancer raises awareness about the symptoms, treatments, and certainly the
effects of the disease (Katapodi, Lee, Facione, & Dodd, 2004). Those who know
someone with cancer often take primary prevention measures such as screenings very
seriously. In addition, these same persons often take part in raising awareness in the
community in events such as walk-a-thons.
The future generations factor (#11) states that fear will increase if children are
involved in the risk. For example, while parents may not be overly concerned about
second-hand smoke exposure for themselves, they are more concerned if their children
are exposed to this hazard or risk. Another example is the fear of vaccines causing or
being related to autism (Woo, Ball, Bostrom, Shadomy, Ball, Evans, et al., 2004). Parents
go to great lengths to keep children safe from perceived hazards.
The “does it affect me” factor (#12) states that a person often perceives a risk
differently for others than they do for themselves and it can be explained by people
thinking “it cannot happen to me” or “this is something that happens to others”. This
factor, also referred to as comparative risk, is especially pertinent because when people
perceive less risk for themselves than for others, risk prevention may not be seriously
considered (Weinstein, 1982).
The risk versus benefit factor (#13) is associated with a person weighing risks and
benefits of a risk or behavior. If the benefits of a behavior outweigh the risks, the person
is less likely to be afraid of the risk or behavior. For example, a person may have a belief
that taking medication is unnecessary, unnatural, costly, and can cause side effects. The
person is prescribed a medication to treat high blood pressure. If a healthcare provider
was able to demonstrate that this medication could decrease the chance for stroke and
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heart attack while also decreasing recent symptoms of impotence, the person may be
more likely to see the benefits of treatment and decide that the risk of taking medication
is worth it.
Lastly, the control versus no control factor (#14) states that if a person perceives
that they can control the outcome of a risk, the person will be less afraid of that risk.
Conversely, if a person perceives that they will have little or no control over a risk, the
person will be more afraid of the risk. Risky sexual practice and the potential contraction
of human immunodeficiency virus (HIV) is one example. Stolte, Dukers, Geskus,
Countinho, & de Wit (2004) conducted a study and observed a correlation between
homosexual men who believed that highly active antiretroviral therapy (HAART) would
prevent the contraction of HIV and unprotected anal sex.
These fourteen factors all contribute to different aspects of risk perception and have
relevant implications for the healthcare environment. Each of these factors serves as a
basis to understand perception by the consumer and may act as a motivator that will
influence consumer behavior. The risk perception factors may be one way for healthcare
providers to understand how health behavior decisions are made. Furthermore, by
studying these factors, healthcare providers may be able to tailor interventions based on
how each person may view risk in a given situation.
Additional literature on risk perception will be examined using subcategories
including demographic variables and risk awareness and knowledge. Both optimism and
optimistic bias will be explored as terms closely related to risk perception.
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Demographic Variables Affecting Perception
Consumer-marketing strategies in the business literature concluded that consumers
are not only influenced by the motivating factors outlined by Ropeik (2002), but vary by
personal characteristics such as age, gender, income, education, marital status, parental
status (Grobe, Douthitt & Zepeda, 1999; Sjöberg, 2000), and also by the context of the
perceived risk (Grobe et al.; Sjöberg, 2000). Age has been established as a variable or
mediator that affects perception of risk (Cohn, Macfarlane, Yanez, & Imai, 1995).
Therefore, conducting research in different populations may elucidate effective strategies
that will increase awareness of risk in different age samples.
Grobe and colleagues investigated the influence of personal characteristics (age,
gender, household size, socioeconomic status, and education level) on risk perception of
recombinant bovine growth hormone (rbGH) using Weinstein’s Self-Protective Theory.
This theory posits that personal susceptibility and severity affect the way an individual
perceived risk. A nationwide telephone survey was conducted on 1,910 (56.1% of the
sample) primary food shoppers regarding recombinant bovine growth hormone (rbGH) in
milk. Data was analyzed using Chi Square analysis. The study concluded that perceived
health risks from rbGH were dependent on individual perceived exposure (χ2= 0.98, p =
0.05), fear of risks in general (χ2 = 0.48, p = 0.05), household size (χ2 = 0.12, p = 0.05),
and socioeconomic status (χ2= 0.125, p = 0.05). Furthermore, level of education ( χ2= 0.024, p = 0.05, χ2= -0.093, p = 0.05, χ2= 0.050, p = 0.05) male gender (χ2= -0.052, p =
0.05), and increased age (χ2 = 0.001, p = 0.05) were associated with higher level of
awareness about rbGH. This finding is particularly poignant since awareness is not only
essential for understanding information, but also for processing it as a risk or threat.
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Additional information regarding awareness and knowledge will be discussed in a later
section of this paper. Lastly, feeling a lack of control in life was associated with increased
concern regarding rbGH, but not enough to exhibit self-protective behaviors. However,
self-protective behaviors increased when the exposure could affect the family members.
Thus, responsibility for others may act as a motivating factor to lessen exposure to a risk
or threat.
Limitations of this study are due to the nonexperimental study design. While survey
research can provide descriptions and breadth, it can lack depth. Thus, it may serve as a
foundation for future studies on the topic. Strength of the results from survey research
can vary based upon the expertise of the researcher(s) in sampling, survey construction,
interviewing, and data analysis. In this study, the researchers stated that questions were
compiled from risk perception theories and results from focus group research. However,
it is not stated whether the questionnaire was piloted prior to use or if it was tested for
construct, face, or content validity. Furthermore, the authors did not report reliability or
validity data from this study. Such information would be useful for further research in
this area.
Risk Benefit Ratio
Risk benefit ratio has been identified in the business (Dholakia, 2001; Ropeik,
2002), psychology (Simonet & Wild, 1997; Weinstein, 1988; Weinstein, Marcus, &
Moser, 2005), and sociology (Wilkinson, 2001) literature. The risk benefit ratio posits
that persons make decisions based on the risk versus the benefit in a given situation,
whether it involves a purchase or behavior choice, supporting that health behavior
decisions are made consciously and not haphazardly. Before making a decision to
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incorporate a lifestyle change, a person carefully weighs the benefits and risks of the
behavior. While consumer psychology tends to evaluate risk as a condition that arises
from a potentially negative outcome, behavioral based disciplines such as psychology,
sociology, medicine, and nursing take into account both potential positive and negative
outcomes that guide individual decision making processes (Dholakia, 2001). In effect, the
perception factors defined by Ropeik (2002) can be viewed as motivational factors that
could influence behavior regarding the risk. The conclusions drawn from the business
literature may be helpful in planning education strategies for the public in matters of
disease risk and prevention. Consumers of healthcare are influenced by the same
motivational factors (table 2) as consumers of products and services in the business
industry. However, little is known about how healthcare consumers use a risk benefit
ratio that may influence decision making lifestyle behaviors. Instead, the healthcare
discipline utilizes health behavior models and theories that attempt to explain behavior
choices.
Risk Awareness and Knowledge
The concept of risk perception has not been used consistently in the healthcare
literature. While some studies state that risk perception is being measured or use the term
“perception of risk” in their title, it is commonly awareness or knowledge about risk
factors that is being measured and reported (King et al., 2002; Oliver-McNeil & Artinian,
2002). For example, in an article titled Perception of risk for coronary heart disease in
women undergoing coronary angiography, King and colleagues surveyed a convenience
sample of 450 women undergoing coronary angiography to examine the relationship
between a woman’s recollection of being told that she was at risk for CHD and the
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presence of personal risk factors. The mean age of the participants was 64.5 years and
ranged from 32-93 years. The sample was 94% white/Caucasian, 5.8% African
American, and 0.2% Hispanic, thus not ethnically/racially diverse. However, the authors
reported the sample as representative of the community, having a similar percentage of
those with hypertension, diabetes, and physical inactivity. Results found that 83.6% had
three or more risk factors, 12.2% had one or two risk factors, and 0.9% had no risk
factors. Furthermore, only 35% of the women recalled being told that they were at risk
for CHD, even though 84% reported having three or more risk factors. Using a
multivariate regression analysis, age (95% CI = 0.96-0.99; p= 0.03), education (95% CI =
1.03-1.79, p= 0.03), and being told by provider about high cholesterol level (95% CI =
1.01-2.45, p= 0.05) were the only significant variables that predicted recollection of being
told about personal risk for CHD. Results from this study highlight the importance of
providing accurate information about risk factor for CHD. However, while awareness
about risk factors plays a significant role in the formation of risk perception, risk
awareness and risk perception are two separate and distinct concepts.
In critiquing this study, it is noted that threats to internal validity are addressed by
using two trained nurses to conduct the structured interviews and following a set
procedure for data collection. In addition, all but two of the participants were interviewed
in person in the same hospital setting. This study included a large cohort of women with a
wide range of ages. While the mean age was 64.5 years, there were participants as old as
95. At first glance, it appears that a participant at the age of 95 would be an outlier in the
sample. It would have been helpful to provide the reader with the number of participants
within a given age range. In addition, data analyzed by age category may provide
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information about how knowledge and awareness about CVD changes with life stage and
life experience. Due to the survey design of this study, causality and relationships cannot
be assigned. However, this study can act as a basis for future research on this topic.
Perception of risk for CHD cannot be formed without awareness and knowledge of
risk factors for CHD. For example, if a person does not know what factors contribute to
the development of CVD (knowledge), then it would be difficult to become aware of the
potential risk to health. Risk knowledge can arise from several sources including: media
such as television, radio, internet, and printed sources; and dialogue with those who can
provide accurate and candid information, whether they are healthcare professionals or
well-informed lay persons. In addition to general knowledge, individualized information
about personal risk factors such as blood pressure readings or lipid profile results further
contribute to risk awareness and the subsequent formation of risk perception. Accurate
perception of a risk is not necessarily guaranteed, even if complete and thorough
knowledge is given and awareness of the risk is raised because the individual must be
able to process the information to perceive a threat to well-being. The key to risk
perception is how a person cognitively processes the information and subsequently is able
to internalize and personalize the threat. Both internal and external influences affect how
an individual processes a risk.
Lefler (2004) completed an integrative review of 11 studies including both men and
women to examine why women do not perceive they are at risk for a myocardial
infarction (MI) or heart attack. Lefler listed the following as some of the major findings
from the studies: women were unaware that heart disease was the number one killer of
women and believed that it is a male disease; women often underestimate the significance
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of chest pain; women’s symptoms for MI are often different that for their male
counterparts; women reported paternalistic attitudes from physicians about symptoms;
women often felt uninformed about heart disease; women often use print media as a
primary source of health information; fewer physicians discussed heart disease with
women; primary care providers often did not discussed disease prevention; and lower
perceived risk was commonly reported by women, African American, those with lower
levels of education, and younger patients. She concluded that there are gender differences
that affect perceived risk of a heart attack. Moreover, she concluded that there is a need to
involve the patient, family, and community to provide knowledge and reinforce behavior
changed that will positively impact the lives of women. While Lefler did include both
qualitative and quantitative studies that increased the richness of the findings, no audit
trail was provided other than which search terms and databases were investigated. In
addition, findings from quantitative studies were not supported by either significance
levels or indication of sufficient power within the studies. Furthermore, there was no
evidence presented about the strengths and limitations of the studies. Therefore, without
this information, the conclusions drawn by Lefler may be weak and have limited
application in practice.
Terms Related to Risk Perception
Both optimism and optimistic bias are terms closely associated with risk perception.
When examining studies that involve risk perception, one or both of these related terms
are often measured. In some cases, while optimism or optimistic bias is measured, results
are reported as risk perception. Both optimism and optimistic bias will be examined in
more detail later in this paper. But first the following meta-analysis is presented as a
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poignant example of how risk perception was studied in the breast cancer literature and
how the term overestimation (optimistic bias) was reported in many of the studies.
Katapodi and colleagues (2004) conducted a meta analysis on 42 studies related to
risk perception and breast cancer screening using clearly described research methods. In
addition, search terms, limitations, inclusion and exclusion criteria, and coding/analysis
of data were provided in detail. Effect sizes were calculated using Hedge’s G statistic in
which g = 0.20 were considered small, g = 0.50 were considered moderate, and g = 0.80
were considered large. Odds ratios were also calculated along with a 95% confidence
interval. The use of Hedge’s G statistic is appropriate for the calculation of effect sizes in
meta analysis. Thus, those studies with a small effect size have a stronger instrument to
measure perceived risk. There is a large amount of variation is the type of instrument
used to measure perceived risk. In this analysis, the authors noted that perceived risk was
measured in a variety of ways, ranging from a single question to an eight-item panel of
questions. In addition, both subjective and objective risk can be measured verbally on a
Likert-type scale, or numerically as a percentage. Furthermore, Katapodi reported that in
these studies, questions were formulated as subjective risk (the risk an individual
assigned to him/herself based on variables such as knowledge and personal risk factors),
or comparative risk (the risk an individual assigns to him/herself while comparing their
risk against others), or both (see Appendix A). Most often, the comparison included
demographics such as age group, gender, socioeconomic status, education level, and
race/ethnicity. The table in this analysis clearly shows that the concept of risk perception
has not been consistently defined and measured which poses a threat to reliability and
validity of individual study results. For example these authors explain that while single-
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item scales can be administered easily due to brevity and have adequate face validity the
major limitation is limited discriminatory capacity. In addition, since the data is most
often classified as interval level data, there is an increased risk for limited reliability due
to measurement error. Lastly, single item scales have commonly been used to measure
more than one construct leading to measurement errors.
Unlike the study conducted by Grobe and colleagues (1999), these researchers
found conflicting results on the influence of demographic characteristics on breast cancer
and perceived risk. Although seven of the studies concluded that younger women were
more likely than older women to perceive higher risk for developing breast cancer, the
effect size was small and the confidence interval was low (total N= 38,000, g = 0.13,
95%, CI 0.13-0.14). Katapodi and colleagues (2004) ultimately concluded that no
relationship exists between age and increased perceived risk due to the small effect size
for these seven studies and insufficient data to calculate an effect size for the remaining
five studies. This conclusion limits the application of the findings.
This meta analysis is important to include for several reasons. To begin with, after
searching the literature, this was one of the studies that ultimately revealed that risk
perception is being measured in a variety of ways. In addition, risk perception is often
reported as optimistic bias. Lastly, the analysis found gaps in the breast cancer literature
that not only lays the groundwork for future research in breast cancer, but also in the
areas of cardiovascular disease.
Literature on Optimism
The relationship between the concepts of optimism and risk perception was
identified by this author after reviewing several studies that discussed risk perception, but
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measured optimism (Facione, 2002; Katapodi, et al., 2004). Optimism, dispositional
optimism, or “overestimation” can be defined as either a state or trait of personality or
character in which a person views the word positively. It is thought that optimistic
individuals make the best of things and are able to cope with adversity; hence they may
make better choices related to healthy behaviors (Scheier & Carver, 1992).
Optimism has been most often measured with the Life Orientation Test (LOT)
(Scheier & Carver, 1985) or the Life Orientation Test-Revised (LOT-R) (Scheier, Carver
& Bridges, 1994). The original LOT is a twelve-item self report of both positive and
negative outcome expectancies measured on a five point Likert response scale (Appendix
B). There are four filler items, four positively phrased items, and four negatively phrased
items on the instrument. Acceptable reliability and validity has been established and
published in a variety of health related areas.
The concept of pessimism is commonly integrated within the same literature and is
often explained as the opposite of optimism. Research has been conducted to further
elucidate the relationship between optimism and pessimism (Kubzansky, Kubzansky, &
Maselko, 2004). In some instances, pessimism has been more significantly correlated to
health than optimism (Carver, Lehman, & Antoni, 2003; Brenes, Rapp, Rejeski, &
Miller, 2002). However, there is some discussion among researchers whether optimism
and pessimism are two separate constructs rather than opposite measures of a single
construct (Brenes et al., 2002; Kubzansky et al. 2004; Scheier et al., 1994). Thus, it is
difficult to discuss one concept without the other. In fact, more recent literature has
discussed the concepts as optimism-pessimism rather than separate terms (Carver et al.,
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2003). Even though there is not complete agreement regarding the relationship between
these terms, there is evidence to suggest that both constructs affect health.
Kubzansky and colleagues (2004) explored whether optimism and pessimism, as
measured on the LOT and LOT-R, are measures of the same construct. The study was
designed to examine three versions of the LOT instrument: the original LOT, a halfreversed version of the LOT, and finally, a fully-reversed version of the LOT. In the halfreversed version the framing was reversed on half of the questions, while maintaining the
intent of the item. The fully-reversed version reversed the framing of all questions. In
reversed items, positively phrased items are changed to negatively phrased items. For
example, if the original items states “In uncertain times, I usually expect the best,” the
reversed item would state, “In uncertain times, I rarely expect the worst.” Thus, the
connotation opposes the meaning of the statement but the intent of the item is the same.
To ensure item meanings were intact, pilot testing was performed on the two reversed
versions of the instrument. In addition, both versions kept the same order as the original
LOT and the filler items were left unchanged. One version of the LOT was administered
along with health-related measure for trait anxiety, trait anger, symptom measures,
general health status and health behaviors. In addition, external health behavior
information was obtained from the university health services for each of the 429
participants, including information on gastrointestinal problems, back and neck injuries,
asthma, skin rashes, and regular preventive vaccine acquisition, to name a few.
Optimism and pessimism independently predicted anxiety, anger, and depressive
symptoms (p<0.01), suggesting that optimism and pessimism are separate constructs.
These researchers posit that negative emotions may act as a mediator between optimism
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and pessimism. In addition, they suggest that positive expectations may play a role in
how persons cope with adverse conditions such as illness. Finally, further investigation
into the conceptual nature of optimism and pessimism has been suggested to explore the
concepts of risk persistence, risk behaviors, risk tolerance, denial, and coping styles.
Optimism has been the focus of studies that examine human immunodeficiency
virus and disease progression (Ironson, Balbin, Stuetzle, Fletcher, O’Cleriegh,
Laurenenceau et al., 2005), immune function (Sergerstrom, Taylor, Kemenym & Fahey,
1998; Von Ah, Kang & Carpenter, 2007), breast cancer and social interaction (Carver et
al., 2003; Von Ah et al., 2007), and carotid artery disease progression (Matthews et al.,
2004; Matthews et al., 2006). While it makes logical sense to think that a positive outlook
on life can affect overall physical health and functioning, there is objective evidence to
support this position.
Immune Function. Optimism has also been shown to affect the immune system of
healthy individuals. Sergerstrom et al. 1998) studied 50 first year law students with
confirmed healthy immune systems to determine if optimism is associated with mood,
coping, and immune function in response to stress. Immune measures included CD4+
cells (helper T), CD3+, CD8+ cells (cytotoxic C), CD19+ cells (B), CD3+, CD3-CD16+56+
cells (NK), and natural killer cell cytotoxicity (NKCC). Strict methods of collection,
handling, and processing of the samples were described adding to internal validity of the
study. Dispositional optimism (trait optimism) was measured using the LOT, which has
already been described. To capture situational optimism, a 10-item scale was specifically
developed for this study based on a previous study examining optimism with HIV.
Reported reliability was α = 0.86 at Time 1 and α = 0.91 at Time 2. The correlation
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between dispositional and situational optimism was 0.30 suggesting sufficient ability to
discriminate between the two concepts. The Coping Operations Preference Enquiry
(COPE) measured several factors including problem solving, mental accommodation, and
avoidance. The Profile of Moods State (POMS), a well-established instrument to assess
mood, was used to measure mood state over the past week. It assesses 65 different moods
using a 5-point Likert type scale. Measures assessed for the previous week included:
amount of exercise, average amount of sleep, and intake of caffeine, alcohol, nicotine,
and/or drugs. Demographic characteristics were collected. Lastly, each participant was
asked to describe extremely stressful recent school related experiences using a 7-point
Likert type scale. The instruments were not included in the publication therefore, it is not
possible to examine how these concepts were explored.
Self-reported optimism and situational optimism, related to college life as first year
law students, were measured at baseline and mid-semester. Situational optimism, in this
study, was defined as the outlook a student had related to school related stress. Results
indicated situational optimism was associated with less perceived stress (r = -0.28, p<
0.05) and less avoidance coping (r = -.27, p< 0.05). In addition, both dispositional and
situational optimism were associated with less mood disturbance at both Time 1 (r = -.25,
p< 0.05; r = -.28, p< 0.01) and Time 2 (r = -.33, p< 0.01; r = -.39, p< 0.01) respectively.
Lastly, situational optimism was significantly associated with levels of CD4+ cells (helper
T cells) (r = 0.35, p< 0.05).
Results from this study suggest that individuals who are more optimistic are less
likely to perceive stress and have less mood disturbances. While only situational
optimism was significantly associated with increased helper T-cells it may be that
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individuals are able to remain optimistic while enduring the stress of a situation that has
limits. For example, students often feel stressed before a paper is due or before an exam.
However, the student is able to endure this stress without deleterious effects because it
occurs during a relatively short period of time (days to weeks depending on the student’s
schedule and classes). However, if an individual is enduring stress over a long period of
time, it may not be possible for the body to react in a protective manner. Since there is
evidence to support that CVD is related to an inflammatory response, which is part of
immune functioning, further research regarding optimism should be included in the area
of CVD. This study provides a strong foundation for more research in this area. Not only
can other age groups be studied, but also different ethnicities, and those with different
disease processes.
A more recent study conducted on 54 women newly diagnosed with breast cancer
found optimism to moderate the immune response while it did not have a direct effect on
natural killer cell activity (NKCA) in this sample (Von Ah, Kang, & Carpenter, 2007).
These researchers posit that in some instances optimism may be more of a state
previously thought. In addition, Von Ah and colleagues suggest that not only does more
research need to be done in this area, but specifically longitudinal studies to determine
how psychosocial factors influence immune response in breast cancer.
Social Interaction. Carver and colleagues (2003) examined social interaction
among women with breast cancer using a cross-sectional design. The authors
hypothesized that pessimism would be correlated with less social interaction in these
participants. The sample consisted of 235 women with a first experience with cancer who
were otherwise physically and psychologically healthy. The participants were recruited at
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three, six, or twelve months post-surgery; had either Stage 0, 1, or 2 cancer; and ranged in
age from 27 to 87 years. Women with more advanced cancers were excluded from the
study. The sample ethnicity was: 63.4% Caucasian/White, 11% African American, 25.5%
Hispanic. Instruments included both the LOT-R to measure “optimism-pessimism” with a
reported α = 0.75 for this study. Social disruption was measured using two subscales of
the Sickness Impact Profile (SIP). The first scale assessed impact on social activities (α =
0.86), while the second examined recreation and pastime activities (α = 0.70). In addition,
emotional distress was measured with small sets of adjectives that respondents rated
according to severity. For example, distress was measured as anxiety using “tense,
nervous, and anxious”. Furthermore, the sets were also combined to yield a composite
index by averaging responses with a correlation of 0.43. Lastly, fatigue was measured by
using three descriptors from the fatigue scale (“tired, worn out, and exhausted”) of the
Profile of Moods State (POMS) with a reported α =0.90 when the responses were
averaged across items. These sets of adjectives were described as having adequate
measures of reliability and had been used in earlier breast cancer research. In addition,
the researchers did not explain why the entire fatigue scale from the POMS was not used.
Perhaps it was for brevity and to lessen the burden on the participant. However, the use of
only a few adjectives to measure a significant part of the study poses a threat to internal
validity and may negatively impact the findings.
Regression analysis found that optimism was inversely related to social disruption
(β = -.25, t(231) = 4.16, p< 0.001), distress (β = -.41, t(231)= 6.97, p< 0.001), and fatigue
(β = -.29, t(231) = 4.59, p< 0.001); thus higher levels of optimism were correlated to less
social disruption, distress, and fatigue. While treatment for breast cancer does imply a
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certain amount of social disruption, it appears that optimism may play a role in the
recovery and resultant positive social interaction for those with breast cancer. While it is
not known whether the same would be found for those at risk for cardiovascular disease,
further research may help to further define the relationship between optimism and
pessimism, negative emotions and health outcomes. One possible explanation is that
optimism acts as a mediator for more positive health outcomes.
Disease Progression. Evidence supports the premise that optimism may slow
disease progression. For example, Ironson and colleagues (2005) examined the effect of
optimism on human immunodeficiency virus (HIV) disease progression. The sample of
177 participants had CD4 counts between 150 and 500, were HIV positive with at the
beginning of the study, denoting they were all in the “midrange” of the illness. The
sample was 70% male and diverse, with 31% Caucasian, 36% African American, 28%
Hispanic, and 5% reported as other ethnicity/race. Disease progression markers,
psychosocial measures and adherence to the medication regimen were measured
longitudinally every six months over a two and a half year period. Psychosocial measures
included: optimism, depression, coping, and perceived stress. The LOT-R, which was
previously discussed, was used to measure optimism. The Beck Depression Inventory
(BDI), a well-established instrument, was used to measure depression. The Coping
Operations Preference Enquiry (COPE) was used to measure coping ability. Lastly, the
Perceived Stress Scale (PSS) was used to measure degrees of perceived stress. While
these measures were very briefly discussed, no reliability or validity data was provided.
However, these instruments are used widely with established reliability and validity data
supporting the integrity of internal validity. The researchers explained that the statistical
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method of hierarchical linear modeling (HLM) was specifically chosen to predict CD4
and viral load at each point in time, rather than predicting data at a single point in time.
HLM is an appropriate method, given the nature of the data and design of the study. After
controlling for significant covariates of: viral load intercept (intercept, age, gender,
cocaine use), viral load slope (average slope, education, sexual orientation, optimism),
antiretroviral 1 (average increment), and antiretroviral 2 (average increment), optimism
measured at baseline predicted the change in CD4 and viral load over the 2 year time
period. So, while the group as a whole lost CD4 cells due to the disease process (as
expected), results showed that optimistic individuals showed less disease progression
through an increase in CD4 cells (0.19, t = 2.08, p= 0.04) and a slower increase in viral
load (-0.001, t = –2.007, p= 0.04).
This was an in depth, highly structured study that serves as a foundation to support
the impact that optimism has on the immune function in those with HIV. While it is not
known whether optimism has any effect on the development and/or progression of CVD,
further study in this area could elucidate this relationship. If the results could be
replicated in CVD, even more could be understood about immune response and the
development and progression of CVD leading to new prevention and treatment measures
to prevent or halt the progression of disease.
There are few studies that examine optimism and the development and progression
of CVD. However, two studies most relevant to this paper correlate increased optimism
and life engagement with decreased levels of CVD. Matthews, et al., (2004) measured
carotid intimal thickness, a surrogate marker for atherosclerosis, in a prospective,
longitudinal study of 209 middle-aged healthy women. The women were part of the
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Healthy Women Study (HWS) and were premenopausal at enrollment. Data was
collected on demographics, blood glucose and cholesterol levels, body mass index, blood
pressure, optimism, and depressive symptoms. Carotid intimal thickness, a surrogate for
atherosclerosis, was measured via ultrasound scans using certified readers with pre-study
interrater reliability for establishing intima medial thickness (IMT) with an intraclass
correlation of 0.86. Carotid scans were performed at 10 and 13 years into the study when
women were 5 and 8 years postmenopausal.
The Life Orientation Test (LOT) was used to assess optimism-pessimism and was
administered upon entry into this part of the study and at the time of the first carotid scan.
Blood draw parameters were given for all laboratory assessments. Body mass index
(BMI) and blood pressure (BP) procedures were described. Self-reported measured
included: current medication therapy for hypertension, hyperlipidemia, and hormone
replacement; smoking history and alcohol intake. In addition, the Paffenbarger Activity
Questionnaire (PAQ) was used to collect data on leisure time activity spenditure. Lastly,
The Beck Depression Inventory (BDI) was used to measure depression. However,
information on the timing of the PAQ or BDI measures was not specified. Sound
measures to collect data supporting internal validity of the study.
Multiple linear regression analysis and univariate analyses of covariance
(ANCOVA) were used to analyze the data. Results showed that women who remained
optimistic for the longest periods of time had less disease progression (p < .001) and
those who reported higher pessimism scores were more likely to have greater increases in
carotid intimal medial thickness (p < .007). Pessimism scores collected at study entry
were related to an increase in mean IMT (β = 0.17, t = 2.71, p< 0.007). After being
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placed in quartiles based on the distribution of pessimism scores, significant linear effects
of pessimism were seen on the percentage of increase in both mean (linear contrast, F =
3.29, p< 0.002) and maximum IMT (linear contrast, F = 2.85, p< 0.25). The lowest
quartile (most optimistic) showed that this group had less progression than the other three
groups for both mean (F = 15.4, p< 0.001) and maximum IMT (F = 5.6, p< 0.02).
Optimism and pessimism scores remained stable over the 10.4 years of follow-up
(Pearson R = 0.71, p < .0001).
These results bring new information about optimism and cardiovascular disease
progression. Findings from this study should leave researchers thinking that more needs
to be done to examine the relationship between optimism, pessimism and the
development and progression of CVD. Several limitations must be examined in light of
the findings. To begin with, the subjects were all female. In addition, the study population
was homogenous, with 90% of the participants being white. Additional study, including a
broader range of ethnicities and with men is necessary to examine whether similar results
could be replicated. Lastly, the sample was comprised of healthy individuals, thus it is
not known whether similar results would be found in those with established CVD or in
those with co-morbid states such as hypertension, or diabetes.
The second study, conducted by Matthews et al. (2006), found similar findings
among 155 healthy women who completed instruments to measure cognitive affect and
optimism before and after an electron beam tomography scan (EBCT) to measure aortic
and coronary calcification. Similar to the previous study, the participants were part of the
larger Healthy Women Study. This study is a continuation of the first study by Matthews
et al. (2004), thus the women were now post-menopausal with a mean age of 65.1 years.
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EBCT was used to measure calcification in the aorta and coronary arteries. The
Agatston scoring method was used contributing to reliable and valid score reporting.
Coronary and aortic calcium scores showed moderate association (Spearman’s p = 0.40,
p< 0.001). In addition to assessment of cardiovascular risk factors, several psychological
attribute tests were administered to identify optimism, depression tendencies, self-esteem,
and hostility. Elements of each measure including number of items, rating/scoring
system, sample items, and alpha coefficients were described and presented as a table. All
instruments reported alpha coefficients of 0.70 or higher. Similar to the previous study,
the use of well-established instruments supports strong internal validity. However, there
was no discussion as to which instrument measured which construct. Therefore, unless
the reader is familiar with the name of the scale, it might prove difficult to fully
understand the reported findings. For example, after scanning the references, it was
determined that the LET is the Life Engagement Test. However, it was necessary to read
that article to learn that the LET measures life engagement and life satisfaction and was
explicitly designed for researchers in the fields of behavioral medicine and health
psychology (Scheier, Wrosch, Baum, Cohen, Martire, & Matthews et al., 2006). So,
while the LET does not measure optimism specifically, it was tested and was moderately
correlated (r = 0.39 to r = 0.61, p = 0.01) with measures of optimism in eight separate
studies. In fact, one of the eight studies is this very study (Matthews et al., 2006). The
introduction of the LET without using the LOT does pose some questions since Dr.
Scheier was key in the development of both instruments. Is it possible that since the LOT
is correlated with optimism, researchers are now beginning to focus on engagement in
life as a measure of positive emotion, namely optimism?

53
Findings from both studies may have a tremendous impact on the way we view
emotional attributes and their impact on the development and progression of CVD.
However, this impact must be tempered due to study limitations. Similar to the 2004
study, the non-diverse sample was comprised of middle-aged, highly educated white
women. Only one participant had less than some college education. Thus, findings from
neither study can be generalized to all women. Additional research is needed to establish
whether similar relationships exist in different ethnicities and in men. While the clarity of
the measures used in the study and some of the findings were difficult to interpret, brief
reporting in both areas may be due to journal publication limitations and, therefore, may
not a true reflection of study strength or design.
Clearly, these two studies were conducted with attention to detail in many areas and
measures were taken to support strong internal validity such as the use of wellestablished instruments, the appropriate use of statistical regression to identify
relationships, and strict data collection protocols. Both studies support a relationship
between psychological factors and the development of CVD. Therefore, further research
on the impact of psychological variables needs to be conducted on both men and women
and in different ethnicities. As was seen in these two studies emotions played a
significant role and should be investigated further.
Positive and Negative Emotions. While optimism has been studied with regards to
other positive emotions such as resilience (Bowen, Morasca, & Meischke, 2003),
pessimism has been examined in relationship to negative emotions such as depression,
depressive symptoms, Type A personality, and anger; as well as other emotional factors
such as social support, coping, and helplessness (Blumenthal, Burg, Barefoot, Williams,
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Haney, & Zimet, 1987; Ironson et al., 2005; Sergerstrom et al.,1998; Shnek, Irvine,
Stewart, & Abbey, 2001). The literature explaining negative emotions will be examined
later in this paper.
Bowen and colleagues (2003) analyzed the relationship among resiliency variables
and optimism in 357 women with a family history of breast cancer using a cross sectional
design. While optimism was measured using the LOT-R, resiliency was measured using
the Life Ladder Scale and the Life Attitude Profile-revised (LAP-R). The Life Ladder
Scale was described as measuring comparative levels of past, present and future thriving
and the LAP-R was reported to measure meaning and purpose in life as well as the
motivation to find meaning and purpose in life. In addition, data was gathered using the
MOS Social Support Survey; the SF-36 sub-scales of mental health, physical functioning,
and perceived health; the Cancer Worry Scale; and the subscales of depression and
anxiety from the Brief Symptom Inventory. Subjective risk perception was obtained by
asking the participant to rate their chance of getting breast cancer on a scale from zero to
100. Lastly, quality of life (QOL) was asked as a single item “Overall, how would you
rate the quality of your life?” using an 11-point Likert scale. Even though some
information about these instruments and measures was reported, there were areas that
were difficult to understand. For example, the authors mention using the MOS Social
Support Survey, but fail to define MOS, which may assist the reader to understand more
about the measure. In addition, reliability and validity were not presented for all
measures, which may affect the strength of study results and contribute to Type I error.
Optimism was not correlated with any of the resilience variables and LOT-R values
were lower than in previously reported studies, which may explain why the LOT-R did
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not load high enough on exploratory factor analysis (EFA) to be considered a measure of
resiliency. However, the researchers did suggest that the LOT-R be used in further
studies since it was very close to meeting the criteria. The specific statistics for the EFA
cannot be discussed because they were not included in the publication. Using multiple
regression analysis, independent predictors of resilience included: age (β = 0.92, p<0.01),
perceived risk of breast cancer (β = 1.73, p< 0.01), mental health (β = 0.38, p< 0.01), and
general health (β = 1.3, p<0.01). It is interesting that perceived risk of breast cancer was
an independent predictor of resilience and supports the intricate relationship between
these closely linked concepts. However, limitations of this study should be considered.
Similar to many studies in breast cancer research, this sample consisted of mostly
Caucasian (93%) and well-educated women with 65.8% completing at least four years of
college. Without representation from other ethnicities, it is difficult to say whether or not
similar findings would be replicated. In fact, studies of African American and Chinese
American women have reported an association with fatalism and breast cancer, which
definitely would impact resilience. The concept of fatalism will be discussed later in this
paper. In addition, there may be significant gender differences regarding resilience and
optimism. Thus, further study is warranted to explore the relationship between optimism
and resiliency in more diverse populations.
Summary. Overall, there has been extensive work completed on many aspects of
optimism, including influence on health and health related behaviors. However, limited
exploration has been completed in the areas of CVD. Specifically, only two studies
examine the development and progression of cardiovascular disease. Results from both
studies demonstrate the importance of investigating this area more fully with CVD.
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Additional research should include more diverse samples to see if findings can be
replicated.
The long-term challenge may be figuring out if individuals can be “taught” to be
more optimistic. Certainly individuals that already possess trait optimism have a head
start. However, it may not be completely unrealistic to teach state optimism. Behavior
modification techniques, such as meditation and reframing, have proven to be successful
in managing stress and adverse visceral reactions.
Literature on Optimistic Bias
Optimistic bias or unrealistic optimism is demonstrated when individuals believe
that their own risk is less than that of their peers (Weinstein, 1987). Work conducted on
risk perception relative to health and illness has shown that Americans tend to be
optimistically biased about their susceptibility to disease and illness (Facione, 2002;
Kreuter & Strecher, 1996; Weinstein, 1982, 1987).
Optimistic bias has been used to measure individual behaviors such as smoking
(Ayanian & Cleary, 1999; Hahn, Rayens, Hopenhayn, & Christian, 2006; Strecher,
Kreuter, & Kobrin, 1995; Weinstein et al., 2005), but has also been used to examine the
Health Belief Model (Clarke, Lovegrove, Wiliams, & Machperson, 2000), susceptibility
to health problems (Kruger & Burrus, 2004; Strecher et al., 1995; Weinstein, 1982),
intent to change behavior (O’Brien, Fries, & Bowen, 2000) and breast cancer (Facione,
2002; Katapodi et al., 2004).
Personal Characteristics. Researchers have found that, similar to risk perception,
personal characteristics also influence optimistic bias (Avis, Smith, & McKinlay, 1989;
Ayanian & Cleary; 1999; Hahn et al., 2006). For example, Ayanian and Cleary examined
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smokers’ perception of risk for heart attack and cancer using both a telephone interview
and a self-administered survey. The sample included 737 current smokers and 2,294
former smokers.
Increased perceived risk for heart attack was correlated with age greater than 65
years (O.R. = 0.2, 95% CI = 0.1-0.8, p < .05), less education (O.R. = 0.5, 95% CI = 0.21.1, p < .05), lighter smokers (less than 20 cigarettes per day) (O.R. = 3.0, 95% CI = 1.55.8, p < .05), and self-reported fair or poor physical health (O.R. = 1.6, 95% CI = 1.0-2.7,
p < .05). Perception of an increased risk of cancer was correlated age greater than 65
years (OR 0.2, 95% CI 0.1-0.5, p < .05), less education (OR 0.5, 95% CI 0.2-0.9, p <
.05), lighter smokers (less than 20 cigarettes per day) (OR 1.8, 95% CI 1.0-3.3, p < .05),
Increased perceived risk for heart attack was correlated with age greater than 65 years
(O.R. = 0.2, 95% CI = 0.1-0.8, p < .05), less education (O.R. = 0.5, 95% CI = 0.2-1.1, p
< .05), lighter smokers (less than 20 cigarettes per day) (O.R. = 3.0, 95% CI = 1.5-5.8, p
< .05), and self-reported fair or poor physical health (O.R. = 1.6, 95% CI = 1.0-2.7, p <
.05). Perception of an increased risk of cancer was correlated age greater than 65 years
(OR 0.2, 95% CI 0.1-0.5, p < .05), less education (OR 0.5, 95% CI 0.2-0.9, p < .05),
lighter smokers (less than 20 cigarettes per day) (OR 1.8, 95% CI 1.0-3.3, p < .05),
In examining the results, it may appear unusual that increased perceived risk for
heart attack and cancer occurred in only the light smokers (less than 20 cigarettes per
day). However, this difference may be due to the fact that these individuals may have
been heavy smokers at one time and cut down knowing there was a risk associated with
heavy smoking. In addition, the number of light smokers may be skewed due to the selfreported nature of the data. While the results of this study highlight personal
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characteristics that contribute to perceived risk for heart attack and cancer, the use of self
-reported data can introduce bias and can threaten internal validity.
Avis, Smith, and McKinlay (1989) investigated influences on perceptions of heart
attack risk in a random sample of 732 men and women, ages 25-65 years. Using logistic
regression, the study found elevated perceived risk for heart attack was seen with
increased age (O. R. = .90, 95% CI = .87, .92), self-reported poor health (O.R. = 1.80,
95% CI = 1.25, 2.58), and death of a parent caused by heart disease (O.R. = 2.72, 95% CI
= 1.52, 4.87). Both increased age and self reported poor health were findings similar to
those found by Ayanian and Cleary (1999). However, these values were reported without
a reference to a p value, thus increasing the risk for a Type I error when interpreting the
results. It is possible that the journal did not require this information to be reported nearly
19 years ago. However, this foundational study is important since it examined personal
characteristics that affect risk perception. In addition, these researchers found that 42 %
of the respondents underestimated their risk, 18% overestimated their risk, and 40%
estimated their risk accurately when compared to an estimate provided by the RISKO
tool, which is based on objective data regarding risk factors for CVD such as blood
pressure and cholesterol. An overwhelming 60% of respondents inaccurately perceived
their estimated risk for a heart attack. This is an important message because if individuals
do not form an accurate perception of risk, there is little chance improvement in health
behaviors will occur.
Individual Behaviors. Optimistic bias research centered around individual
behaviors and/or risk factors includes areas such as: seat belt use, binge drinking, condom
use, vaccine effectiveness, food safety, bicycle helmet use, dietary choices, and traffic
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accidents, to name a few. Since the purpose of this paper is not to explore optimistic bias
specifically as related to individual behaviors, this area will not be explored in depth.
However, one example will be discussed to demonstrate the difference with this
application. Using grounded theory method, Wolburg (2001) studied risk perception of
binge drinking among 81 college students at a small Midwest university. Focus group
data gathering took place prior to in depth interviews by paid volunteer participants.
Results of the study revealed the following items as potential risks encountered while
drinking: drunken driving, illegal activities such as fake identification and underage
drinking, sexual experience including rape, passing out/losing control, fights, vandalism,
physical illness, physical injuries, emotional consequences such as guilt or humiliation,
drug use with alcohol, academic failure, financial consequences, and parent knowledge.
The study concluded that students who feel personally vulnerable to threats/risks are
more likely to understand the real risks in binge drinking. The prevailing attitude of most
college students was that getting sick from drinking was the worst outcome to expect and
most do not care if they get sick from drinking because they feel it is a part of college life
(Wolburg). Most students conveyed that they feel “invincible” and free from
consequences; therefore they do not feel vulnerable to the risks of binge drinking.
The results of this study are important for two reasons. First, because it
demonstrated that these college age students participated in risky behavior such as binge
drinking, despite identifying potential risks such as physical and social consequences.
Second and perhaps more importantly, although this study has found this behavior to be
true with college binge drinking, it may also carry over into health behaviors that affect
the development of CVD such as smoking, unhealthy eating, and physical inactivity. This
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study may have biased results based on the self-reported nature of the topic and use of
volunteer subjects. It is possible that many participants may have purposely given
misinformation about this controversial topic. Both biases may threaten the internal
validity of the study.
Screening Behaviors. Facione (2002) examined screening behavior for breast
cancer in 770 women ages 19-99 years (mean age 46.18 years). The sample was diverse
with 26.7% African American, 33.3% Latino, and 33% White. Only 8.3% had less than a
high school education. This was a secondary analysis of data collected from a previous
survey study. Instruments used in the study included: the Life Orientation Test (LOT)
used to measure the trait of optimism; Breast Cancer Fatalism used to examine attitudes
about developing and surviving breast cancer; Breast Cancer Symptom Knowledge
(BCSK) used to evaluate knowledge about breast cancer; and the Reynolds Form of the
Crowne-Marlow Scale used to analyze social desirability response bias. Satisfactory
validity and reliability measures were provided for each instrument used in the study
supporting internal validity. Facione hypothesized that women with more knowledge
about symptoms of breast cancer and the disease process would show less optimistic bias
about their personal risk and make more realistic judgments about their own risk. Results
confirmed this hypothesis and showed women with a college education scored higher on
the BCSK (mean 9.44, SD 3.44) than women without a college education (mean 7.04, SD
4.31) and that higher education levels were significantly related to less optimistic bias on
the BCSK scale (Chi square = 7.28, p= 0.007). In this study, LOT scores (trait optimism)
did not significantly differ between those perceiving themselves to be at lower risk for
breast cancer (mean 5.31, SD 1.84) and those perceiving themselves to be at higher risk
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(mean 5.46, SD 1.70, t = .996, p = 0.314). Thus optimism did not influence their personal
perception of breast cancer risk. Similar findings were described for the measure of
fatalism in this study. However, 75.8% of the women gave comparative risk estimates
lower than that of other women. Both the survey design and the use of a convenience
sample may have produced biased results. However, the findings from this study may be
cursory in helping to explain the delay in screening for breast cancer and related
symptoms. Thus, communicating relative risk to women could ultimately influence
preventive health practices for breast cancer.
This study is a good example of how both survey research and a secondary analysis
of data is useful to researchers in examining strategies to influence health behaviors.
While bias may be present, there is still enough evidence to further investigate how
individuals perceive risk. The strength of this study was using established instruments
with strong reliability and validity data. In addition, demographic data supported that
level of education may be a powerful predictor of optimistic bias.
Susceptibility. Weinstein, Marcus, and Moser (2005) conducted a telephone
interview with 6,369 participants and found that smokers underestimate their risk for lung
cancer both relative to other smokers and to non-smokers. These findings support work
completed by other researchers such as Ayanian & Cleary (1999) that was previously
discussed. Strecher, Kreuter, and Kobrin (1995) examined perceived risk and optimistic
bias for heart attack, cancer, and stroke in smokers and nonsmokers. In contrast to
previous studies, Strecher and colleagues found that smokers estimated their risk for each
disease higher than non-smokers. However, the smokers in this study underestimated the
degree of health-related problems caused by smoking. Thus, smokers knew that smoking
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had negative effects, but underestimated the severity of the consequences. This may
explain why smokers continue to smoke, even though they know they are putting
themselves at risk for cardiovascular disease and cancer. However, the difference in
methods between these studies is that Strecher and colleagues conducted personal
interviews with subjects. The technique may be partially responsible for personal bias in
reporting risk. Weinstein believes that the specific questions asked have more influence
on response than the type of interview. However, any type of telephone interviewing and
voluntary participation may contribute to bias in the data collection affecting internal
validity of the study.
Summary. Optimistic bias has been studied in many disease processes. Research
has shown that personal characteristics such as age, gender, and education play a role in
how individuals perceive risk. In addition, research conducted with breast cancer patients,
in particular, demonstrated that optimistic bias is not only influenced by personal
characteristics, but may also play a role in preventative screening behaviors. Because this
concept has not been studied in CVD, it is not known how optimistic bias affects
preventive health behaviors related to this disease process or risk perception for CVD.
Understanding this relationship could potentially influence interventions that will
effectively decrease the development and progression of CVD. The impact of primary
prevention not only affects disease development and progression, but ultimately impacts
healthcare resources.
Literature on Negative Emotions
While the purpose of this paper is not to specifically discuss negative emotions,
psychosocial components are becoming more widely recognized as risk factors for CVD,
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hence it is necessary to address this area of literature. In addition, research related to
optimism has suggested that the opposite of optimism may be depression and not
pessimism. Research in this area is ongoing to determine this relationship. Initially, “type
A” behavior was examined and attributed as a risk factor. More recently, however, other
psychosocial components such as depression, anxiety, hopelessness, and worry have been
recognized as contributing factors to CVD (Elovainio et al., 2005; Ferketich,
Schwartzbaum, Frid, Melvin, & Moeschberger, 2000; Matthews, Nelesen, & Dimsdale,
2005; Matthews, Owen, Edmunsowicz, Lee, & Kuller, 2006; Shnek et al. 2001; WeberHamann et al., 2002). These components are often referred to collectively as negative
emotions. It is important to examine how pessimism is related to other negative emotions.
Rozanski, Blumenthal, and Kaplan (1999) describe depression as the presence of
depressed mood and a marked decrease in all activities that persists for at least two
weeks. In addition, this mood alteration is also accompanied by at least two of the
following symptoms: “changes in appetite, sleep disturbance, fatigue, psychomotor
retardation or agitation, feelings of guilt or worthlessness, problems concentrating, and
suicidal thoughts” (p. 2193). Depressive symptoms may have components of clinical
depression, but lack sufficient magnitude to be classified as such. Rozanski and
colleagues outlined the presence of a threefold higher depression rate among those with
CAD. It is important to distinguish between depression and the presence of depressive
symptoms because research demonstrates that CAD is associated with the degree of
depressive symptoms present (Matthews, Nelesen, & Dimsdale, 2005). These findings
suggest that depression manifests along a continuum. Shnek and colleagues (2001)
examined the relationship between psychological factors and depressive symptoms in
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post-myocardial infarction patients using repeated measures at one-month post discharge
and one-year follow-up. Regression analysis was run controlling for confounding
variables of depressive symptoms, helplessness, self-efficacy, and cognitive distortions;
optimism was the only variable negatively correlated with depressive symptoms (ΔR2
0.34, p< 0.001) at time 2. This supports work initially completed in this area by Scheier
and Carver (1985) conceptualizing optimism as a stable trait that is not affected by health
status, mood or circumstances.
Gender. There is evidence to suggest that there are gender differences in how
negative emotions manifest as part of the atherogenic process. For example, Elavainio et
al. (2005) reported findings from the Young Finns study showing that higher levels of
depressive symptoms, measured using a modified version of the Beck Depression
Inventory, were correlated with increases in carotid intimal medial thickness in men, even
after adjusting for age and cardiovascular risk factors in adolescence and childhood (β =
0.08, F[1, 405], 9.24, p< 0.003). The Young Finns Study examined both men and women
(n= 1126) over a 21-year period, capturing adolescence through young adulthood. The
researchers suggest that one possible explanation for the expressed difference between
genders is that women develop atherosclerosis later in life. However, further studies
between men and women may help to explain the intricacies of these differences. More
recent studies have indicated that negative emotions may also contribute to the
development of atherosclerosis in middle-aged women (Matthews, Raikkonen, SuttonTyrrell, & Kuller, 2004; Matthews, Owens, Edmunsowicz, Lee & Kuller, 2006). These
studies were previously discussed in the section on optimism.
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Race/Ethnicity. In addition, there is evidence to support a link between
race/ethnicity and depressive symptoms. Results from the Coronary Artery Risk
Development in Young Adults (CARDIA) Study followed a cohort of 5,115 participants
ages 18-30 for 15 years (Knox, Barnes, Kiefe, Lewis, Iribarren, Matthews, et al. (2006).
This prospective study included African American men and Caucasian men and women.
Measures of depressive symptoms were obtained with the Center for Epidemiology
Studies Depression Scale (CES-D) instrument, a 20-item self-reported measure using a 4point Likert scale. Reliability and validity measures have been reported widely for this
well-established instrument.
Results found African American women had more episodes of depression (n = 625)
compared to African American men (n = 367), Caucasian men (n = 276), and Caucasian
women (n = 413). In addition, there was a significant association between diabetes and
reported episodes of depression in African American men and women in both unadjusted
(β = 0.09, SE = 0.02, p< 0.0001) and adjusted (β = 0.06, SE = 0.02, p< 0.0008) regression
models. A significant inverse correlation between physical activity and depressive
episodes was seen across all groups: African American men and women: β = -32.16, SE
= 8.21, p = 0.0001; Caucasian men and women: β = -27.26, SE = 8.27, p = 0.001). A
positive correlation between smoking and depressive episodes was seen across all groups:
African American men and women: β = 0.09, SE = 0.02, p = 0.0001; and Caucasian men
and women: β = 0.07, SE = 0.02, p = 0.003). Similarly, a positive correlation was also
seen between BMI and depressive episodes across groups: African American men and
women: β = 0.18, SE = 0.18, p = 0.0001; and Caucasian men and women adjusted: β =
0.54, SE = 0.19, p = 0.006). This study showed both differences and similarities between

66
African Americans and Caucasians regarding depressive symptoms and risk factors for
CVD. This is an important first step in tailoring treatment options that not only affect
depression, but also CVD. If, in fact, African Americans experience more depression,
could this also be considered a comorbid state for this population? Further study may
help to explain more about the relationship between negative emotion and the
development and progression of CVD in various ethnicities.
Socioeconomic Status. Socioeconomic status is also a factor related to the presence
of depression, anxiety and CHD. Thurston, Kubzansky, Kawachi, and Berkman (2006)
examined data from the First National Health and Nutrition Survey (NHANES I) to see if
depression and anxiety mediate the relationship between low socioeconomic status (SES)
and CHD using regression analysis and proportion hazard ratios. In this analysis, the
researchers considered negative affect to be the presence of depressive and anxious
symptoms. However, specific indicators of these symptoms were not outlined in the
paper. Increased risk of CHD was associated with high levels of depressive symptoms
(RR = 1.57; 95% CI, 1.29-1.92) and symptoms of anxiety (RR = 1.60; 95% CI, 1.341.90); as well as moderate levels of depressive symptoms (RR = 1.20; 95% CI, 1.05-1.37)
and symptoms of anxiety (RR = 1.18; 95% CI, 1.03-1.36). Although these researchers
reported that women had higher reports of depressive symptoms than men, after adjusting
for age, the difference was marginal (p<0.05). While both depressive symptoms and
anxiety are correlated to increased risk for CHD and lower SES, data did not support the
hypothesized mediating effect.
Fatalism. While fatalism has not been examined closely in cardiovascular research,
the concept is worth exploring for two reasons. First, literature on fatalism in breast
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cancer research has examined fatalism along with optimism, optimistic bias, and risk
perception to examine risk perception with respect to that disease process. Second, and
perhaps most important in this review, is that fatalism is present in several groups that
have already been identified as high risk to develop CHD, namely African Americans,
and Hispanics (Facione, Giancarlo, & Chan, 2000; Franklin, Schlundt, McClellan,
Kinebrew, Sheats, Belue, et al., 2007; Kwok & Sullivan, 2006; Simon, 2006). Thus, a
brief review of fatalism will be discussed. Fatalism can be defined as a predetermined
health outcome controlled by a higher power and not the individual (Franklin et al.,
2007). Fatalism is often associated with religious or cultural beliefs among Chinese
Americans (Franklin et al., 2007; Faccione et al., 2000), African Americans (Franklin et
al., 2007), and Hispanics (Simon, 2006). Fatalism has been shown to hinder both
screening and treatment in breast cancer, thus there is increasing interest to study its
effect on daily health behaviors. Whether or not fatalism can be considered a negative
emotion related to cardiovascular disease still needs to be determined, however,
exploring pre-existing concepts from related disease processes such as breast cancer may
help to increase knowledge about primary prevention for cardiovascular disease.
There is an ever-increasing body of research that supports the relationship between
negative emotions and the development of CHD. Furthermore, continued study of
negative emotions may help to elucidate their role in personal health behavior choices
and strategies to treat those with depression and depressive symptoms. It is important to
continue to explore the relationship between negative emotions and health status.
Summary. In summary, the literature on risk perception, optimism, optimistic bias,
and negative emotions clearly shows that these areas overlap conceptually. However,
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since these concepts have not been used or measured consistently, gaps in the both the
literature and research are present. Health behavior choices, whether positive or
negative, are conscious decisions made by individuals. Investigators want to know how
factors such as risk perception, optimism, optimistic bias, and negative emotions
influence a person to choose health behaviors that will influence health status or disease
progression. Findings from such research may be helpful in planning primary prevention
strategies, such as tailored interventions, that could ultimately impact the onset of
cardiovascular disease.
Chapter Summary
The evidence reviewed in this chapter presents some concerns that need to be
addressed. While the author addresses many critiques during the review of specific
studies, there are a few global areas of concern. To begin with, none of the studies
discussed power analysis or effect size in relation to the sample size. In addition, most
samples were nonrandom convenience samples that increased the risk for bias. Second,
with few exceptions (Clarke et al., 2000; Facione, Giancarlo, & Chan, 2000; Hahn et al.,
2006, Meischke, et al., 2000; Scheier et al., 2006; Weinstein, 1982) studies did not use or
discuss theoretical frameworks or models to guide the study. The two theoretical
frameworks most frequently cited in these studies were the Health Belief Model or the
Stages of Change Model.
While each study has made a contribution in understanding how risk perception,
optimism, optimistic bias, and negative emotions affect health and health related
outcomes, more research is needed for a number of reasons. First, there has been
inconsistency in the terms used. For example, risk perception has often been used when
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knowledge and awareness is being studied. In addition, comparative and subjective risk
can and have been measured in many different ways. These inconsistencies present a
problem when comparing study results and making conclusions regarding the findings.
Adding to this concern is the use of many different instrument measures. While some
instruments such as the LOT are well-established, some of the studies have used only
parts of scales or descriptive words to gather data (Carver et al., 2003). Moreover, much
of the work has been limited to cancer research. The knowledge gained from these
studies needs to be replicated in the area of CVD. Furthermore, both genders need to be
studied. Both breast cancer research and foundational research in CVD conducted by
Matthews et al., (2004) and Matthews et al., (2006), has focused only on women. It is
necessary to see if research including both genders would produce similar results.
In conclusion, knowledge about risk factors, alone, is not enough for individuals to
make decisions about health behaviors. More understanding is needed on how
psychological variables such as risk perception, optimism, optimistic bias, and negative
emotions govern an individual’s consciousness to make decisions regarding health
behavior. Future work examining the relationship of risk perception and related concepts
with CVD disease development and progression is necessary in order to make an impact
on morbidity and mortality rates.

CHAPTER THREE
METHODS
The previous sections have described several factors that are conceptually related
to risk perception. Psychological variables such as optimism, life satisfaction and
depressive symptoms may play an important role in how persons perceive risk. In
addition, other influences, such as demographic and personal variables, may also be
helpful when examining risk perception. The relationships between and among these
variables will help to establish how risk perception is formed and may be an important
component in understanding the decision-making process that leads to behavior changes.
Therefore, the purpose of this study is to examine the concept of risk perception in
cardiovascular disease. The primary aims are to: 1) examine the accuracy of one’s
perceived risk for CVD; and 2) examine the relationship between perceived risk and key
sociodemographic and psychological variables thought to influence risk perception.
Hence, the study will be framed by the following research questions: 1) Do persons
perceive their risk for cardiovascular disease accurately? 2) How do the
sociodemographic variables of age, gender, socioeconomic status, level of education,
family history of CVD, and knowledge of someone with CVD contribute to risk
perception? 3) How do the psychological variables of optimism, life satisfaction, and
depressive symptoms contribute to risk perception?
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Study Design and Rationale
This study used a cross-sectional descriptive correlational design to explore the
relationship between perceived versus calculated risk, the demographic variables that
may affect perceived risk and the relationship between optimism, optimistic bias, and
depressive symptoms and how each contributes to perceived risk. For the remainder of
this study, the term psychological variables will refer to optimism, optimistic bias, life
purpose, and depressive symptoms. The conceptual framework developed by the author
supports this design and the proposed study questions (Appendix C). In addition, the
review of literature also confirms the importance of examining the relationship between
risk perception, demographic variables, and psychological variables.
Setting: Health Screenings
The study was conducted at monthly Health Screenings (called CV Health Risk
Appraisals) in a multi-hospital system that serves racially and ethnically diverse
populations in Northwest Indiana and neighboring Illinois. The three hospitals in this
system have a capacity of over 750 beds. The Community Hospital is located in Munster,
Indiana; St. Mary Medical Center is located in Hobart, Indiana; and St. Catherine
Hospital is located in East Chicago, Indiana..
The three hospitals host the Health Screenings each month on different days of
the week and at a variety of times to allow people of all ages to attend. These screenings
include the following measures: systolic and diastolic blood pressure, body mass index,
fasting blood sugar, measures for determining metabolic syndrome, lipid levels (total,
HDL, LDL cholesterol, and triglycerides), and a heart health profile. The heart health
profile ascertains family history of heart disease and dyslipidemia, as well as personal
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history of diabetes, disylipidemia, hypertension, and stroke. Other measures include:
intake of saturated fat, dietary sodium, and alcohol; exposure to secondhand smoke;
weekly exercise patterns; and coping status. Lastly, women are asked to report use of
birth control pills and hormone replacement therapy.
Recruitment
Pre-registration is required to attend a health screening even. Health screening
events are advertised throughout the institutions in the hospital system. Those interested
in attending a screening must call to reserve a spot and are given a designated time to
arrive on the day of the screening along with instructions for fasting prior to the
screening. The number of participants who attend the monthly health screenings varies,
but average attendance is 10 and 20 individuals. Attendance is affected by the time and
day of the screening as well as weather conditions.
The researcher planned to recruit participants from those already attending the
screening event. Since the average attendance is 10-20 people per event, additional
methods were used in an effort to recruit a sufficient number of participants for this
study. The first supplemental method was to advertise the research study at each of the
hospitals and their associated outpatient clinical facilities. Approved study fliers were left
and replenished in waiting rooms at these facilities which included: wellness centers,
outpatient physical therapy and rehabilitation departments, and outpatient diagnostic
centers. The second method was to advertise in the community at area churches and
community centers that offer instructional classes. Similarly, approved study flyers that
explained the purpose of the study were sent to these facilities to be posted in a visible
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area. In addition, contact information for the researcher was made available. See
Appendix D for Flyers.
All departments who had staff working at the coronary risk appraisals were sent
information about the participation and recruitment for the study. The researcher met
with the screening coordinator prior to the start of the initial data collection to discuss the
purpose of the study, approved recruitment procedure, and the informed consent process.
Before each screening, the researcher talked to staff working at the screening to reinforce
that any questions about the study be referred to the researcher for clarification.
The researcher was present at all screenings during the study period to advertise
and recruit. The researcher sat in a designated recruitment area to discuss the purpose of
the study, obtain informed consent, and complete the data collection booklet. The
screening event areas were all located in well-marked areas in each hospital and easily
accessible to participants.
Sample
A nonprobability convenience sample meeting both inclusion and exclusion
criteria were enrolled in the study. The types of people who typically attend the
screenings are: both insured and uninsured people seeking an economical way to get
laboratory testing related to cardiac wellness; the ”worried well”- people who are well,
but worry about their health status and frequently seek out health screenings; and those
referred by their physicians for annual laboratory work.
The inclusion criteria for participation were: men and women over the age of 40
years, who are able to participate in the informed consent process and could read, speak,
and understand English. The preselected age range was based on the 2012 AHA Heart
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Disease and Stroke statistics that states that average age of onset for the initial major
cardiovascular event is 70.4 years for women and 64.5 years for men (American Heart
Association 2012 update). The age range has been selected to capture both men and
women who have not experienced a cardiovascular event nor who have been diagnosed
with cardiovascular disease.
The exclusion criteria for participation included: self-report of diagnosed
cardiovascular disease; inability to participate in the informed consent process and
inability to read, speak or understand English; those who have been diagnosed with
clinical depression or are taking medications to treat depression; and those who have
undergone percutaneous coronary transluminal angioplasty (PTCA) or coronary artery
bypass graft surgery (CABG).
The number of pre-registered persons for each screening was communicated to
the researcher so that an appropriate amount of material was brought to each screening.
Each person who arrived for the screening was given a study flyer which included the
description and purpose of the study (Appendix D). Those interested in participating in
the study were referred to talk with the researcher and were screened for inclusion and
exclusion criteria. Those meeting the stated eligibility criteria were encouraged to ask
questions about the study. After all questions were answered, the participant was asked to
sign duplicate informed consent and HIPAA documents (Appendices E and F,
respectively).
Data Security
Each participant was assigned a study number to de-identify the data and protect
the anonymity of the participant. A directory of study numbers and corresponding
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participant names is kept in a locked file cabinet in the researcher’s home office.
Completed questionnaire booklets were transported directly from each data collection site
to the researcher’s home. De-identified data was entered into a password protected
database on a laptop computer.
Measurements
The outcome variable in this study is risk perception, while the independent
variables included: demographic variables, health history, actual/predicted cardiac risk,
and psychological variables (life satisfaction, and optimism, and depression). Each
variable and related measurement tools are discussed next. Instruments with acceptable
reliability and validity were selected to measure these variables. See Table 3 for an
overview.
Table 3. Measurement Instruments
Variables
Outcome:
Risk Perception
Dependent:
Demographics & Health History

Life Satisfaction
Optimism
Depression
Actual/Predicted Cardiovascular Risk

Measurement
•

CRIP Instrument

•
•

Demographic Study Questionnaire
Wellsource© Health History Form

•
•
•
•

Life Engagement Test (LET)
Life Orientation Test Revised (LOT-R)
Patient Health Questionniare-8 (PHQ-8)
Framingham Risk Score (estimate of 10 year risk for
CVD)
Heart Health Score(Wellsource©) (estimate of level
of coronary risk)

•

Risk Perception
Risk perception is relatively new to the area of cardiovascular research. The
Cardiac Risk Perception (CRIP) instrument (Barnhart, 2009) was used in this study
(Appendix G). The CRIP is a six point Likert-based instrument composed of 19 questions
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encompassing the domains of perceived vulnerability, worry, self-efficacy, & perceived
health status through both comparative and subjective risk statements. Scoring entails
adding the total responses once the worry and self-efficacy questions are reversed (# 5, 7,
11, 14, 16), with higher scores indicating increased risk perception. The Likert response
range is: Strongly Disagree/ /Disagree/ /Somewhat Disagree/ /Somewhat Agree/ /Agree/ /
Strongly Agree. The CRIP has undergone vigorous pilot testing in several populations
involving postmenopausal women, persons with diabetes, and mixed genders. Reported
Cronbach’s alpha = 0.78 in a recent study (Barnhart, 2008). The time needed to complete
the instrument is approximately 10 minutes.
Demographic Variables and Health History
The demographic study questionnaire consisted of demographics such as: age,
gender, marital status, socioeconomic status, and number of children as well as questions
that examined health maintenance behaviors. Examples included: How often do you see
your primary care provider? How often do you visit your dentist? These questions were
structured to elicit ordinal or continuous level of measurement (See Appendix H). In
addition, health history information was gathered using the Wellsource© Heart Health
Profile. Wellsource© is a company that provides health appraisal programs widely used
for more than 30 years. The Wellsource© program reports a combination of ordinal and
continuous measurement data and will be discussed in the section on projected cardiac
risk.
Psychological Variables
The psychological variables assessed in this study included: optimism, life satisfaction,
and depressive symptoms. These types of variables may lead to misleading results during
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this current economic climate. Therefore, a number of single question items were also
added to the Health History Questionnaire to help determine if the presence of any
depressive symptoms are situational and related to the current economic
environment or whether they are more dispositional in nature. Each of these instruments
are discussed in this section.
Optimism. The Revised Life Orientation Test (LOT-R) was used to measure
optimism. Although there are several versions of this instrument, this study used the
modified version of the tool (Appendix B) (Scheier, Carver, & Bridges, 1994). The life
orientation test-revised (LOT-R) is a LIKERT scale based instrument consisting of ten
questions. In the revised version, there are four filler questions (#2, 5, 6, 8), three
positively worded questions (#1, 4, 10), and 3 negatively worded questions (#3, 7, 9). The
coding of the LOT-R (with a total possible score of 24) is positively worded so that high
values imply optimism, while low values imply pessimism (Scheier et al., 1994).
Reported Cronbach’s alpha for the LOT-R = .90, making the instrument highly reliable
and valid for measuring optimistic bias (Scheier et al., 1994). This instrument has been
used widely to measure optimism in areas previously discussed such as: immune
response (Sergerstrom, Taylor, Kemeny, & Fahey, 1998), cancer, cardiovascular disease
progression (Matthews 2004), and arthritis (Brenes, Rapp, Rejeski, & Miller, 2002).Time
to complete this instrument is approximately five minutes.
Life Satisfaction. Life satisfaction was measured using the Life Engagement Test
(LET). The LET is a five point Likert scale based instrument consisting of six questions
(Appendix I). Three items (# 2, 4, and 6) are positively framed, while the other three
items (# 1, 3, and 5) are negatively framed. The LET is scored in a two-step process.
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First, three questions (# 1, 3, and 5) are reverse coded and then the scores are summed.
The higher the summary score, the higher the reported purpose in life. Reported
Cronbach’s alpha for the LET in initial testing ranged from .72 to .80, making the LET
reliable, especially for a newer instrument. Purpose in life has been shown to affect how
persons make decisions about health behaviors and also has been correlated with
development of CVD in a longitudinal study (Matthews, Owens, Edmundowicz, Lee &
Kuller, 2006). Although this variable is relatively new in cardiovascular research, it may
be directly related to both optimism and depressive symptoms. Time needed to complete
this instrument is approximately 3-5 minutes.
Depression. The PHQ-8 (Appendix J) is a self-reported depression screening
instrument using the first eight questions of the Patient Health Questionniare-9 (PHQ-9).
Comparative analysis of the PHQ-9 with the PHQ-8 indicated similar operating
characteristics with respect to predictability of depression severity (Kroenke, Spitzer, &
Williams, 2001). The PHQ-8 omits the ninth item asking about “thoughts that you would
be better off dead or of hurting yourself in some way”. The use of this alternate form is
supported for use in populations or samples in which one or more of the criteria are met:
there is a low or negligible risk of suicide; depression is being assessed as a secondary
outcome and not the focus of the research; and data is collected using self-report
measures (Kroenke & Sptizer, 2002).
The questions are scored on a 0-3 Likert scale with 0 = not at all, 1 = several days,
2 = more than half the days, and 3 = nearly every day. The scoring for the PHQ-8 is
summative with a score ranging from 0 –24. Current literature supports a score of > 10 on
the PHQ-8 as being positive for symptoms of depression (Kroenke, Strine, Spitzer,
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Williams, & Mokdad, 2009). In addition, reported reliability for the PHQ-9 is 0.89 in a
study of 3,000 primary care patients and 0.86 in the OB-GYN study of 3,000 women.
Calculated Cardiovascular Risk
Framingham Risk Score. The Framingham Risk Score is a calculation that projects
one’s 10-year risk for a cardiac event, and has been widely used and reported in the
literature. Calculated cardiovascular risk is based on physiological measures and selfreported health behaviors obtained at the coronary risk appraisal. This calculation used
the following variables: age, gender, total and HDL cholesterol, systolic blood pressure,
smoking history and diabetic history.
Calculations were performed using a gender appropriate tool and risk scores
were categorized as low, medium, and high (Appendix K). Those participants with
coronary risk equivalents (diabetes, stroke, and peripheral artery disease) were scored as
>20% risk of developing CHD over the next 10 years. The researcher completed the
calculations of the scores using the online risk calculator. This score serves as a surrogate
for “actual/predicted risk for heart disease”. During the calculation of the Framingham
Risk Scores, the researcher noted little variability in the scores. Therefore, it was decided
to also include the Heart Health Scores (HHS) in data analysis. Though the HHS is a
similar concept, it does not project future risk, rather it reflects current risk based on the
number and severity of risk factors.
Heart Health Score. The Heart Health Score is based on a scoring strategy using
the NCEP III revised guidelines based on the severity and amount of the risk factors and
includes the same variables: age, gender, lipid profile, systolic blood pressure, BMI,
smoking history and diabetic history listed for the Framingham Risk Score, but the HHS
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also adds fitness level and personal and family history of cardiovascular disease
(Wellsource©, 2012). The Wellsource© program assigns a score based on the number
and severity of risk factors (major versus moderate) present. A computer program
generates a “Heart Health Score” (HHS) in one of four categories:


“Excellent” or “Ideal risk” (score of 75-100), defined as no risk factors other than
age;



“Doing Well” or “Low Risk” (score of 50-74),defined as having 1 to 3 moderate
CHD risks factors not including age, or having a personal history of CHD when blood
lipids are “not known”



“Needs Improving” or “Moderate Risk” (score of 25-49), defined as having only one
major CHD risk factor not including age or family history or having 4 or more
moderate CHD risk factors (counting age and family history as moderate risk factors),
and



“Caution” or “High Risk” (score of 0-24 defined as having moderate CHD risk blood
lipids AND 2 or more major CHD risks OR having two or more major CHD risks not
including age OR having one major CHD risk, plus the age major risk AND Low
fitness OR having blood lipids or triglycerides within “Ultra-high” category.

The score is part of a report generated from the Wellsource© computer program and was
provided to the researcher by the coordinator of the screening. See Appendix L.
Knowledge and Attitude Questions
Chapter two highlighted that the concept of risk perception has not been used
consistently in the healthcare literature. Examples were provided that illustrated that
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while some studies stated that risk perception was being measured or used the term
“perception of risk” in their title, it was found that awareness or knowledge about risk
factors was really being measured (King et al, 2002; Oliver-McNeil & Artinian, 2002).
Knowledge and awareness are thought to be related to CVD and is therefore foundational
to the formation of personal risk perception. Thus, in addition to answering the aims of
the study, questions that gathered information on worry about disease, knowledge related
to CVD, being informed about heart disease, risk factors to CVD, and risk factor
modification strategies were also included. In addition, permission was obtained to
include specific questions from the American Heart Association 2009 telephone survey
tool (Mosca, Mochari-Greenberger, Dolor, Newby and Robb, 2010).
Data Collection Procedure
The usual health risk appraisal screening procedure required individuals to preregister for the event. When participants arrived at the screening, the study was briefly
explained and if they were interested in participating in the study, they were told to report
to a specific area in the room after their testing was completed. Participants were given a
15 question Wellsource© Heart Health form to complete prior to having blood pressure,
height, and weight taken and recorded by an exercise physiologist. Next, blood was
drawn by a qualified hospital phlebotomist in order to generate laboratory results for a
fasting blood sugar and lipid profile. Each sample was coded with the patient’s name and
patient identification number. The collected blood was later sent to the hospital
laboratory where it was analyzed according to hospital policy and standardized
procedures. The researcher did not interfere with nor was involved in the blood sampling
procedures or blood analysis process.
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Persons interested in participating in the study returned to the researcher’s table to
complete the informed consent process and obtain the study booklet containing a unique
participant number. The researcher was available to clarify study information and to
answer any questions. Granola bars were available to participants while they completed
the booklet. The researcher verified that all items had been answered prior to giving a
$10.00 gift card to the participant.
Approximately one week after the screening, the Health Screening Appraisal
coordinator received a report containing all laboratory results. She entered the laboratory
results into a Wellsource© computer program to generate a personalized report for each
participant. The reports were then mailed to each participant via the United States postal
service. Each report provided a composite “overall” heart health score determined by the
number of risk factors present and offered a detailed explanation of the test results. For
example, the lipid profile was broken down into desirable, borderline, and high risk
results, while also displaying the participant’s results. After results were reported,
suggestions were provided on how to effectively modify any results that needed
improvement. For each category, the report outlined whether the participant is “doing
well” or “needs improvement”. The researcher contacted the coordinator to acquire a
copy of the Wellsource© report and laboratory data for each participant in the study. A
Framingham Risk Score was calculated by the researcher from this report and the
physiological measures taken at the screening.
Power Analysis Calculation of Sample Size
The sample size proposed for this study was estimated using power analysis in an
effort to decrease the chance of making a Type II error and increase the likelihood of
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finding statistically significant results erroneously rejecting the null hypothesis. The
power analysis was calculated framed by the research questions. Regardless of these
questions, the alpha (α) and beta (β) levels were set at 0.05 and 0.80 respectively.
The first research aim examined if persons perceive their risk for the development
of CVD accurately. This aim correlated actual/predicted risk scores measured by a
Framingham Risk Score (FRS) and Heart Health Score (HHS) with risk perception
scores, as measured by the CRIP. Using a moderate effect size (r = 0.30) with α = 0.05, β
= 0.80, the sample estimate was 67 participants (Hulley, 2001). A second calculation was
performed using a method proposed by Cohen (1992). Using a moderate effect size of
0.30 and α = 0.05, the sample estimate was 85 participants.
The second and third research aims examined the contributions of psychological
variables and possible confounders to risk perception: How do optimism (LOT-R), life
purpose (LET), and depressive symptoms (PHQ-8) contribute to the formation of risk
perception (CRIP)? The literature suggests 10-15 participants per independent variable
in a regression analysis. Therefore, based on three independent variables (optimism, life
purpose, and depressive symptoms) and six possible confounding variables (age, gender,
level of education, socioeconomic status, family history, and personal knowledge of
knowing someone with CVD), the estimated number of participants needed for this study
was between 90 (nine variables x 10 = 90) and 135 (nine variables x 15 = 135). A third
method outlined by Cohen (1992) was also examined. Using a moderate effect size
statistic (0.15), α = 0.05, β = 0.80, and nine variables, the sample estimate would be 111.
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Data Analysis
Data analysis was conducted using International Business Machines Statistical
Software Package for Social Sciences (IBM SPSS) version 20 (2012). Alpha and Beta
levels were set at 0.05 and 0.90 respectively for all statistical analyses to limit the
possibility of a Type II error. Data were manually screened for data entry errors including
missing or potentially erroneous data. Identified errors were corrected and frequencies
were run again prior to continuing further data analysis. Data were cleaned using the
process of running frequencies.
Data were analyzed for normality, outliers, and extreme scores that could
influence data interpretation and study outcomes. Descriptive statistics are provided for
the sample and displayed in tabular form. Data obtained from the CRIP, LOT-r, LET, and
PHQ 8 as well as data on the Framingham Risk Scores (FRS) and Heart Health Scores
(HHS) were analyzed for normal distribution by examining histograms, measures of
central tendency, skewness and kurtosis. The reliability of each instrument was examined
for internal consistency using Cronbach’s alpha.
Aim 1: Examine the Accuracy of Perceived Risk
The prevalence of both self-reported and physiological risk factors was examined
to offer a baseline view of risk factors present in the sample. Then, the relationship
between the prevalence of known risk factors and risk perception was explored using
nonparametric correlation analysis. Next, Pearson correlation analysis was used to
examine the relationship between the scores from both the FRS and HHS. Again, using
Pearson correlation analysis the relationship between calculated cardiovascular risk (FRS,
HHS) and risk perception (CRIP) was explored. Finally, a Chi-squared test was used to

85
determine whether there was a significant difference between FRS and HHS on risk
perception scores.
Aim 2: Examine the Relationships between Perceived Risk and
Sociodemographic/Psychological Variables
Relationships between sociodemographic variables (age, gender, level of
education, socioeconomic status, and income), psychological variables (LOT-r, LET, &
PHQ-8) and risk perception were examined using multiple regression analysis including
only those variables that were significantly correlated with risk perception. A backwards
stepwise method was employed since the model used to support this study is new and
untested and therefore will help to account for suppressor effects and reduce the risk of
making a Type II error (Field, 2009).
Institutional Review Board Approval
This study was approved by three independent review boards located at: Loyola
University, Purdue University (the researcher’s faculty appointment), and The
Community Healthcare System (the research setting). Institutional review boards were
not only designed to ensure participant safety, but also to evaluate the risks and benefits
as well as the overall strength of study design thus supporting ethical integrity, sound
study design, and feasibility. The study did not begin until approval was gained from all
three review boards.

CHAPTER FOUR
RESULTS
The overall purpose of this study was to examine the concept of risk perception in
cardiovascular disease using two specific aims: 1) To examine the accuracy of one’s
perceived risk for CVD; and 2) To examine the relationship between perceived risk and
key sociodemographic and psychological variables thought to influence risk perception.
This chapter provides the study results beginning with a discussion of the sample
characteristics and key variables. The results are reported according to the specific aims
of the study.
Sample
Participants were recruited at health screenings hosted by a multi-hospital system
in the Midwest. Over a 14 month period, a total of 296 individuals were pre-registered for
the screenings that the researcher attended, however, 71 (24%) did not show up. Of the
225 individuals present at the screenings, 63 (27%) did not meet one or more of the
inclusion criteria and 48 (21%) declined participation in the study. Therefore, 114
participants were enrolled in the study. However, while matching laboratory data with the
data collection booklets during the data entry process, one participant was excluded
because she came to two separate screenings but used different names in the consent
process. Thus a total of 113 participants who met enrollment criteria completed the
study.
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Sample Characteristics
The mean age of the sample was 58 years, 69% were female, 70% were White
Caucasian (non-Hispanic), and 58% were married. The sample was well-educated, with
42.5% having a 4 year college degree or higher; 28% having vocational training, an
Associate degree or some college; and 21% having a high school diploma. Most
participants were employed full or part-time (63%) with reported annual household
incomes almost evenly split between less than or greater than $50,000. The majority of
the participants (91.2%) reported having private insurance, with only 8.8% having no
health care coverage. Table 4 provides information on the overall sample characteristics.
Because the study took place at four sites in a multihospital system, it was
expected that the study sample would resemble the racial and ethnic composition of the
surrounding communities. Based on the most recent United States Census Bureau
estimates, the population in Lake County, Indiana was 490,093 and included: 62.8%
Caucasian, 25.5% African American, 14% Hispanic or Latino, 1.1% Asian, and 0.3%
American Indiana or Alaskan Eskimo (United States Census Bureau, 2009). The study
sample did closely resemble these statistics with the exception of the African American
representation. See Table 4.
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Table 4. Sample Characteristics
Characteristic
Mean (Standard Deviation)
Median (Range)
Gender
Male
Female
Race/Ethnicity
Hispanic/Latino Culture
Black/African American (Non-Hispanic)
Caucasian/White (Non-Hispanic)
Asian (Pacific Islander)
Other: American Indiana
Marital Status
Married
Living in a marriage-like relationship
Divorced or Separated
Widow/Widower
Never Married
Education
No formal Schooling
Less than 9th Grade
9th -12th Grade (no diploma)
High School Diploma or GED
Vocational School, Some College or Associate Degree
College Graduate degree or higher
Total Annual Household Income
Under $20,000
$20,000 to less than $35,000
$35,000 to less than $50,000
$50,000 to less than $75,000
$75,000 to less than $100,000
$100,000 to less than $150,000
$150,000 to less than $200,000
Employment Status
Full or Part-time
Retired
Homemaker
Other: Currently Unemployed
Health Insurance
Primary Coverage
No Primary Coverage
Secondary Coverage
Age

N
113

Percent
58.02 (+ 9.8)
57.80 (40-83)

35
78

31.0%
69.0%

14
15
80
3
1

12.4%
13.3%
70.8%
2.7%
0.9%

65
4
21
11
12

57.5%
3.5%
18.6%
9.7%
10.6%

2
2
5
24
32
48

1.8%
1.8%
4.5%
21.1%
28.3%
42.5%

12
21
28
20
16
10
6

10.6%
18.6%
24.8%
17.7%
14.2%
8.8%
5.3%

71
29
7
6

62.8%
25.7%
6.2%
5.3%

103
10
11

91.2%
8.7%
9.6%

Knowledge and Awareness Survey
As discussed earlier in chapter 3, questions taken from an American Heart
Association questionnaire were used to determine participants’ overall awareness,
knowledge and perceptions about heart disease that were expected to influence their risk
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perception. Prior studies used these questions to describe their sample of interest using
descriptive statistics. No “total” or “subscale” scores can be derived from these
questions. Therefore, the data is reported here as background information to provide
evidence of how educated and aware the sample was about heart disease and CVD risk.
Awareness and Perception about CVD
When asked to “select the greatest single health problem today from a predetermined list, participants responded as follows: heart disease/heart attack (34.5%),
obesity (25.7%), and cancer-in general (23%). Participants were also asked to identify the
leading cause of death for both men and women. Heart disease/heart attack was
overwhelmingly identified as the leading cause of death for men (77.9%) and women
(63.7%). See Table 5.
Table 5. Awareness and Perception about CVD
N (%)
Greatest health problem?
 Heart disease/ heart attack
 Obesity
 Cancer-in general
Leading cause of death for men?
 Heart disease/ heart attack
 Cancer- in general
 Lung cancer
Leading cause of death for women?
 Heart disease/ heart attack
 Cancer- in general
 Breast cancer

N=39 (34.5%)
N=29 (25.7%)
N=26 (23.0%)
N=88 (77.9%)
N=11 (9.7%)
N= 5 (4.4%)
N=72 (63.7%)
N=21 (18.6%)
N=15 (13.3%)

Knowledge of Heart Disease
When asked about how well informed participants were about heart disease, more
than half or 67 (59.3%) reported being moderately informed, followed by 32 (28.3%)
being well informed, and nine (8%) being very well informed. Despite only five (4.4%)
participants stating that they were not at all informed about heart disease, it is surprising

90
that 14.1% of the participants either strongly or somewhat agreed with the statement
“There is nothing you can do to prevent yourself from getting heart disease”. In addition,
19 participants (16.8%) strongly agreed and 45 (39.8%) somewhat agreed with the
statement “When you think about heart disease, you most often think of someone having
a heart attack and dying quickly”. See Table 6.
Table 6. Knowledge of Heart Disease
How informed are you about heart disease?
 Very well
 Well
 Moderately
 Not at all
There is nothing you can do to prevent yourself
from getting heart disease
 Strongly agree
 Somewhat agree
 Somewhat disagree
 Strongly disagree
When thinking of heart disease, you think of
someone having a heart attack and dying quickly?
 Strongly agree
 Somewhat agree
 Somewhat disagree
 Strongly disagree
 Do Not Know

N= 9 (8.0%)
N= 32 (28.3%)
N= 67 (59.3%)
N= 5 (4.4%)

N= 5 (4.4%)
N=11 (9.7%)
N=24 (21.2%)
N=73 (64.5%)

N=19 (16.8%)
N=45 (39.8%)
N=24 (21.2%)
N=22 (19.5%)
N= 2 (2.7%)

Perceptions of Heart Disease Risk Factors and Prevention
Knowledge related to risk factors and risk factor modification were asked using
two multiple response questions from the American Heart Association. The first question
was: “Based on what you know, what are the major causes of heart disease?” The
participants were asked to “select all that apply” from the following list: family history of
heart disease, being overweight, drinking alcohol, high cholesterol, low levels of
estrogen, exercise, stress, aging, diabetes, high blood pressure, high triglycerides,
menopause (in women), smoking, and racial heritage. The majority of participants
correctly identified high cholesterol (100%), family history (97.3%), being overweight
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(95.6%), stress (92.0%), high blood pressure (89.4%), and lack of exercise (83.2%) as
contributing to heart disease. However, many participants did not identify significant
factors such as: low levels of estrogen (86%), menopause (84.3%), drinking alcohol
(70.2%), racial heritage (64%), aging (60.5%), diabetes (53.5%), high triglycerides
(36.8%), and smoking (28.9%).
The second question asked participants to identify activities from a list that they
believed could prevent or reduce the risk of getting heart disease. The majority of the
participants identified losing weight (99.1%); getting physical exercise (96.5%); reducing
stress (95.6%); maintaining healthy cholesterol (93.8%); quitting smoking (92.9%);
maintaining blood pressure levels (91.2%); reducing dietary sodium (86.7%), dietary
cholesterol intake (80.5%), and dietary animal products (74.3%), as well as taking
aspirin regularly (60.2%) as strategies that prevent or reduce the risk of getting heart
disease. Conversely, only a minority of the sample identified taking special vitamins like
C, D, & E (28.1%) or multivitamins with folic acid (26.3%); aromatherapy (17.5%); and
hormone replacement therapy (11.5%) as being activities that could prevent or reduce the
risk of getting heart disease. See Table 7.
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Table 7.Perceptions of Heart Disease Risk Factors and Prevention
What are major causes of disease? (Check all that
apply).
 high cholesterol
 family history
 being overweight
 stress
 high blood pressure
 lack of exercise
What specific activity could reduce risk of getting
heart disease? (Check all that apply).
 losing weight
 getting more physical exercise
 reducing stress
 maintaining healthy cholesterol level
 quitting smoking
 maintaining a healthy blood pressure
 reducing dietary sodium intake
 reducing dietary cholesterol intake
 reducing dietary animal products
 taking aspirin regularly

N=113 (100%)
N=110 (97.3%)
N=108 (95.6%)
N=104 (92.0%)
N=101 (89.4%
N= 94 (83.2%)

N=112 (99.1%)
N=109 (96.5%)
N=108 (95.6%)
N=106 (93.8%)
N=105 (92.9%)
N=103 (91.2%)
N=98 (86.7%)
N=91 (80.5%)
N=84 (74.3%)
N=68 (60.2%)

Sources of Information about Heart Disease
Information regarding sources for heart disease awareness was asked through two
questions. An overwhelming majority (101 participants/88.6%) reported seeing, hearing,
or reading information about heart disease within the last 12 months. While the majority
of participants (101/88.6%) either strongly or somewhat agreed with the statement “You
are comfortable talking with your doctor about preventive and treatment options
regarding your health”, only 41 (36%) responded that any of their physicians ever
discussed heart disease with them when discussing their overall health.
Worry about Heart Disease
One question focused on whether people worry about getting twelve commonly
occurring conditions and diseases. The question was worded as: “How much do you
worry about getting each of the following health conditions?” The rating scale choices
included “worry a lot”, “worry a little”, “do not worry at all” and “don’t know”. The

93
health conditions were listed in the following order and included: cancer-in general, heart
disease or heart attack, AIDS, breast cancer, lung cancer, drug addiction/alcoholism,
violent crime, stroke, Alzheimer’s disease, diabetes, osteoporosis, and obesity.
Looking only at the “worry a lot” category, participants reported worrying the
most about heart disease or a heart attack (31%) followed by obesity (27.4%) and cancerin general (19.5%). When combining the categories of “worry a lot” and “worry a little”,
participants had more worry related to heart disease or a heart attack (83.2%) and cancerin general (83.2%), than for stroke (77.8%), obesity and diabetes (62.8%), breast cancer
(60.2%), and other non-cardiac conditions. See Table 8.
Table 8. Worry about Heart Disease
Worry “a lot” about Getting Specific Diseases
 Heart disease or heart attack
 Obesity
 Cancer in general
Combined: Worry “a lot” and Worry “a little”
about Specific Diseases
 Heart disease or heart attack
 Cancer in general
 Stroke
 Obesity
 Diabetes
 Breast cancer

N=35 (31.0%)
N=31 (27.4%)
N= 22 (19.5%)

N=94 (83.2%)
N=94 (83.2%)
N=88 (77.8%)
N=71 (62.8%)
N=71 (62.8%)
N= 68 (60.2%)

Note: Only responses with the highest frequencies are reported here.
Data Analysis for Study Instruments
Data obtained from the CRIP, LOT-r, LET, and PHQ 8 as well as data on the
Framingham Risk Scores (FRS) and Heart Health Scores (HHS) were analyzed for
normal distribution by examining histograms, measures of central tendency, skewness
and kurtosis. The reliability of each instrument was examined for internal consistency
using Cronbach’s alpha.
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Data for each of the instruments fell within the prescribed possible scoring range.
Overall, the data (n =113) were found to have a normal distribution based on frequency
distributions and analysis of histograms. However, it should be noted that the Heart
Health Score had a large standard deviation and standard error indicating a larger
variability than the scores calculated using the Framingham Risk Calculator. See Table 9.
Table 9. Distribution Statistics of the Sample for Study Instruments
Variable
n
Participant Range Mean
(Tool Range)

SD

Standard
Error

Risk Perception (CRIP)

113

16-91 (16-96)

50.2

13.7

1.29

Optimism (LOT-r)

113

3-24 (0-24)

16.45

4.55

0.43

Life Satisfaction (LET)

113

15-30 (6-30)

25.23

3.53

0.33

Depression (PHQ-8)

113

0-12 (0-24)

3.27

3.1

0.29

Framingham Risk Score (FRS)

113

<1-25% (0-25%)

7.12

6.88

0.44

Heart Health Score (HHS)

113

4-86 (0-100)

41.09

27.99

2.63

Variables were also assessed for the presence of both skewness and kurtosis. Both
skewness and kurtosis can be positive or negative. In a normal distribution, both
skewness and kurtosis should be zero. Skewness indicates asymmetry related to
distribution of the variable around the mean. Positive skewness occurs when the majority
of the distribution of the variable falls to the left of the mean and negative skewness
occurs when the majority of the distribution of the variable falls to the right of the mean
(Field, 2009). The CRIP, LOT-r, and LET were all negatively skewed, while the PHQ-8
was positively skewed. In addition, the skewness scores were close to zero indicating a
normal distribution. Kurtosis indicates the shape of the distribution where positive values
indicate a “pointy” distribution and negative values indicate a “flat” distribution (Field,
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2009). CRIP, LOT-r, and PHQ 8 had a positive kurtosis, while LET, HHS, and FRS
values had negative kurtosis. Similar to the skewness scores, the values were close to
zero indicating a normal distribution. See Table 10.
Table 10. Skewness and Kurtosis of the Sample on Study Instruments (N=113)
Variable
Risk Perception (CRIP)
Optimism (LOT-r)
Life Satisfaction (LET)
Depression (PHQ-8)
Framingham Risk Score (FRS)
Heart Health Score (HHS)

Skewness
0.65
-0.33
-0.55
1.14
0.89
0.09

Kurtosis
0.81
0.03
-0.16
0.84
-0.55
-1.69

Aim 1- To Examine the Accuracy of Perceived Risk
As background to reporting the results on risk perception, it is important to point
out that perception of risk for CHD cannot be formed without awareness and knowledge
of risk factors for CVD (as described earlier). If a person does not know what factors
contribute to the development of CVD (knowledge), then it would be difficult to become
aware of the potential risk to health. However, accurate perception of a risk is not
necessarily guaranteed, even if complete and thorough knowledge is given and awareness
is raised, because the individual must be able to process the information to perceive a
threat to well-being. This section begins with a report on the perceived risk as measured
by the Coronary Risk Individual Perception (CRIP) instrument, presentation of data
relating to the number and type of cardiac risk factors reported in this study, predicted
cardiac risk using both the Framingham Risk Score (FRS) and the Heart Health Score
(HHS) and the relationship of these variables to overall risk perception. These
instruments were discussed in chapter 3.
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Analysis of Risk Perception
Coronary Risk Individual Perception (CRIP) Scale. The construct of risk
perception was operationalized with the 16-item, Likert scale response, Coronary Risk
Individual Perception (CRIP) Scale. Five items, numbers 5, 7, 11, 12, and 14, were
reverse coded before tabulating the score. CRIP scoring is the simple sum of the item
scores and can range from 16-96. There are no subscales. Higher total scores on the CRIP
indicate higher levels of perceived risk for coronary heart disease. The mean score for the
sample was 50.2 (+ 13.7) with a range from 16-91. Table 11 displays mean and percent
scores for the individual items with the reverse coding adapted for clarity in reading
tables. Internal consistency was examined using Cronbach’s alpha and was 0.90. Barnhart
(2009) reported a mean score of 53.9 + 10.3 with an internal consistency of 0.76. (See
Table 11).
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Table 11. CRIP Item Response (N=113)
Mean
(SD)
1. I’m as healthy as anybody I
know.
2. Compared to others my age
and sex, I am at lower risk of a
stroke.
3. I am at low-risk of a heart
attack.

3.87
(1.28)
3.79
(1.33)

SD
n/%
1
9
8%
12
10.6%

D
n/%
2
33
29.2%
25
22.1%

SomD
n/%
3
31
27.4%
30
26.5%

SomA
n/%
4
16
14.2%
24
21.2%

A
n/%
5
23
20.4%
18
15.8%

SA
n/%
6
1
0.9%
4
3.5%

3.51
(1.35)

10
8.8%

17
15%

29
25.7%

29
25.7%

21
18.6%

7
6.2%

4. In general, my health is very
good.
5. Following a low-fat diet takes
too much effort.
6. Compared to a year ago, my
health is better now.
7. I worry that I might die from a
heart attack.
8. I’m at low risk of having a
stroke.
9. Compared to others my age
and sex, I am at lower risk of a
heart attack.
10. Compared to others my age
and sex, I am in good health.
11. I worry about having a heart
attack.
12. I worry that I might die from
a stroke.
13. I think my personal efforts
will help control my risk of
having a heart attack.
14. I worry more about having a
heart attack than a stroke.
15. I don’t mind the effort it
takes to exercise.
16. I have a low lifetime risk of a
heart attack.

4.37
(1.22)
2.92
(1.36)
3.62
(1.32)
2.94
(1.46)
3.42
(1.32)
3.59
(1.38)

18
15.9%
19
16.8%
10
8.8%
26
23%
9
8%
11
9.7%

42
37.2%
29
25.7%
16
14.2%
20
17.7%
15
13.3%
17
15%

30
26.5%
24
21.2%
39
34.5%
19
16.8%
25
22.1%
35
31%

14
12.4%
27
23.9%
27
23.9%
37
32.7%
38
33.6%
24
21.2%

5
4.4%
10
8.8%
12
10.6%
4
3.5%
18
15.9%
17
15%

4
3.5%
4
3.5%
9
8%
7
6.2%
8
7.1%
9
8%

4.16
(1.25)
3.16
(1.48)
3.14
(1.38)
4.62
(1.08)

14
12.4%
22
19.5%
16
14.2%
23
20.4%

34
30.1%
16
14.2%
19
16.8%
44
38.9%

41
36.3%
22
19.5%
36
31.9%
35
31%

9
8%
35
31%
25
22.1%
6
5.3%

11
9.7%
10
8.8%
9
8%
2
1.8%

4
3.5%
8
7.1%
8
7.1%
3
2.7%

3.44
(1.50)
4.15
(1.50)
3.24
(1.43)

18
15.9%
22
19.5%
9
8%

10
8.8%
36
31.9%
14
12.4%

28
24.8%
21
18.6%
26
23%

28
24.8%
13
11.5%
22
19.5%

19
16.8%
14
12.4%
31
27.4%

10
8.8%
7
6.2%
11
9.7%

Note: SD = Strongly Disagree, D = Disagree, SomD = Somewhat Disagree, SomA = Somewhat Agree, A = Agree, and
A = Strongly Agree

Prevalence of CVD Risk Factors. The risk factors identified in the study were a
combination of self-report and physiological measurements. Self-reported measures
included: gender/age (females >55 years, males >45 years); family history (mother, father
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or sibling) of cardiovascular disease (myocardial infarction, stent placement, coronary
bypass surgery or stroke); and personal history of hypertension, smoking, diabetes, and
physical activity. As shown in Table 12, the sample was relatively young (mean age 58
years) and healthy. The most common risk factor was positive family history reported
by 42% of the sample, while 12% reported they had diabetes, 12% had hypertension, and
9% reported being a current smoker. For levels of physical activity, 62% reported low
levels of activity performed per week.
Table 12. Self-Report Measures
Self-Report Measures:
Age *
Family History*
Hypertension*
Current Smoker*
Diabetes*
Physical Activity (min/week)*

Yes
No
Yes
No
Yes
No
Yes
No
< 100
100-150
> 150

n (%)
Mean (SD) 58.02(+9.81)
48(42.5%)
65(57.5%)
14 (12.4%)
99 (87.5%)
11(9.7%)
102(90.3%)
14(12.4%)
99(87.6%)
70(61.9%)
28(24.8%)
15(13.3%)

Physiological measurements obtained during the screening included: fasting lipids
(HDL-C, LDL-C and triglycerides), fasting blood glucose, body mass index (BMI), and
blood pressure.

Based on lab results, 80% of the sample had glucose levels at goal, 40%

has systolic blood pressures below 120 mm/Hg; 69% had LDL-C levels below 130
mg/dL; 76% had normal triglyceride levels, and 86% had good levels of HDL-C
(>40mg/dL). However, 74% of the sample was either overweight or obese (BMI> 25).
(See Table 13).
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Table 13. Self-Report Physiological Measurements
Physiological Data:
HDL-C (mg/dl)+
High density lipoprotein cholesterol

Mean (SD)
< 40
41-59
> 60

LDL-C (mg/dl)+
Low density lipoprotein cholesterol

Mean (SD)
< 100
100-129
130-159
160-189
> 190

Triglycerides (mg/dl)+

Mean (SD)
< 150
150-199
200-499
> 500

Fasting Blood Glucose (mg/dl)+

Mean (SD)
<100
100-125
>126

BMI (kg/m2)+
Body mass index

Mean (SD)
< 25
> 25
> 30

Systolic BP (mmHg)+

Mean(SD)
< 120
120-139
140-159
> 160

Diastolic BP (mmHg)+

BP Classification+, n (%)

Mean (SD)
< 80
80-89
90-99
> 100
Normal
Prehypertension
Hypertension, Stage 1
Hypertension, Stage 2

56.68(+16.86)
16(14.2%)
57(50.4%)
40(35.4%)
118.37(+33.40)
35(31.0%)
43(38.1%)
16(14.2%)
13(11.5%)
6 ( 5.3%)
121.71(+75.61)
86(76.1%)
16(14.2%)
10 (8.8%)
1(0.9%)
92.38(+15.16)
91(80.5%)
19(16.8%)
3(2.7%)
29.01(+5.8)
29(25.7%)
37(32.7%)
47(41.6%)
123.23(+17.16)
45(39.8%)
49(43.4%)
14(12.4%)
5(4.4%)
79.38(+11.72)
43(38.1%)
48(42.5%)
13(11.5%)
9(8.0%)
27(23.9%)
53(46.9%)
22(19.5%)
11(9.7%)

Note: “*” indicates a self-reported measure, “+” indicates a physiological measure

Because the results of the physiologic measurements were not known to
participants until after the screening results were later mailed to them, the risk factors
used in the initial interpretation of perception of risk for CVD were the self-reported risk
factors. Each of these approaches (using self-report vs. lab results) is prone to error.
Using hypertension as an example, participants may have hypertension but deny it when
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completing the study survey; or participants may self-report having hypertension, but
then have a normal blood pressure reading due to the therapeutic effect of their
medications; or participants may have an elevated blood pressure reading during the
screening, but interpret it as a false finding, believing they don’t have this problem. Since
this study is focused on “awareness” of one’s risk, only the self-reported risk factors were
used for overall prevalence. The number of risk factors ranged from zero to five with a
mean of 3.7 (SD +1.4) and a mode of two (n=42) accounting for 37.2 % of the sample.
See Table 14 Note: Age/gender were combined as one risk factor (females > 55 years,
males > 45 years).
Table 14. Prevalence of Self-Reported Risk Factors (N=113)
Number of Risk Factors

N (%)
0
3 (2.7)
1
19 (16.8)
2
42 (37.2)
3
29 (25.7)
4
13 (11.5)
5
7 (6.2)
Note: Age/gender was considered one (1) risk factor for this calculation

Risk Factor Prevalence and Risk Perception
The prevalence of risk factors was significantly correlated with higher levels of
risk perception as measured by the CRIP (r = .444, p< .01) indicating that those with
more risk factors had higher levels of risk perception and accounting for nearly 20% of
the variance in CRIP scores. In addition, multiple regression analysis was conducted to
see if these risk factors predict CRIP scores and is reported later.
Heart Health Score (HHS). This score was derived from a combination of
physiologic and self-report data from the Wellsource© screening tool. The Heart Health
Score is based on a scoring strategy using the NCEP III revised guidelines based on the
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severity and amount of the risk factors and reflects “current” heart health status. All
scores were examined for normal distribution as previously discussed. Scores ranged
from 4-86; the mean score was 41.09 with a standard deviation of 27.99 indicating
greater variability of scores. Lower HHS scores indicate an increased level of risk with
the presence of more risk factors.
Six participants (5.3%) were categorized as in “Excellent” health (score of 75100), 44 (38.9%) were categorized as “Doing Well” (score 50-74), 20 (17.7%) were
categorized as “Needs Improving” (score 25-49), and 43 (38.1%) were categorized as
“High Risk” (score 0-24).
Framingham Risk Score (FRS). The construct of calculated risk was
operationalized using the FRS. This tool is somewhat different from both the
“prevalence” of risk factors and the HHS scores, in that the FRS is projecting a 10-year
risk for CVD. It is based on current risk factor status using mostly physiological
measures which may have been unknown to participants until after the screening scores
were reported. Scores are based on variables including age, gender, total and HDL
cholesterol, smoking history, systolic blood pressure, and pharmacological treatment of
hypertension. Scores were computed using an online risk calculator found on the
National Heart Lung and Blood Institute website
(http://hp2010.nhlbihin.net/atpiii/calculator.asp). All scores were examined for normal
distribution as previously discussed. Calculation of the FRS is a two-step process. First,
total points for risk factors are determined using a gender specific tool. Point totals using
the ranges for men and women are reported in Table 14.
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The second step in the calculation is to convert the total points to the 10-year risk
score. Scores ranged from <1% -25%. Framingham scores were relatively low (X=7.12,
SD 6.88) classifying the majority of the participants in the “low risk” category.
Combining both genders, 76 (67.25%) were categorized as low risk (score less than
10%), 22 (19.46%) were categorized as intermediate risk (score 10-20%), and 15
(13.27%) were categorized as highest risk (score greater than 20% or having a coronary
risk equivalent). Fourteen of the 15 participants in this category had diabetes, a coronary
risk equivalent considered to be a risk score of >20%. These scores were included in the
subsequent statistical analyses. (See Table 15).
Table 15. Frequency of Participants Total Points and 10 year Risk Scores for Men and Women
using the Gender-Specific Framingham Risk Score Calculation (N=113)
Range of
Point Totals
for Men
<0
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17 or >
Known
Diabetes (risk
equivalent)

Men
Participant
total scores
(n= 35)
0
0
0
0
1
0
0
3
1
0
0
1
5
7
4
4
0
1
0
8

Men
Participant 10
yr risk score

Range of
Point Totals for
Women

<1%
1%
1%
1%
1%
1%
2%
2%
3%
4%
5%
6
8%
10%
12%
16%
20%
25%
>30%
> 20%

<9
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 or >
Known
Diabetes (risk
equivalent)

Women
Participant
total scores
(n= 78)
13
1
9
5
7
5
5
1
6
6
2
5
3
1
3
0
0
0

Women
participant 10
yr risk score

6

> 20%

<1%
1%
1%
1%
1%
2%
2%
3%
4%
5%
6%
8%
11%
14%
17%
22%
27%
>30%

Note: Light Gray= low risk, White= intermediate risk, and Dark Gray= high risk
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Comparison of HHS and FRS
A comparison of the HHS and FRS scores revealed a difference in categorization
of the participants (See Table 16). The HHS categorized more participants in the “high
risk” range and “intermediate risk”/”needs improving” range. Conversely, the FRS
categorized more participants in the “low risk range”. This disparity in classification of
risk may lie in the way the scores are calculated or in the fact that the HHS scores reflect
current risk while the FRS reflects a projected longer term risk.
Table 16. Comparison of HHS and Framingham Scores (N=113)
Category
“Excellent”
Low risk/ “Doing well”
Intermediate risk/ “Needs Improving”
High risk

FRS
N (%)
---76 (67.2%)
18 (15.9%)
19 (16.8%)

HHS
N (%)
6 (5.3%)
44 (38.9%)
20 (17.7%)
43 (38%)

Analysis of the Relationship between CRIP scores and HHS and FRS
Correlational analyses were used to examine the relationship between CRIP
scores and both the Heart Health and the Framingham Risk Scores. Results showed a
significant inverse relationship between HHS scores and CRIP scores (r = -.400, p < .01)
indicating that those with increased risk (using HHS) exhibited increased levels of
perceived risk and accounts for 16 % of the variance in the CRIP scores. There was a
non-significant relationship between perceived risk and “projected” cardiac risk using the
FRS (r = .034, p = .719) indicating that perceived risk is not related to a long-term
projected risk score.
A Chi-Square test was used to determine whether there was a significant
difference between FRS and HHS on risk perception scores. Using the mean score of 50
obtained from this sample on the CRIP as the cut off point for the two levels and the
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categorized FRS and HHS (Table 16), there was no significant difference between risk
perception (CRIP) and Framingham risk scores (FRS), χ2 (2) = 3.33, p = .189. However,
there was a significant difference between risk perception (CRIP) and heart health scores
(HHS), χ2 (2) = 14.61, p = .001. Persons with lower risk scores (using HHS) were more
likely to have lower risk perception scores (using CRIP) whereas persons with increased
risk (using HHS) were more likely to have higher risk perception scores (using CRIP).
The effect size was .36. See Figure 1. In order to meet the assumption of having a
minimum of an expected count of 5 in each category, the “excellent” and “doing well”
categories were combined for this analysis.
Figure 1. Chi Square Analysis of HHS with Risk Perception Scores

Summary of Aim One
Aim 1 was to examine the accuracy of one’s perceived risk for CVD. As stated
throughout this paper, perception of risk for CVD is based on awareness and knowledge
of risk factors for CVD. Overall the sample demonstrated at least a moderate knowledge-
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base of heart disease and the major risk factors associated with it. They recognized heart
disease as the leading cause of death for men and women, and could identify the key
prevention steps to reduce such risk. The majority had seen information on heart disease
in the prior 12 months. More than half the sample admitted to “worrying a little” about
getting heart disease or having a heart attack, with 30% admitting to “worrying a lot”. In
reviewing the self-reported risk factors, 42% had a positive family history, 12% had
diabetes, 12% had hypertension, but most were physically inactive. Physiological
measurements obtained during the screenings also revealed a relatively healthy group,
with the majority of participants at goal for glucose, LDL-C, HDL-C and triglyceride
levels. However, the majority of participants were found to be overweight or obese.
Overall, 80% had 2 or more self-reported risk factors, and 43% had three or more.
Perceived individual risk scores for CVD as measured by the CRIP fell into the
middle range. The participants did seem to accurately perceive their risk for CVD. The
prevalence of risk factors (self-reported) was significantly correlated with higher levels of
risk perception as measured by the CRIP (r=.44, p < .01).
HHS scores showed that more than 55% of the participants were categorized as
either “Needs Improving” or “High Risk”, indicating the presence of multiple risk
factors. HHS scores were also statistically correlated with risk perception (r=.40, p< .01).
In addition, Chi Square analysis showed a significant difference between increased risk
(using HHS) and increased risk perception scores (using CRIP). Framingham Risk
Scores, a measure of projected future cardiac risk, were not correlated with risk
perception.
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Aim 2-Examination of the Relationship between Perceived Risk and Key
Sociodemographic and Psychological Variables
Psychological variables such as optimism, optimistic bias, life satisfaction and
depressive symptoms may play an important role in how persons perceive risk. In
addition, other influences, such as demographic and personal variables may also be
helpful when examining risk perception. Therefore the second aim of this study was to
examine the relationship between perceived risk and key sociodemographic and
psychological variables thought to influence risk perception. This section begins with the
report on the sociodemographic variables.
Sociodemographic Variables
The sociodemographic variables of age, gender, socioeconomic status, level of
education, family history of CVD and knowledge of someone with CVD were discussed
earlier in this chapter as part of the sample characteristics. As previously shown in Table
4, the sample can be described as: middle-aged (M=58.02 + 9.8) with a range from 40 to
80 years; mostly female (69%); and well educated with approximately 70% having
vocational training, an associate degree or higher. Income was almost evenly split
between less than or greater than $50,000. Less than half of the sample reported knowing
a relative with CVD (42.5%) or friend with CVD (36.3%).
Psychological Variables
Psychological variables include: optimism (measured by the LOT-r), life
satisfaction (measured by the LET), and depressive symptoms (measured by the PHQ-8).
These instruments were discussed in detail in Chapter 3 and briefly here. See Table 17.
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Optimism: Life Orientation Test-revised (LOT-r). The construct of optimism
was operationalized using the life orientation test-revised (LOT-R). This is a Likert scalebased instrument consisting of ten questions. In the revised version, there are four filler
questions (#2, 5, 6, 8), three positively worded questions (#1, 4, 10), and 3 negatively
worded questions (#3, 7, 9). The coding of the LOT-R (with a total possible score of 24)
is positively correlated so that high values imply optimism, while low values imply
pessimism (Scheier, Carver, & Bridges). Reported Cronbach’s alpha for the LOT-R =
.90. All scores were examined for normal distribution as previously discussed. In this
study, internal consistency was 0.719; participant scores ranged from 3-24 with a mean of
16.45 (SD + 4.55) and a median of 16. See Table 18. Overall, participants in this study
were optimistic about their life.
Table 17. Descriptive Statistics for Psychological Variables
Mean (SD)

N
113

LOT-r
16.45 (4.55)

Range
Possible range
Range for Sample
Internal Consistency

113
113
113
113

3-24
0-24
3-24
.719

LET
25.23
(3.53)
15-30
6-30
15-30
.712

PHQ-8
3.2
(3.1)
0-12
0-27
0-12
.738
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Table 18. Item Response for Revised Life Orientation Test (LOTr) (N=113)
Mean
(SD)
Item Response Score
1. In uncertain time, I usually
expect the best.
2. It is easy for me to relax.*
3. If something can go wrong
for me, it will.
4. I’m always optimistic about
my future.
5. I enjoy my friends a lot.*
6. It’s important for me to keep
busy.*
7. I hardly ever expect things to
go my way.
8. I don’t get upset too easily.*
9. I rarely count on good things
to happen to me.
10. Overall, I expect more good
things happen to me than bad.

2.90
(1.06)
2.71
(1.21)
1.58
(1.19)
2.89
(1.02)
3.58
(0.63)
3.36
(0.83)
1.53
(1.22)
2.38
(1.08)
1.43
(1.32)
3.26
(0.99)

Strongly
Disagree
N (%)
0
3
2.7%
4
3.5%
28
24.8%
2
1.8%
0
0%
1
0.9%
32
28.3%
5
4.4%
39
34.5%
3
2.7%

Disagree

Neutral

Agree

N (%)
1
11
9.7%
19
16.8%
24
21.2
12
10.6%
0
0%
2
1.8%
21
18.6%
21
18.6%
23
20.4%
5
4.4%

N (%)
2
19
16.8%
10
8.8%
33
39.2%
17
15%
9
8%
14
12.4%
34
30.1%
28
24.8%
22
19.5%
11
9.7%

N (%)
3
41
36.3%
52
46%
23
20.4%
47
41.6%
29
25.7%
34
30.1%
20
17.7%
43
38.1%
21
18.6%
34
30.1%

Strongly
Agree
N (%)
4
39
34.5%
28
24.8%
5
4.4%
35
31%
75
66.4
62
54.9%
6
5.3%
16
14.2%
8
7.1%
60
53.1

Note: “*” denotes filler items that are not included for instrument scoring
.
Life Satisfaction: Life Engagement Test (LET). The construct of life
satisfaction was measured using the LET. The LET is a five point Likert Scale instrument
consisting of six questions (Appendix G). Three items (# 2, 4, and 6) are positively
framed, while the other three items (# 1, 3, and 5) are negatively framed. The higher the
summary score, the higher the reported purpose in life. Reported Cronbach’s alpha for
the LET in initial testing ranged from 0.72 to 0.80. All scores were examined for normal
distribution as previously discussed. For this sample internal consistency was 0.712;
scores ranged from 15-30, with a mean of 25.23 (SD + 3.53) and a median of 25.
Participants in this study reported increased levels of life satisfaction. See Table 19 for
individual item scores.
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Table 19. Item Response for Life Engagement Test (LET) (N=113)
Mean
(SD)
Item Response Score
1. There is not enough
purpose in my life.
2. To me, the things I do are
all worthwhile.
3. Most of what I do seems
trivial and unimportant to me.
4. I value my activities a lot.
5. I don’t care very much
about the things I do.
6. I have lots of reasons to
live.

1.8
(1.00)
3.91
(1.02)
1.92
(0.95)
4.12
(0.80)
1.59
(0.73)
4.47
(0.89)

Strongly
Disagree
N (%)
1

Disagree

Neutral

Agree

N (%)
2

N (%)
3

N (%)
4

56
49.6%
6
5.3%
41
36.3%
3
2.7%
59
52.2%
4
3.5%

36
31.9%
6
5.3%
52
46%
2
1.8%
44
38.9%
1
0.9%

9
8%
10
8.8%
11
9.7%
6
5.3%
8
7.1%
4
3.5%

11
9.7%
61
54%
6
5.3%
69
61.1%
1
0.9%
32
28.3%

Strongly
Agree
N (%)
5
1
0.9%
30
26.5%
3
2.7%
33
29.2%
1
0.9%
72
63.7%

Depression Screening: Patient Health Questionnaire-8 questions (PHQ-8).
The construct of depression was operationalized using the PHQ-8. The questions are
scored on a 0-3 Likert scale with 0 = not at all, 1 = several days, 2 = more than half the
days, and 3 = nearly every day. The scoring for the PHQ-8 is summative with a score
ranging from 0 –24. The PHQ-8 divides scores into 4 categories: no depression (scores <
5), mild depression (scores from 5-9), moderate depression (scores from 10-14), and
severe depression (scores > 20). However, a score of > 10 on the PHQ-8 is considered as
being positive for symptoms of depression. All scores were examined for normal
distribution as previously discussed. For this study internal consistency was 0.738; scores
ranged from 0-12 with a mean of 3.27 (SD + 3.1) and median of 2. Categories for this
tool are based on the following cut-points: <5 = no depression, 5-9 = mild depression, 1014 = moderate depression, 15-19 = moderately severe depression, and >20 = severe
depression. While the majority of the sample reported no symptoms of depression,
approximately one fifth reported having mild symptoms. None of the participants scored
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as being moderately severe or severe on the scale indicating that overall, the participants
in this study were not depressed. See Tables 20 and 21.
Table 20. Item Response for the Eight item Patient Health Questionnaire (PHQ-8) (N=113)
Over the last 2 weeks, how often have you been bothered by any of the following:
Mean
(SD)

Item Response Score
1. Little interest or pleasure in doing things.
2. Feeling down, depressed, or hopeless.
3. Trouble falling or staying asleep, or
sleeping too much.
4. Feeling tired or having little energy.
5. Poor appetite or over-eating.

6. Feeling bad about yourself – or that you
are a failure or have let yourself or your
family down.
7. Trouble concentrating on things, such as
reading the newspaper or watching TV.
8. Moving or speaking so slowly that other
people could have noticed? Or the
opposite- being so fidgety or restless that
you have been moving around a lot more
than usual.

Not At
All

Several
Days

Nearly
Every
day

2
46
14.2%
25
22.1%
33
29.2%

More
than
half the
days
N (%)
3
9
8%
4
3.5%
15
13.3%

N (%)

N (%)

1.32
(0.66)
1.29
(0.52)
1.74
(0.91)

1
87
77%
84
74.3%
58
51.3%

1.84
(0.83)
1.55
(0.83)

42
37.2%
72
63.7%

53
46.9%
22
19.5%

11
9.7%
16
14.2%

7
6.2%
3
2.7%

1.22
(0.47)

91
80.5%

19
16.8%

3
2.7%

0
0%

1.23
(0.55)
1.07
(0.33)

93
82.3%
103
91.2%

15
13.3%
8
7.1%

4
3.5%
1
0.9%

1
0.9%
0
0%

N (%)
4
1
0.9%
0
0%
7
6.2%

Table 21. Summary Scores on PHQ-8 for Study Sample (N=113)
Total Scores for
Sample

<5 =
No depression

5-9 =
Mild
depression

10-14 =
Moderate
depression

81
(71.7%)

24
(21.2%)

8
(7.1%)

15-19 =
Moderately
Severe
Depression
0
(0%)

20 or more =
Severe
depression
0
(0%)

Analysis of the Relationship between Predictor Variables and Risk Perception
Multiple regression analysis was performed to determine predictors of risk
perception (Field, 2009). Thus, this method was used to explore the relationship between
these potential predictor variables and the outcome variable of risk perception as
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measured by the CRIP. The nine assumptions associated with multiple regression
include: 1) variable types, 2) non-zero variance, 3) multicollinearity, 4) predictors which
are not correlated with external variables, 5) homoscedacticity, 6) independent errors,
normal distribution, 8) independence, and 9) linearity. These assumptions were met in
order to complete the regression analysis.
Spearman’s rho correlation analysis for ordinal level variables was used to
examine the relationship between the sociodemographic and psychological predictor
variables and outcome variable of risk perception. The results are shown in Table 22. The
reported significant correlations for each of these relationships were small (< .334) and
indicates that none of these variables are highly correlated with each other demonstrating
non-multicollinearity between the variables (Field, 2009). The variables that were
significantly related to risk perception (CRIP) were used to perform multiple regression
analysis in the next section.
Table 22. Correlation Matrix of Potential Covariate Predictor Variables and Outcomes Variable
2

3

4

5

6

7

8

9

10

1. Age
-.055 -.315** -.226* -.033 -.200* -.105 -.196* -.324** -.140
2. Gender
---.013
-.155
.005 -.107
.184
.184
-.076
-.021
3. Income
---.181 -.118
.005
.156
.214*
-.048
-.020
4. Education
---.106
.097
.187*
.069
-.008
-.009
5. Relative with
--.022
-.062
.027
-.022
-.170
CVD
6. Friend with CVD
---.172
-.145
.148
.194*
7. LOTr
--.256**
-.173
-.125
8. LET
---.188* -.201*
9. PHQ8
--.334**
10. CRIP
--Note: * = p< .05; ** = p< .01; CVD = cardiovascular disease; LOTr = Life Orientation Test-revised; LET
= Life Engagement Test; PHQ8 = Patient Health Questionnaire (eight question); CRIP = Coronary Risk,
Individual Perception

Multiple regression analysis was conducted to examine whether specific variables
contribute to the outcome variable of risk perception. A backwards stepwise method was
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employed to account for suppressor effects and reduce the risk of making a Type II error
(Field, 2009). The variables found to be significantly related to risk perception: knowing
a friend with CVD, life satisfaction, and depression were entered into the regression
model and produced two models. The final model removed life satisfaction as a
contributing predictor. Overall, the model explained 11.3% of variance which was found
to be significant, R2= .113, F(2, 110) = 7.03, p < .01. An examination of individual
predictors revealed that only depression (β = .278, p = .003) was a significant predictor.
Having a friend with CVD (β = .163, p = .07) was not found to be significant.
(Appendix M).
Summary of Aim Two
Aim Two was to examine the relationship between perceived risk and key
sociodemographic and psychological variables thought to influence risk perception. The
majority of the sample had high levels of optimism and life satisfaction and low levels of
depression. Correlation analysis between the risk perception and the potential variables
showed that there were three variable associated with risk perception: having a friend
with CVD, optimism, and depression. These variables were then used to perform multiple
regression analysis and revealed that depression was the single predictor in the model, but
accounted for only 11.3% of the variance. Further exploration is needed to identify
salient variables that may contribute to risk perception.

CHAPTER FIVE: DISCUSSION
Sample and Setting
Data collection took place at four separate sites within a single hospital system
located throughout the county. Compared to the most recent census bureau statistical
data noted in Chapter Four, the overall sample of 113 participants was representative of
the county except for an underrepresentation of African Americans. This was expected,
as most African Americans are established patients at other hospital systems that were
not part of the study and therefore were not recruited to attend the screenings. The sample
was younger and more educated than had been expected, and were employed either full
or part time. The majority had primary health insurance. One would expect that
participants at a community health screening would be more representative of individuals
without other sources for preventive health care. It is likely that those with more
education understand and value preventive healthcare and thus sought opportunities for
cardiovascular health screening. Even though the screening cost was reasonable
($30.00), it is possible that those unemployed were not able to attend due to financial
constraints. The screening coordinator did share that insurances with wellness benefits
cover the cost of the screening, while those without insurance or those without wellness
benefits paid “out of pocket” for the screening. An interesting comment made by many
participants was that their primary care providers encouraged them to obtain annual
laboratory work at such screenings since it was more economical than going through
traditional hospital or office based laboratory methods.
113
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Knowledge and Awareness Survey
It is reassuring that public health efforts to raise awareness of heart disease were
effective in this sample of low risk patients. Most of the sample rated themselves as
well-informed or moderately informed about heart disease. They correctly identified
traditional risk factors known to contribute to cardiovascular disease, such as high
cholesterol, family history, obesity, stress, hypertension, and lack of exercise. Similarly,
most of the sample reported that heart disease and heart attack were the leading cause of
death in both men and women. Overall they were actively engaged in efforts to prevent
heart disease. These findings indicate a high level of health literacy and may be related
to the large number of participants educated beyond the 12th grade level. Health literacy
is an important determinant of health, and has been defined as the way in which
individuals are able to obtain, process, understand and communicate about health-related
information needed to make informed health decisions (Berkman, Davis & McCormick,
2010). Most participants reported the source of their cardiovascular health information
came from reading magazines, brochures, and newspapers, from viewing television, and
from the internet. Regrettably, only slightly more than one third of the sample reported
that their physician ever initiated a discussion on this topic.
In response to “What is the greatest health concern today?” the sample reported
“heart disease or heart attacks” followed by “obesity, and “cancer-in general”. Curiously,
they reported these same categories in response to a question about personal worry
related to health conditions in their own lives. One would expect that most people have
some experience and exposure to both heart disease and cancer (e.g., knowing family or
friends with these conditions) which could increase personal worry/concern. However, it
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was surprising that obesity caused such a high amount of concern and worry. Perhaps
this is due to the more recent attention focused on obesity in America, with more
individuals finally taking notice of this health problem. Or it may be related to the high
number of participants in this sample who were overweight or obese. They may be
sensitive to the health issues that obesity poses.
While this sample exhibited health literacy in many areas, it is troubling that
smoking was not identified by the sample as a contributor to CVD. In fact, there were
curious inconsistencies noted in the smoking and triglycerides categories. Only 29% of
the participants thought that smoking contributed to CVD, yet almost every participant
(93%) answered that quitting smoking would prevent or reduce CVD. These findings are
contradictory. This inconsistency was also noted for triglycerides; however, this response
may be explained by a lack of knowledge that triglycerides are part of the cholesterol
profile.
Mosca et al. (2013) have partnered with the American Heart Association to
examine changes in awareness of heart disease, especially among women, with the most
recent telephone survey conducted in 2003. Since the present study had a majority of
women (69%), some comparisons to the Mosca study will be made here. Both samples
rated themselves as well or moderately informed about heart disease. Interestingly, both
studies reported comparable results related to sources of information about heart disease,
with 75-88% using the media for information, and only 36-38% having had a discussion
about heart disease with their health care provider. While both samples did identify the
major risk factors for heart disease, the Mosca study had much lower rates (7-36% of
major risk factors identified) versus this study with ranges of 82-100%. This difference
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may be related to interview methodologies. This study used a paper survey with the
various choices listed and asked participants to select “all that apply”; the Mosca study
asked participants to “spontaneously identify” the causes of heart disease. Only 31% of
Mosca’s women identified high cholesterol as a cause, with 1% reporting high
triglycerides as a risk factor. This study had 100% of participants identifying high
cholesterol, and 36.8% identifying high triglycerides. It is unclear whether the testing
format, the span of 10 years since the Mosca study, or the combination of men and
women participants resulted in the increased awareness of these risk factors. Both studies
reported similar data for those activities that could potentially reduce one’s risk of getting
heart disease. Finally, the Mosca study of only women found cancer rated as the greatest
health threat (41%) with breast cancer= 35% and cancer in general = 16% as compared to
this study where 34% selected heart disease/heart attack. Cancer in general was listed as
the third greatest health threat (23%). Another major difference was the reporting of
obesity was high in this study (26%) and only 6% in the Mosca study. These differences
could be related to the setting in which the current study was conducted—a
cardiovascular health screening event.
Discussion of Aim 1
Perception of risk requires some awareness and knowledge of risk factors for
CVD. As just discussed, this sample reported being well-to-moderately informed about
heart disease. In this section we will discuss the actual risk for CVD as related to the
number and type of cardiac risk factors reported, and the relationship to risk perception
using the CRIP tool. Further comparisons using both the Heart Health Score (HHS) and
the Framingham Risk Score (FRS) will also be discussed.
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Prevalence of CVD risk factors
The sample was knowledgeable about the causes/risk factors for heart disease in
general and was also able to self-report personal behaviors and family history known to
contribute to the development of heart disease. Overall this sample had a significant
number of major risk factors, as 37% had two and 43% had three or more. Thus they
would be expected to have some concerns about their “personal risk” for heart disease.
This number is comparable to Barnhart’s sample where 51.6% had three risk factors and
were deemed to be at high risk for CHD. It is interesting to note that 74% of the sample
was either overweight or obese (BMI> 25) and 62% reported low levels of activity
performed per week. The majority of the sample was either overweight or obese with
12.4% reported being diabetic. The number of persons with normal fasting glucose levels
and triglyceride levels was only 80% and 76% respectively, suggesting that more of the
sample either does not know that they are pre-diabetic or diabetic or chose not to report
being in either category.
Analysis of Risk Perception- CRIP
Risk perception was quantified using the Coronary Risk Individual Perception
(CRIP) tool. This relatively new instrument was easy to administer and score. During the
screenings there were no questions from the participants requiring clarification of items.
Scoring for the instrument is logical with higher scores relating to increased levels of risk
perception. Many of the item responses fell in “somewhat disagree” (3) and “somewhat
agree” (4) categories with calculated item means near 3.5. While many scores on
individual items did fall within this “middle range”, several CRIP items warrant further
discussion. For example, overall the sample somewhat agreed that their health was very
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good (item four; X= 4.37) and compared to others their health was good (item ten; X=
4.16). They felt that personal efforts will help to control the risk of having a heart attack
(item thirteen; X= 4.62) and they don’t worry about dying from a heart attack (item 7; X=
2.94). These responses indicate that this sample felt positive and relatively optimistic
about their health status and risk for a heart attack. While the participants were not made
aware of the results of the screening lab tests conducted during the health screening, the
results later did reveal that this was a relatively healthy group, with the majority at goal
for glucose, LDL-C, HDL-C, and triglyceride levels. Thus their self-perceptions of
overall “middle-level risk” were accurate.
The range of CRIP scores for this study was wide (16-91). A closer examination
of the score frequencies revealed that the same number (eight) of participants reported
scores on the low end (scores of 16, 24, 26, 29) as on the high end (scores of 69, 72, 75,
83, 91). Thus there were no clear outliers. It is interesting that the mean score on the
CRIP for the sample (X= 50.2; SD 13.7) was similar the one reported by Barnhart and
colleagues (X=53.9; SD 10.3) (2009). Although there were some differences between the
two samples with respect to race/ethnicity and education levels (Barnhart sample was
predominantly Hispanic, uneducated, and poor), one striking similarity was gender; both
studies were approximately 70% female.
The data supports the accuracy of the sample’s risk perception. As in Barnhart’s
study (2009), a simple index for risk of CHD was derived by summing the participant’s
number of major risk factors. The prevalence of these self-reported risk factors was
significantly correlated with higher levels of risk perception as measured by the CRIP.
Again—this is not a surprise, in that this sample was well-educated, employed, and had
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primary health insurance. And they were seeking out a health screening opportunity—
that may have contributed to their accurate risk perception.
The small sample size limited the number of analyses that could be made with
the CRIP. In Barnhart’s larger study, risk perception was correlated with individual risk
factors such as diabetes, hypertension, and obesity. Barnhart (2009) used the median
score (55) to divide her group into high vs low levels of risk perception. The same type of
analysis was not conducted in this study since it did not match the aims of this study.
However, additional analysis such as this will be planned for in a secondary analysis of
data.
Heart Health Score (HHS). The HHS score reflects risk at the current time and
is based on both self-reported and physiological measures. The summative scoring
method is somewhat counterintuitive from other methods, with low scores indicating
higher levels of risk and high scores indicating lower levels of risk. The HHS not only
presents a numeric risk, but also a semantic descriptor. Since a large number of the
sample had multiple risk factors, it was not surprising to see 17% of the sample
categorized as “Needs Improving” and 38% categorized as “High Risk”. Thus it was
logical that the HHS scores were statistically correlated with risk perception on the CRIP
since they were both measuring similar risk factors. Likewise the Chi square analysis
showed a significant relationship between increased risk and increased risk perception
scores.
Wellsource© has been a recognized leader in corporate health screenings for more
than 30 years and it used extensively in cardiac rehabilitation programs as a tracking and
motivational strategy. However, it was not possible to make any comparisons of data
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from this study with other studies, as Wellsource© has not published any results as
pooled data related to the HHS tool. The HHS tool has been primarily used to collect
data from individuals and provide individualized risk scores. It is possible that due to
health privacy laws and/or contracts with data sources (hospitals, corporations),
Wellsource© has chosen not to make pooled data available.
Despite these limitations, the HHS tool seems useful in assessing patient’s health
risk. There is evidence that providing individuals with “current risk” data is more
advantageous than using “future risk”. Waldron, Weijden, Ludt, Gaalacher and Elwyn
(2011) conducted a systematic review of risk communication strategies and found that
when methods used long-term projected risk (10 years or longer as in the FRS) persons
had less accurate risk perception and intention to change behaviors. Thus using this
method may help those with increased levels of risk to perceive risk more accurately and
plan health behaviors accordingly. Moreover, it may be vital in providing motivation for
positive health behaviors.
Framingham Risk Scores (FRS). This scoring method also uses physiological
measures and current risk factors; but unlike the HHS, it calculates a “projected” 10 year
risk for CVD and cardiac events. In addition, the scores are gender-based, with women’s
cardiovascular risk typically underestimated due to the older age in which they exhibit
coronary heart disease (Marma & Lloyd-Jones, 2009). Thus with the predominantly
female sample, it is not surprising that so few participants were categorized as moderate
to high risk based on a mean age of 58. Likewise, the FRS also underestimates risk in
younger men, and this sample had an overall mean age of 58 years. It was not really
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surprising that the FRS was not correlated with current risk perception (CRIP) since that
is not the aim of the tool.
Analysis of the Relationship between CRIP Scores and HHS and FRS. When
comparing HHS and FRS, it was interesting to find that the FRS revealed more of the
sample to be at “low risk” while the HHS found the majority of the sample to be in the
“high risk” and “intermediate risk” range. Given this fact, it was not surprising that only
one of the methods (HHS) was correlated with risk perception. The explanation is likely
due to the differences in the methods used for calculating current and projected risk, but
may also be due to the large proportion of women in the study.
Discussion of Aim 2
The second aim of this study was to examine the relationship between perceived
risk and key sociodemographic and psychological variables thought to influence risk
perception. This section will begin with a discussion on the psychological variables of
optimism, life satisfaction and depression.
Optimism: Life Orientation Test- revised (LOT-r)
Previous research has shown that optimism is linked to multiple positive
outcomes including mental and physical well-being (Carver, Scheier, & Sergerstom,
2010), less incidence of depression (Chang, Wang, Li, & Liu, 2011; Giltay, Zitman, &
Kromhout, 2006; Manjilovich, 2005; Tindle et al. 2012), decreased risk of CVD (Boehm,
Peterson, Kivimaki, & Kubzansky, 2011; Kubzansky & Thurston, 2007), and even
decreased mortality (Giltay, Geleijnse, Zitman, Hoekstra, & Schouten, 2004).
The LOT-r was administered and scored without any changes to either the
contents or format. Participants completed the instrument easily without questions on
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how to complete the instrument or on specific items. Scoring of the instrument was
equally uneventful. The sample indicated that overall they were moderately optimistic
about life (mean of 16.45, SD + 4.55). Glazer, Emery, Frid, and Banyasz (2002) found
that when controlling for age, higher levels of optimism and lower levels of both
depression and neuroticism had a positive effect on adherence to exercise. However, this
all male sample with known cardiac disease was much smaller with only 46 participants,
thus limiting the generalizability of the results. Lastly, Matthews et al. (2004) used a
prospective design to follow 209 middle- aged women for a total of 13.5 years and found
that women with the highest reported levels of optimism showed less progression of
CVD as measured by carotid intimal thickening. While both of these studies used the
original LOT instrument, it should be noted that Scheier, Carver, & Bridges (1994)
conducted an evaluation between the two instruments and found a correlation of 0.95 and
stated there was no reason to believe that the revised scale would produce any
appreciable differences in study findings. In addition, the authors of the LOT and LOT-r
have never assigned cut points for either scale. Instead, they ascribe to the interpretation
that higher scores represent increased levels of optimism whereas lower scores represent
decreased levels of optimism. So it is therefore prudent to examine overall study results
and the variables that correlate with optimism rather than focusing solely on mean study
scores for any population.
It was surprising that in this study there was no significant inverse correlation
between optimism and depression as has been noted in the literature (Chang, Wang, Li, &
Liu, 2011; Giltay, Zitman, & Kromhout, 2006; Manjilovich, 2005; Tindle et al. 2012).
However, there were differences between these studies and the current study that may
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explain this result. For example, Giltay and colleagues (2006) did examine the same
constructs but used different instruments to do so. Giltay used a 15 year prospective study
of 464 men between 64 and 84 years, but used the dispositional optimism scale and the
Zung depression scale. In addition, these authors disclosed that a major limitation for this
study was that the dispositional optimism scale has not been validated against the LOT or
LOT-r. So while these researchers did study the same constructs/variables, they used
different scales with clear limitations to measurement validity.
Chang et al., (2011) studied 314 staff nurses in Taiwan exploring depression rates
among nurses and reported that 52.5% of the nurses reported mild to moderate depressive
symptoms. Chang and colleagues used the Center for Epidemiologic Studies-Depression
Scale (CES-D), the LOT-r, and General Self-Efficacy Scare (GSES) and found
depression to be significantly correlated to optimism (r= -.50, p<0.01) and self-efficacy
(r= -.43, p<0.01). Multiple regression analysis showed that optimism (β -.38, p< 0.01)
and self-efficacy (β -.44, p< 0.01) protected against depression. Since the CES-D and
LOT-r instruments have been used widely and have acceptable psychometric properties,
it is more likely results from the current study differ due to the population being studied,
the smaller sample size, or the fact that the sample reported much lower levels of
depression than the nurses in Taiwan, not to mention the possibility of cultural
differences in these variables.
Life Satisfaction: Life Engagement Test (LET)
The concept of life satisfaction is similar to optimism in that both can be
categorized as a positive emotion. Work completed in this area has shown that there is a
positive relationship between emotional vitality and lack of CVD (Cohen & Pressman,
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2006; Kubzansky & Thurston, 2007, Matthews, Owens, Lee & Kuller, 2006). However,
research specifically related to the use of the life engagement test related to
cardiovascular disease is somewhat limited (Matthews, Owens, Lee & Kuller, 2006).
This might be explained by the fact that this is a relatively new tool.
The LET was administered and scored without any changes to either the contents or
format. Participants found this brief instrument easy to complete. Scoring of the
instrument was equally uneventful. The sample indicated high levels of life satisfaction
(25.23, SD + 3.53). These scores were similar to two recent cohort studies. Pearson et al.
(2012) studied a cohort of 545 community dwelling adults ages 55-94 to establish
normative data on a non-clinical sample of adults. The survey was administered twice, 12
months apart as part of a larger study on relocation to a residential retirement facility.
These researchers found that scores on the LET at both time intervals were high (mean=
24.86, SD + 4.16; mean= 23.43, + 3.79). In addition, the scores for the designated age
groups (55-64 years, 65-74 years, and >75 years) were all similar.
Both increased age and income were significantly correlated with increased levels
of life satisfaction. This may be explained by the fact that as a person ages there is more
certainty, stability and satisfaction in life. This may be especially true in this welleducated, largely employed and relatively healthy group of individuals.
Optimism was significantly correlated with life satisfaction. This finding is
supported by the work done in the construction and validation of the LET instrument (r=
.39, p < 0.01) (Scheier et al., 2006). It is logical that if someone is optimistic that they
would also tend be satisfied with life. Since that time, this is the only study that has
compared these two constructs at the same time. In the two studies by Matthews,
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discussed in previous parts of this paper and also below, these constructs were studied
separately with respect to the surrogate markers for CVD. Matthews et al. (2006)
followed 155 healthy women enrolled in the Healthy Women Study and found that those
with the highest scores on the LET had lower aortic calcium scores (p= 01). This is a
follow up to their 2004 study that reported that women with the highest LOT-r scores had
the least progression of CVD as measured by carotid intimal thickening. Thus optimism
and life satisfaction seem to correlate with less evidence of CAD and may be acting as
mediating variables.
Patient Health Questionnaire-8 questions (PHQ-8)
Depression is well recognized as a risk factor for CVD and a consequence of
CVD (Baune, Stuart, Gilmour, Wersching, Arolt, & Berger, 2012; Borowicz et al., 2002;
Grenon, Hiramoto, Smoderen, Vittinghoff, Whooley & Cohen, 2012). Previous research
has shown that major depressive disorder (MDD) occurs in as many as 20% of those with
CVD (Thombs et al., 2004). Furthermore, even in the absence of MDD, the presence of
depressive symptoms has been shown to increase the incidence of CVD (Thombs et al.,
2004) as well as morbidity and mortality associated with CVD (Stewart, et al., 2003).
The PHQ-8 was administered and scored without any changes to either the
contents or format. Participants were able to complete this instrument without
explanation or assistance. The instrument was scored without any difficulty. The sample
generally reported low to mild levels of depression (mean= 3.27 + 3.1) with more than
70% of the sample reporting no depression and 21% reporting mild depression. The mean
score is comparable to a study by Pressler et al. (2010) who reported a score of: mean=
2.6 (+ 3.0) in 63 healthy persons, mean= 3.7 (+ 3.4) in 102 medical patients, and
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mean=6.5 (+ 5.5) in 249 patients with heart failure. So, while this sample fell between the
healthy person and medical patients, keep in mind that scores below 5 indicate no
depression. In addition to this comparison, it is noteworthy to highlight that scores on the
PHQ-8 in this study were significantly correlated with risk perception. This will be
further discussed in the following section.
Analysis of the Relationship between Predictor Variables and Risk Perception
It should be noted that although there were some significant correlations, none of
them were particularly strong. In fact, they were all < .334. Despite this fact, there are
several interesting relationships to discuss. For example, women had higher life
satisfaction scores (r = -.196, p< .05). As previously discussed above those with increased
levels of optimism also had higher life satisfaction scores (r = .256, p<.01). In addition,
one unexpected finding was that optimism was not correlated with depression since this
finding has been reported in previous studies (Giltay, Zitman, & Kromhout, 2006; Chang,
Wang, Li, and Liu, 2010; Weber, Puskar, & Ren, 2010). Scheier et al. (2006) in an article
describing the LET instrument stated “It is our belief that purpose in life represents an
important but overlooked psychosocial predictor of health outcomes” (p. 291). In the
construction of this instrument, Scheier and colleagues found that depression and LET
scores were inversely correlated to depression in six separate samples including
undergraduate students, community based samples of women, female osteoarthritis
patients and their spouses, and women with various stages of breast cancer. However, the
CES-D was used to operationalize the construct of depression.
One of the most surprising findings in this study was that although there is much
written about optimism and positive health outcomes, it was not found to correlate with
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risk perception as expected. Those with higher levels of education reported higher levels
of optimism (r= .187, p<.05) which has also been noted in previous studies (Robb,
Simon, & Wardle, 2009). In addition, those reporting higher levels of optimism also
report lower depression levels (r = - .188, p<.05). This finding not only appears as a
logical conclusion, but it supported by empirical findings as discussed in the above
sections on optimism and depression.
An expected finding was that increased levels of reported depression was also
correlated with increased risk perception (r = .334, p< .01). Since depression has been
established as a risk factor for CVD (Baune, Stuart, Gilmour, Wersching, Arolt, &
Berger, 2012; Grenon, Hiramoto, Smoderen, Vittinghoff, Whooley & Cohen, 2012), it is
important that persons suffering from depressive symptoms recognize that they are at risk
for CVD.
One of the objectives of this study was to examine the variables thought to
contribute to the formation of risk. Unfortunately, results from this study did not meet
this objective. Multiple regression analysis showed that depression was the only variable
found to be a significant predictor of risk perception (β = .278, p = .003). Perhaps the
absence of optimism is not as powerful as the presence of depressive symptoms. Perhaps
there are other sociodemographic and psychological variables that will provide more
insight into this puzzle. So, while this study did not shed light in this area, it provides this
researcher, as well as others the opportunity to examine other variables in the quest for a
more viable model attempting to explain the perception of risk. Clearly, more research
needs to be conducted in this area to understand how risk perception is formed.
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Summary of Aim 2
The majority of the sample exhibited moderate levels of optimism, high levels of
life satisfaction, and low levels of depression. In addition, while there were some
interesting relationships found between variables, the relationships were weak at best.
Lastly, depression was the sole predictor in the model examining factors that contributing
to the formation of risk perception, accounting for a modest 11.3% of the model. Clearly,
further exploration is needed to identify other variables that may contribute to the
formation of risk perception.
Study Limitations
The limitations of any study are based on study design as well as threats to internal
and external validity. A descriptive correlational design cannot establish causation
between variables. Despite this fact, this study was able to highlight some of the
relationships that exist between risk perception and several demographic and
psychological variables. Thus, this study provides a solid foundation on which to build
further studies in the area of risk perception. In addition, since this was a cohort study,
data for risk perception was only collected at the time of screening prior to participants
truly knowing their calculated risk. Therefore, this study cannot establish if or how much
CRIP scores would change if individuals knew the results of their tests. Furthermore, the
use of survey instruments limits the researcher’s ability to gain insight into how persons
express their personal risk.
There were threats to both internal and external validity identified in this study. The
use of a convenience sample contributes to participant selection bias and limits
generalizability of the results. Self-selection bias was also evident in the study. Although

129
many of the participants were referred by their primary care providers for screening as a
cost-effective way to have lab work completed, the vast majority of the sample was selfselected and therefore, may represent “the walking well” or those who are at least more
conscious about their health status. In addition, the sample was primarily women
potentially contributing to gender bias in the results. The current sample was also welleducated, presently employed either part- or full-time, had health insurance and the
majority were “at goal” for major risk factors, except for weight and physical activity.
Exclusion criteria also limit applicability of the results. This study excluded those with
established heart disease or diagnosed depression as well as those younger than 40 years.
Therefore, results from the study can only be applied to similar groups.
While the instruments selected for this study had acceptable reported reliability and
validity statistics, the information was self-reported which also introduces bias and limits
generalizability of the findings. The CRIP and the LET are relatively new instruments.
While both exhibit strong validity, there are fewer published studies and thus less
normative data available for comparison. The same can be said for the HHS scores as
Wellsource© has not published normative data, despite using current guidelines
established for risk factor data as well as collecting health screening data for so many
years.
Summary of Major Findings
Study participants had a mean age of 58 years, 69% were female, 70% were
White Caucasian (non-Hispanic), and were predominantly married, well-educated,
employed, and had private insurance. Overall the sample recognized heart disease as the
leading cause of death for men and women and could identify the key prevention steps to
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reduce personal risk. While physiological measurements obtained during the screenings
also revealed a relatively healthy group, with the majority of participants at goal for
glucose, LDL-C, HDL-C and triglyceride levels, the majority of participants were either
overweight or obese and reported being physically inactive. Overall, 80% had 2 or more
self-reported risk factors, and 43% had three or more.
The prevalence of risk factors (self-reported) was significantly correlated with
higher levels of risk perception as measured by the CRIP (r=.44, p < .01). HHS scores
showed that more than 55% of the participants were categorized as either “Needs
Improving” or “High Risk”, indicating the presence of multiple risk factors. HHS scores
were also statistically correlated with risk perception (r=.40, p < .01). In addition, chi
square analysis showed a significant relationship between increased risk (using HHS) and
increased risk perception scores (using CRIP). Framingham Risk Scores, a measure of
projected future cardiac risk, were not correlated with current risk perception.
The majority of the sample had increased levels of optimism and life satisfaction
and low levels of depression. While three variables (having a friend with CVD,
optimism, and depression) were correlated with risk perception, depression was found to
be the single predictor of risk perception when entered into multiple regression analysis
(β = .278, p = .003).
Implications for Providers
The sample in this study was knowledgeable about both CVD and risk factors. In
addition, those with risk factors had an accurate perception of their risk. This knowledge
may be related to their familiarity and participation in other wellness programs within
this community hospital system. Hospital administrators should be encouraged to

131
continue with these successful primary prevention efforts. Perhaps ‘having a friend with
CVD” also helped raise their awareness. It may be useful for health care providers to
explore such personal experiences with their patients as this may enhance attention to risk
factor reduction.
The majority of the sample was “at goal” for most of the major risk factors with the
exception of weight and physical activity. Those with lipid disorders and hypertension
may be motivated to stay at goal, are compliant with their prescribed treatment regimes,
and use the community screening opportunities to “check their status”. This provides an
excellent opportunity for health care providers to reinforce participants’ efforts as a way
to foster ongoing compliance.
It is possible that the group is “a work in progress” with regards to their weight and
that while they are still categorized as either overweight or obese, they are attempting to
address this risk factor. The lack of physical activity is of concern, however, since the
majority of the group is either employed full or part-time and may not have made
physical activity a priority, especially if they are otherwise doing well. While persons
may understand that there are consequences to their health behaviors it is possible that
they are not inclined to exercise or lose weight since subclinical atherosclerosis goes
unnoticed. Thus health care providers should continue to use every opportunity,
especially as related to community screenings, to counsel participants on effective
methods for promoting physical activity and weight loss.
More than 80% of the sample reported having seen, read, or heard about CVD in
the last 12 months, while only 35% reported having had a discussion about CVD in the
last year. It is noteworthy that the general public is gaining more awareness and
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knowledge about heart disease and the effects it has on health and well-being. However,
this sample has shown that they are getting most of the information from mass media and
not from health care providers. In addition, they have shown that they worry about heart
disease, especially those that have risk factors. While it is positive that media campaigns
are increasing health literacy, it is also very important that health care providers be more
proactive about discussing heart disease with their patients.

They need to take

advantage of teachable moments when persons present with risk factors, and take every
opportunity when reviewing results from routine lab work or from health screening
events to reinforce that patients can reduce their risk of heart disease.
Depression needs to become more of a focus during screening events. Depression
was the single predictor of risk perception in this study. In recent years, research has
highlighted the relationship between depression and CVD and the need for depression
screening. However, screening is only recommended for those who have been diagnosed
with CVD (Lichtman et al., 2008) and not for the general public. It makes sense that if we
believe that there is a relationship between depression and CVD, that screening should be
part of primary prevention efforts and treated as a modifiable risk factor.
Lastly, there was a disparity in how the sample viewed smoking. While greater than
90% identified “quitting smoking” as an activity they believed could prevent or reduce
the risk of getting heart disease, only 28% of the sample identified it as a major cause or
risk factor for heart disease. This was a surprise since this sample was well educated. It is
therefore very important for providers to make sure that discussions about smoking be
included in health teaching.

133
Implications for Future Research
In order to learn more about risk perception in cardiovascular disease, more studies
need to examine risk perception and must be designed so that the construct of risk
perception is being measured. As demonstrated in the review of the literature, the term
risk perception is often used when risk knowledge is being measured. Moreover, other
instruments such as the LOT and LOT-r have been used to operationalize risk perception
rather than the optimism and life satisfaction that they were designed to measure.
Furthermore, studies should use validated instruments such as the CRIP to measure risk
perception as opposed to one or two question items. Lastly, qualitative studies in this area
may help to elucidate how persons think about their risk for CVD, thus providing more
insight into formation of risk. Since depression was the only variable that contributed to
risk perception in this study, it is important to plan further studies to examine different
variables and constructs that may contribute to the formation of risk which may lead to
more effective education measures and tailored interventions.
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Effect
Size
(g)
0.36
0.32
0.75
1.20
0.51
0.31
0.28
0.98
1.65
0.29
5.08
2.07
0.35
0.34
0.57
0.51
0.59
0.49
0.53
0.35
0.15

Author

Type of Risk

Number of Items/Type of
Measure

Cole et al.
Donovan &
Tucker
Facione et al.

Comparative

1/Verbal

Comparative

1/Verbal or Numerical

Comparative

1/Verbal

Comparative

1/Verbal

McDonald et al.
Bowen et al.
Clark et al.
Daly et al.

Comparative
Subjective
Subjective
Subjective

1/Verbal
1/Numerical
1/Numerical
1/Numerical

Dolan et al.
Erlich et al.
Jacobsen et al.
Lindberg &
Wellisch

Subjective
Subjective
Subjective

1/Numerical
1/Numerical
1/Numerical

Subjective

1/Numerical

Subjective

1/Numerical

Metcalf & Narod

Subjective

1/Numerical

0.88
1.73

Schwartz et al.
Stefanek et al.

Subjective

1/Numerical

0.48

Subjective

1/Numerical

0.71

Subjective

1/Verbal

Subjective
Subjective

1/Verbal
1/Verbal

Subjective

1/Verbal

Subjective

1/Verbal

Subjective

1/Verbal

Subjective
Comparative &

2/Verbal
2/Numerical

Hughes et al.

Meiser et al.

Audrain et al.
Culver et al.
Diefenbach et al.
Foxall et al.
Lipkus et al.

Vernon et al.

Absetz et al.
Andrykowski et

0.31
0.69
0.27
0.40
0.13
0.12
0.52
0.75
1.25
0.41
1.23
0.12
0.12
0.25
0.24
0.05
0.48
0.59

Variable
Mammography
Race/culture
Family History
Optimistic bias
Mammography
Age
Education
Worry
Optimistic bias
Family history
Optimistic bias
Optimistic Bias
Race/culture
Optimistic bias
Family History
Genetic Testing
Mammography
Breast self-exam
Optimistic bias
Age
Education
Optimistic bias
Prophylactic
Mastectomy
Mammography
Prophylactic
Mastectomy
Education
Race/culture
Mammography
Genetic testing
Mammography
Race/culture
Mammography
Family History
Worry
Perceived control
Family History
Race/culture
Age
Breast symptom
Mammography
Breast self-exam
Optimistic bias
Mammography

136
al.
McCaul et al.

Subjective
Comparative &
Subjective

Aiken et al.

Comparative &
Subjective

2/Verbal

Brain et al.

Comparative &
Subjective

2/Verbal

Clemow et al.

Comparative &
Subjective
Comparative &
Subjective
Comparative &
Subjective
Comparative &
Subjective
Comparative &
Subjective

0.47

Worry

0.45
0.56
0.45
0.79
0.26
0.69
0.19
0.07

Optimistic bias
Family history
Breast symptoms
Breast self exam
Age
Worry
Breast self exam
Mammography

2/Verbal

0.13

Mammography

2/Verbal

0.35

Optimistic bias

2/Verbal

2.17

Optimistic bias

2/Numerical & Verbal

0.79

Family history

2/Numerical & Verbal

0.72

Family history

Subjective

3/Verbal

0.91

Family history

Comparative &
Subjective

3/Numerical & Verbal

Drossaert et al.

Comparative &
Subjective

4/Numerical & Verbal

0.74
0.67
0.38
0.18
0.32
0.18

Optimistic bias
Worry
Family history
Age
Anxiety
Mammography

Lipkus et al.

Comparative &
Subjective

4/Numerical & Verbal

0.22

Breast symptoms

Hatcher et al.

Comparative &
Subjective

5/Numerical & Verbal

0.25

Prophylactic
mastectomy

Comparative &
Subjective

8/Quantitative &
probability estimates

0.57

Education

Evans et al.
Foster et al.
Mouchawar et al.
Polednak et al.
Finney & Iannotti
et al.
Lipkus et al.

2/Numerical

Black et al.
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Please be as honest and accurate as you can throughout. Try not to let your response to
one statement influence your responses to other statements. There are no "correct" or
"incorrect" answers. Answer according to your own feelings, rather than how you think
"most people" would answer.
A = I agree a lot
B = I agree a little
C = I neither agree nor disagree
D = I disagree a little
E = I disagree a lot
1. In uncertain times, I usually expect the best.
2. It's easy for me to relax.
3. If something can go wrong for me, it will.
4. I'm always optimistic about my future.
5. I enjoy my friends a lot.
6. It's important for me to keep busy.
7. I hardly ever expect things to go my way.
8. I don't get upset too easily.
9. I rarely count on good things happening to me.
10. Overall, I expect more good things to happen to me than bad.
-----------------------------------------------------------------------Note:
Items 2, 5, 6, and 8 are fillers. Responses to "scored" items are to be coded so that high
values imply optimism. Researchers who are interested in testing the potential difference
between affirmation of optimism and disaffirmation of pessimism should compute
separate subtotals of the relevant items.
http://www.psy.miami.edu/faculty/ccarver/sclLOT-R.html
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Study Title: Risk Perception in Heart Disease
Principal Investigator: Michelle Block
Phone Number: 219-989-2847
INTRODUCTION:
You are being asked to take part in a research study because you are over 40 years of age and
want to take part in a Coronary Health Appraisal at one of the hospitals in The Community
Healthcare System. You will not be able to participate if you have been diagnosed with
depression, have experienced a heart attack or a heart intervention, such as an angioplasty, stent,
or heart bypass surgery.
This study is being conducted by Michelle Block, Assistant Professor of Nursing, Purdue
University Calumet, as part of a PhD dissertation at Loyola University Chicago.
Please read this form carefully and ask any questions you have before deciding if you want to
take part in this study.
WHY IS THIS STUDY BEING DONE?
The purpose of this study is to look at how people perceive (look at) their risk for getting heart
disease and to see if people can tell their own risk for developing heart disease.
HOW MANY PEOPLE WILL TAKE PART IN THE STUDY?
Approximately 120 people (participants) will be a part of this study. The participants will have all
taken part in a Coronary Health Risk Appraisal screening at one of the hospitals in the
Community Healthcare System.
WHAT IS INVOLVED IN THE STUDY?
If you agree to be in this study, you will be asked to:
• Complete a booklet of questions about your personal background, risk perception for
cardiovascular disease, your outlook on life, your satisfaction about life issues, and how
you have felt over the last few weeks.
• Give permission to share the answers you provided for the Coronary Health Appraisal
and the results of the laboratory work that is part of the appraisal. This information will
be used to calculate your chance of getting heart disease.

Version/Date:

Page 144 of 3
Initials ________
Revised:

ORIGINAL-Medical Record

COPY-Patient

COPY-Principal Investigator

CONSENTS

145
HOW LONG WILL I BE IN THE STUDY?
Participation in this study will take approximately 20 minutes and is voluntary. If you do not want
to be in this study, you do not have to participate. Even if you agree to participate in this study,
you do not have to answer any question if it makes you uncomfortable or you may withdraw at
any time without penalty.
WHAT ARE THE RISKS OF THE STUDY?
There is minimal risk in participating in this study. It is possible that thinking about your health
and risk for heart disease will be upsetting.
ARE THERE ANY BENEFITS TO TAKING PART IN THE STUDY?
You may benefit from participating in this research because it may help you to understand your
views and risk for developing heart disease. Your participation in this study may help health
professionals understand the factors that play a part in the formation of risk perception. This
understanding may lead to new approaches in the prevention of heart disease.
CONFIDENTIALITY:
If you are eligible to take part in this study, you will be assigned a participant number. The data
collected will be identified using this number and your name will be removed from all collected
information. Records will be stored in a locked cabinet and the computer used to enter data will
be password secured. Study information including your original records, research/clinic/hospital
records may be reviewed by representatives of the Institutional Review Board (CHS CIRB), the
board charged with the protection of human subjects involved in research at The Community
Healthcare System.
Because these parties may inspect your study records, absolute confidentiality cannot be
guaranteed. Results from this study may be published for scientific purposes, but your name will
remain confidential. Study records will be kept confidential to the extent provided by law. The
name of individual subjects or other identifying information will not be used in any publications
of this study.
WHAT ARE THE COSTS?

There is no cost to participate in this study. In appreciation for taking time to participate and once
the study question booklet is completed, you will be given a $10.00 Meijer gift card.
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FINANCIAL DISCLOSURE
Michelle Block, the principal investigator, will not be receiving funds from outside companies to
defray the costs to conduct this research study.
WHAT ARE MY RIGHTS AS A PARTICIPANT?
For questions about your rights as a research participant, contact the Community Healthcare
System Central Institutional Review Board (which is a group of people who review the research
to protect your rights) or the Human Protections Administrator (the patient advocate) at 219-8366862.
Taking part in this study is voluntary. You may choose not to take part or may leave the study at
any time. Leaving the study will not result in any penalty or loss of benefits to which you are
entitled. No matter what decision you make, leaving the study will not affect your medical care.
WHOM DO I CALL IF I HAVE QUESTIONS OR PROBLEMS?
WHERE CAN I GET MORE INFORMATION?
You will get a copy of this form. You may also request a copy of the protocol (full study plan).
Michelle Block is available to answer any questions you have. She can be reached at 219-9892847.
Patient Statement
My signature on this consent form means the following:
• The study has been fully explained to me and all of my questions have been answered.
• I understand that I may ask questions at any time during the study by contacting
Michelle Block at 219-989-2847.
• I understand what will be required of me to participate in this study.
• I understand that I may withdraw my consent at any time during the study.
• I agree to take part in this study.

___________________________________
Participant’s Signature

________________________
Date

___________________________________
Participant’s Printed Name
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Statement of Investigator Obtaining Informed Consent
I have fully explained the details of this study to my patient. In my judgment, there was sufficient
access to information, including risks and benefits, to make an informed consent.
___________________________________
Investigator Signature

________________________
Date

___________________________________
Investigator Printed Name

Page 3
Rev. 1/26/2010
Initials _______
MR Y

COPY-Participant

COPY-Principal Investigator

APPENDIX F
COMMUNITY HOSPITAL HIPAA FORM

148

149
HIPAA Authorization
The Community Hospital and its representatives are committed to protecting your health
information. Protected health information is information in any form relating to the
health care provided to you. By signing this form, you agree to permit the Community
Hospital staff, and any member of the Community Hospital clinical research team to
retrieve, use and disclose your health care information.
Your health care information will include any records that are retrieved and created
during the extent of the research study in which you are participating in. The documents
include but are not limited to:
•
•
•

past, present and future health information in your medical records relevant to the
research
medical records from my primary care and consulting physicians relating to
participation in research
data created and recorded specifically for the research study

The Community Hospital, its staff, the sponsors of the research and their contractors will
do everything possible to ensure the privacy of your personal health information. Any
publications related to the research study will not contain any identifying information
about you.
Participant Authorization Statement:
To the extent permitted by the applicable laws and regulations, I give my permission to
release my personal health information to the following entities:
•
•
•
•
•
•
•

Michelle Block, the principal investigator and her dissertation committee at
Loyola University Chicago
Members, consultants and staff of the Community Healthcare System Central
Institutional Review Board
Members, consultants and staff of Loyola University Chicago Institutional
Review Board
Community Hospital billing and quality assurance personnel
Joint Commission of Accreditation of Health Care Organizations
The Food and Drug Administration
Other regulatory authorities to whom this research may be submitted

The researchers, Community Hospital staff, sponsor and other agents, may use and share
my personal health information among themselves in order to conduct the
research. My health information may be used for verification of research procedures and
data.

150
I understand that once my personal health information is disclosed to a third party,
federal privacy laws may no longer protect the information from further disclosure.
I know that I do not have to sign this authorization; however, I have been told that if I do
not sign this authorization, I may not be able to participate in this research study.
I may revoke my authorization at any time and for whatever reason. I will be asked to
revoke this authorization in writing to the Principal investigator at:
Michelle Block, MS, RN
c/o Meg Gulanick, PhD, RN
Loyola University Medical Center
Bldg 105 Room 2840
2160 South First Avenue
Maywood, Illinois 60153
I realize that if I revoke this authorization, I will not be allowed to continue participation
in the research study. I also am aware that the researchers and sponsor and their agents
may continue to use and disclose any information that they have retrieved prior to my
revoking the authorization.
I understand that while the research is being conducted, I will not be able to access or see
my health information that was collected or created for the purposes of this research
study because it may affect the integrity of the research. I, however, may access this
information after the completion of the research study.
Who to contact if you have any questions about confidentiality:
If at any time before, during and after the study, you have questions about the use or
disclosure of your study related information, you may contact the following person (s):
Community Healthcare System
Privacy Officer
219-836-3620
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I give my authorization with no ending date, however, I understand that I may revoke this
authorization at any time.
I will be given a copy of this authorization.

Participant Signature

Date and Time

Printed Name of Participant

Legally Authorized Representative
(If applicable)

Printed Name of Legally Authorized Representative

Relationship of Authorized Representative to Participant

Date and Time
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Tell me how much you disagree or agree with each statement.

1. I’m as healthy as anybody I
know.
2. Compared to others my age
and sex, I am at lower risk of a
stroke.
3. I am at low-risk of a heart
attack.
4. In general, my health is
very good.
5. Following a low-fat diet
takes too much effort.
6. Compared to a year ago, my
health is better now.
7. I worry that I might die
from a heart attack.
8. I’m at low risk of having a
stroke.
9. Compared to others my age
and sex, I am at lower risk of a
heart attack.
10. Compared to others my
age and sex, I am in good
health.
11. I worry about having a
heart attack.
12. I worry that I might die
from a stroke.
13. I think my personal efforts
will help control my risk of
having a heart attack.
14. I worry more about having
a heart attack than a stroke.
15. I don’t mind the effort it
takes to exercise.
16. I have a low lifetime risk
of a heart attack.

Strongly
Disagree
n/%

Disagree
n/%

Somewhat
Disagree
n/%

Somewhat
Agree
n/%

Agree
n/%

Strongly
Agree
n/%

1

2

3

4

5

6
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Thank you for taking part in this research study: Risk Perception in Heart Disease.

The question booklet is made up of 6 sections. Feel free to ask the researcher if you have any
questions while you are filling out the booklet.

Let’s get started……….

Please place an “X” next to the answer(s) you choose
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1. What do you think is the one greatest problem today? (Choose only one)
 AIDS
 Alzheimer’s
 Breast Cancer
 Cancer (general)
 Diabetes
 Drug Addiction/Alcoholism

 Heart Disease/Heart Attach
 Lung Cancer
 Obesity
 Osteoporosis
 Smoking
 Stroke

2. As far as you know, what is the leading cause of death for men? (Choose only one)
 AIDS
 Alzheimer’s
 Breast Cancer
 Cancer (general)
 Diabetes
 Drug Addiction/Alcoholism

 Heart Disease/Heart Attack
 Lung Cancer
 Obesity
 Osteoporosis
 Smoking
 Stroke

3. As far as you know, what is the leading cause of death for women? (Choose only one)
 AIDS
 Alzheimer’s
 Breast Cancer
 Cancer (general)
 Diabetes
 Drug Addiction/Alcoholism

 Heart Disease/Heart Attack
 Lung Cancer
 Obesity
 Osteoporosis
 Smoking
 Stroke

4. Using the following scale, how much do you worry about getting each of the
following health conditions?

Cancer (in general)
Heart Disease or
Heart Attack
AIDS
Breast Cancer
Lung Cancer
Drug
Addiction/Alcoholism
Violent Crime
Stroke
Alzheimer’s Disease
Diabetes
Osteoporosis
Obesity

Worry a Lot

Worry a Little

(1)

(2)

Do not worry
At all
(3)

Don’t know
(4)
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5. Have you seen, heard, or read information about heart disease within the past 12
months?
 Yes
 No
 Don’t Know

6. If you answered YES to Question 5, where did you see, hear, or read this
information? (Choose ALL that apply)
 In a magazine
 On the radio
 In a book
 On TV
 Information in a brochure
 Library
 In a newspaper
 On the internet
 Provided by physician, nurse, or other healthcare provider
 From a friend or relative
 Other: Please be specific:

7. Have any of your doctors ever discussed heart disease with you when discussing
your health?
 YES
 NO

8. How informed are you about heart disease?
Very well informed
 Well informed
 Moderately informed
Not at all informed
 Don't know

For questions 9, 10 and 11, indicate if you: “strongly agree”, “somewhat agree”,
“somewhat disagree”, “strongly disagree”, or “don’t know”
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Strongly
Agree
1

Somewhat
Agree
2

Somewhat
Disagree
3

Strongly
Disagree
4

9. When you think about heart
disease, you most often think of
someone having a heart attack and
dying quickly.
10. There is nothing you can do to
prevent yourself from getting heart
disease.
11. You are comfortable talking
with your doctor about preventive
and treatment options regarding
your health.

12. Based on what you know, what are the major causes of heart disease? (Choose all
that apply)
 A family history of heart disease
 Aging
 Being overweight
 Diabetes
 Drinking alcohol
 High Blood Pressure
 High Cholesterol
 High Triglycerides
 Low levels of estrogen
 Menopause
 Not exercising
 Smoking
 Stress
 Your racial Heritage
 Don’t know
 Other, please specify: _____________________________________________
__________________________________________________________________
__________________________________________________________________
13. Which of the following activities do you believe can prevent or reduce the risk of
getting heart disease? (Choose all that apply)
 Quitting smoking
 Getting physical exercise
 Losing weight
 Reducing dietary cholesterol intake
 Reducing stress
 Maintaining a healthy blood pressure
 Taking multivitamins with folic
 Reducing dietary sodium or sale
Acid
 Maintaining a healthy cholesterol level
 Taking aspirin regularly (daily)
 Taking special vitamins like C, D & E
 Taking hormone replacement therapy (for women)
 Reducing animal products in your diet such as meats, whole milk, butter and
Cream
 Aromatherapy (the practice of using natural plant oils, such as lavender or
Lemongrass, for psychological and physical well-being)

For questions 14 through 25, indicate if you: “strongly agree”, “somewhat agree”,
“somewhat disagree”, “strongly disagree”, or “not sure”.

Don’t
Know
5
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Strongly
Agree
1

Somewhat
Agree
2

Somewhat
Disagree
3

Strongly
Disagree
4

Not
Sure
5

14. You know how much exercise
you need to prevent heart disease.
15. You know what type of diet is
best to protect your heart.
16. You know how to stop
smoking.
17. You know how to control your
cholesterol.
18. You know how to control your
blood pressure.
19. You know how to control your
weight.
20. You know if fish oils are
recommended to prevent heart
disease.
21. You know if you should take
aspirin routinely
22. You know if you should take
antioxidant vitamin supplements to
prevent heart disease.
23. You know how depression
affects your heart.
24. You know how stress affects
your heart.
25. You know how to take the
medications prescribed to you.

YOU HAVE COMPLETED THE FIRST SECTION……..Please continue to the next section.
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Section 2: This section asks a few questions about you. This information is for research purposes
only. No one will be able to identify you based on your answers to these questions. Everything
is kept confidential.
1. What is your age? __________
2. Gender:

 Male

 Female

3. What is your occupation: ___________________________________________
4. Are you currently?
 Employed (full or part-time)
 Retired
 Homemaker, raising children, caretaker for others
 Disabled, unable to work
 Other, please specify: ________________________________________
5. How worried are you about your employment status at this time?
 Worried a lot  Worried a little

 Not worried at all

6. What is your health insurance now? (Mark all that apply)
 Pre-paid private insurance (for example: HMO, HIP, etc.)
 Other private insurance (for example: Blue Cross, Aetna, etc.)
 Medicaid or Public Assistance (for example: DPA or ADCC)
 Medicare
 No Insurance
 Other, Please specify: ________________________________________
7. What is your marital status?
 Married
 Divorced or separated
 Never married

 Living in a marriage-like relationship
 Widow/Widower
 Other, please specify:_________________

8. How would you describe your race/ethnicity? Are you?
 Hispanic/Latino culture
 Black/African American (non-Hispanic)
 Causasian/White (non-Hispanic)
 Asian/Pacific Islander
 Other, please specify: ___________________________________
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9. What is the highest grade or year in school that you completed? If less than a high
school diploma, fill in two digits to indicate the last grade completed (e.g. 07 for
7th grade).
 ___grade
 High school diploma or GED
 No formal schooling
 Vocational school, some college or Associate degree
 College graduate/degree or higher
 Other, please specify: ______________________________________
10. Household Income: What is the total annual income before taxes of everyone
living in the household?
 Under $20,000 a year
 $20,000 to less than $35,000
 $35,000 to less than $50,000
 $50,000 to less than $75,000
 $75,000 to less than $100,000
 $100,000 to less than $150,000
 $150,000 to less than $200,000
 $200,000 or more a year
11. Activity Level: Aerobic exercise means activities that are continued for a least
20 minutes at a time and that raise the heart rate. This can include things like
jogging, walking, riding a bike, and raking leaves. How much aerobic activity are
you doing?
 Less that 20-30 minutes at a time, 5 days per week or less
(Less than 150 minutes per week)
 20-30 minutes of aerobic activity, 5 days per week
(150 minutes per week)
 More than 20-30 minutes, 5 or more days per week or more
(Greater than 150 minutes per week)
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Personal and Family History: Do you or any of your blood relatives have any of
of the following:
Has a healthcare provider (or doctor) said that YOU have or ever
had…
12. High Blood Pressure

_____Yes

_____No

13. Diabetes (sugar) in your blood

_____Yes

_____No

14. Congestive Heart Failure

_____Yes

_____No

15. Angina (Chest pain with exertion)

_____Yes

_____No

16. Stroke

_____Yes

_____No

17. Trans-ischemic attacks (TIAs or mini-strokes)

_____Yes

_____No

18. Peripheral Artery Disease (Blockage in the legs)

_____Yes

_____No

19. Depression

_____Yes

_____No

Now we want to know about your family history…..
Have any of the following relatives had…
20. High Blood Pressure… if YES, then who?

21. Diabetes (sugar in the blood)…if YES, then who?

22. Congestive heart failure…if YES, then who?

23: Angina (chest paid with exertion)…if YES, then who?

24. Stroke…if YES, then who?

25. Transischemic attacks (TIAs or ministrokes)…
if YES, then who?
26. Peripheral Artery Disease (Blockage in the legs)…if
YES, then who?
27. Depression…if YES, then who?

Who?
_____Father
_____Mother
_____Brother or Sister
_____Father
_____Mother
_____Brother or Sister
_____Father
_____Mother
_____Brother or Sister
_____Father
_____Mother
_____Brother or Sister
_____Father
_____Mother
_____Brother or Sister
_____Father
_____Mother
_____Brother or Sister
_____Father
_____Mother
_____Brother or Sister
_____Father
_____Mother
_____Brother or Sister
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Health Treatment:
28. How often do you see your primary care provider?
 Every year

 When I have a health concern

29. How often do you visit your dentist?
 Every 6 months

 Every year

 When I have a dental problem

30. Do you receive a flu vaccine every year?
 Always

 Sometimes

31. Do you know anyone living with heart disease?
If so, are they a:
 friend
 relative

 Never
 Yes

 No

32. When was the last time you had the following checked:
Blood Pressure__________________________
Lipid Levels (Cholesterol)_________________
Blood Sugar____________________________

 I am unsure
 I am unsure
 I am unsure

Please list any additional health problems.
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
Current Medications. Please list all medications you are currently taking.
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________

YOU are Doing Great!

APPENDIX I
LIFE ENGAGEMENT TEST
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Instructions and Items:
Please answer the following questions about yourself by indicating the extent of your
agreement using the following scale:

(1) = strongly disagree
(2) = disagree
(3) = neutral
(4) = agree
(5) = strongly agree
Be as honest as you can throughout, and try not to let your response to one question
influence your response to other questions. There are no right or wrong answers.

1. There is not enough purpose in my life.
2. To me, the things I do are all worthwhile.
3. Most of what I do seems trivial and unimportant to me.
4. I value my activities a lot.
5. I don’t care very much about the things I do.
6. I have lots of reasons for living.

Scoring:
1. Reverse code items 1, 3 and 5 prior to scoring.
2. Sum six items together to obtain an overall score

Citation: Scheier, M. E, Wrosch, C., Baum, A, Cohen, S., Martire, L M., Matthews,
K. A., Schulz, R., & Zdaniuk, B. (2006). The Life Engagement Test: Assessing
purpose in life. Joumal ojBehavioral Medicine, 29, 29!-298.

APPENDIX J
PATIENT HEALTH QUESTIONNAIRE-8
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Item Response Score

Not At
All

Several
Days

Nearly
Every day

N (%)
2

More than
half the
days
N (%)
3

N (%)
1

Not at
all
difficult

Somewhat
difficult

Very
Difficult

Extremely
difficult

N (%)
4

1. Little interest or pleasure in doing
things.
2. Feeling down, depressed, or
hopeless.
3. Trouble falling or staying asleep, or
sleeping too much.
4. Feeling tired or having little energy.
5. Poor appetite or over-eating.
6. Feeling bad about yourself – or that
you are a failure or have let yourself
or your family down.
7. Trouble concentrating on things,
such as reading the newspaper or
watching TV.
8. Moving or speaking so slowly that
other people could have noticed? Or
the opposite- being so fidgety or
restless that you have been moving
around a lot more than usual.

If you checked off ANY problems,
how difficult have these problems
made it for you to do your work, take
care of things at home or get along
with other people?

APPENDIX K
FRAMINGHAM RISK SCORE
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APPENDIX L
WELLSOURCE©
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APPENDIX M
MULTIPLE REGRESSION ANALYSIS STATISTICS
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c

Regression Analysis Model Summary
Model
R
R
Adjusted Std. Error of
Change Statistics
DurbinSquare
R
the Estimate R Square
F
df1
df2
Sig. F Watson
Square
Change
Change
Change
a
1
.359
.129
.105
13.01435
.129
5.388
3 109
.002
b
2
.337
.113
.097
13.07210
-.016
1.978
1 109
.162
2.036
a. Predictors: (Constant), PHQtotal, FriendCVD, LETtotal
b. Predictors: (Constant), PHQtotal, FriendCVD
c. Dependent Variable: CRIPTOT_RC
a

ANOVA
df

Model
Sum of Squares
Mean Square
F
Regression
2737.786
3
912.595
5.388
1 Residual
18461.683
109
169.373
Total
21199.469
112
Regression
2402.688
2
1201.344
7.030
2 Residual
18796.781
110
170.880
Total
21199.469
112
a. Dependent Variable: CRIPTOT_RC b. Predictors: (Constant), PHQtotal, FriendCVD, LETtotal
c. Predictors: (Constant), PHQtotal, FriendCVD

Sig.
b

.002

c

.001

a

Model

Unstandardized
Coefficients
B
Std. Error

Standardized
Coefficients
Beta

t

Sig.

Coefficients
95.0% Confidence Interval for
B
Lower Bound Upper Bound

Correlations
Zero-order

Partial

Collinearity Statistics
Part

Tolerance

VIF

(Constant)

52.540

10.849

4.843

.000

31.038

74.041

1 FriendCVD
LETtotal
PHQtotal
(Constant)
2 FriendCVD

4.111
-.505
1.132
38.609

2.588
.359
.406
4.448

.144
-.129
.255

1.589
-1.407
2.792
8.680

.115
.162
.006
.000

-1.018
-1.217
.328
29.795

9.239
.207
1.936
47.424

.192
-.202
.295

.150
-.134
.258

.142
-.126
.250

.968
.943
.957

1.033
1.060
1.045

4.632
2.572
PHQtotal
1.234
.401
a. Dependent Variable: CRIPTOT_RC

.163
.278

1.801
3.078

.074
.003

-.466
.439

9.730
2.028

.192
.295

.169
.282

.162
.276

.989
.989

1.012
1.012
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